Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ABI3BP	"DKFZP586L2024, NESHBP, TARSH"	ENSG00000154175	"ABI family member 3 binding protein"	Q7Z7G0	3	100749156-100993515	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 57.7;Fibroblasts: 213.8;Leydig cells: 97.3;Muller glia cells: 93.7;Skeletal myocytes: 106.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 10.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 437.3;hTEC/SVTERT24-B: 840.8;hTERT-HME1: 818.4;TIME: 1405.8;U-2197: 311.0"	"Group enriched"	"Detected in many"	4	"amygdala: 4.2;basal ganglia: 15.9;cerebellum: 5.5;cerebral cortex: 13.9;olfactory bulb: 12.0"	"Low region specificity"	"Detected in all"			HPA044127	Uncertain				"Secreted in other tissues"	NA	NA		550000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"			"HPA044127: AB_2678823"	"unprognostic (4.32e-2)"	"unprognostic (3.32e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.20e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.46e-2)"	"prognostic favorable (6.14e-4)"	"unprognostic (2.27e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.07e-3)"	41.3	9.9	3.9	57.0	9.7	0.2	23.1	0.8	4.1	56.4	3.1	36.5	5.3	49.5	10.7	35.1	46.9	97.9	44.5	3.8	26.6	12.2	7.8	68.7	25.9	3.4	5.7	89.4	12.7	3.0	4.7	51.9	7.3	8.7	56.2	57.5	13.7	12.3	6.7	14.0	15.4	72.0	5.6	12.4	25.5	17.1	6.7	7.9	25.0	41.1	39.9	96.7	23.7	9.1	1.3	0.3	0.1	0.0	37.0	437.3	0.4	91.9	90.2	171.4	79.9	0.0	0.2	0.9	0.4	25.0	0.3	0.0	0.1	1.0	278.2	0.8	0.7	2.4	1.6	0.0	23.7	0.5	0.1	26.6	1.0	840.8	818.4	3.6	267.1	0.0	0.5	1.3	158.6	0.0	0.5	0.3	0.1	0.0	87.5	0.4	0.7	0.7	54.0	0.2	0.2	0.6	0.0	0.6	0.1	0.8	0.3	0.1	1405.8	37.7	0.4	311.0	19.7	1.0	0.0	0.0	43.7	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	9.7	0.8	4.1	3.8	26.6	3.4	5.7	7.3	5.6	6.7	9.1	9.1	57.7	5.5	26.1	0.3	15.9	1.5	5.8	4.6	1.2	0.6	1.8	9.7	10.0	39.8	18.4	2.1	0.5	0.1	0.4	0.0	0.3	10.3	1.2	30.6	23.6	1.2	0.0	2.6	0.4	0.4	213.8	9.7	2.4	3.8	0.2	16.1	0.1	0.9	0.0	47.0	0.8	0.0	0.6	23.2	8.8	97.3	1.8	19.6	7.5	0.0	93.7	0.0	1.5	3.3	1.9	5.4	27.8	0.7	1.5	0.2	9.0	5.0	3.7	0.0	106.8	17.5	0.1	0.3	3.9	19.9	0.7	2.1	3.6	1.0	2.9
ANK2	"CFAP87, FAP87, LQT4"	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818032-113384221	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 165.7;retina: 191.2;skeletal muscle: 171.7;tongue: 150.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1101.2;Bipolar cells: 376.6;Cone photoreceptor cells: 479.6;Excitatory neurons: 1282.0;Horizontal cells: 1431.8;Inhibitory neurons: 1060.7;Oligodendrocyte precursor cells: 497.1;Oligodendrocytes: 1351.0;Rod photoreceptor cells: 484.4"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 32.2;RH-30: 49.6;SH-SY5Y: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893"	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	31.0	13.6	94.9	11.2	109.0	0.1	18.3	63.1	165.7	31.6	0.0	30.1	8.5	15.8	5.9	12.9	9.6	22.5	119.5	103.9	77.5	110.1	2.4	7.2	9.2	130.2	61.1	27.3	3.2	1.2	19.3	2.1	119.5	7.8	11.4	191.2	6.7	13.3	171.7	8.7	12.7	24.9	51.9	28.3	8.3	9.4	84.8	4.4	9.6	150.5	7.2	9.5	12.3	116.2	0.1	2.9	18.7	5.2	29.2	32.2	0.1	1.5	3.4	0.9	2.6	4.2	0.0	6.9	2.1	5.9	4.1	0.1	11.0	0.6	1.0	2.3	7.3	4.0	0.0	2.9	1.7	1.9	1.2	15.2	3.0	1.2	6.0	3.9	0.0	0.4	0.0	9.3	5.8	0.3	0.2	0.1	9.4	0.1	2.0	0.7	49.6	0.0	0.2	0.0	13.6	24.1	0.2	0.7	8.1	11.7	0.1	1.1	0.0	4.7	2.2	0.4	3.0	6.8	1.8	0.9	20.1	0.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	109.0	63.1	165.7	103.9	77.5	130.2	61.1	119.5	51.9	84.8	116.2	6.9	0.0	3.9	1101.2	1.1	10.5	0.0	0.0	1.8	376.6	0.2	0.6	188.5	0.0	1.3	20.2	479.6	0.1	0.0	0.0	15.6	0.0	111.2	36.4	6.0	6.4	66.0	0.0	1282.0	1.6	0.1	79.0	2.0	7.2	1.3	81.8	0.0	0.4	1.0	1431.8	1060.7	0.4	8.2	0.0	19.7	49.8	36.4	2.9	17.8	90.9	0.6	44.5	0.0	497.1	1351.0	0.1	5.0	30.1	0.9	0.4	0.1	127.9	0.8	484.4	6.6	24.3	26.5	2.3	1.5	0.8	9.5	0.0	1.9	2.6	0.3	0.2
ARSI	"FLJ16069, SPG66"	ENSG00000183876	"Arylsulfatase family member I"	Q5FYB1	5	150296343-150339307	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 12.1;Fibroblasts: 10.8;Melanocytes: 21.4;Smooth muscle cells: 6.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 15.7;HaCaT: 31.4;Hep G2: 19.9;hTEC/SVTERT24-B: 30.9;U-87 MG: 39.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA038386, HPA038398"	Uncertain		Approved	"Golgi apparatus"	"Secreted in other tissues"	NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"		"HPA038386: AB_10669781, HPA038398: AB_2675995"	"unprognostic (6.08e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.41e-3)"	"unprognostic (4.77e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.83e-3)"	"unprognostic (2.76e-1)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.06e-1)"	"unprognostic (5.81e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.39e-7)"	"unprognostic (7.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.64e-3)"	"prognostic unfavorable (1.19e-4)"	1.2	0.3	1.6	2.3	2.6	0.6	0.4	2.5	2.1	2.7	0.7	1.6	0.6	3.1	0.6	1.8	2.1	1.1	1.3	1.4	1.8	0.7	0.4	4.5	0.3	3.6	2.4	0.4	0.4	0.6	1.0	2.8	3.9	1.7	0.4	0.4	0.5	0.8	0.8	4.8	0.7	2.8	2.6	0.8	0.8	0.4	2.8	0.3	0.2	0.5	0.4	3.8	2.7	5.5	1.0	3.8	1.1	0.0	0.0	0.8	0.0	8.1	12.1	15.7	11.5	1.1	1.8	0.0	3.1	11.5	1.3	31.4	0.2	5.3	5.6	0.0	0.1	0.0	0.4	19.9	1.5	0.0	0.0	0.8	3.4	30.9	0.9	10.7	0.2	0.0	0.0	0.2	2.5	0.0	0.0	0.0	1.7	0.0	0.8	0.0	0.0	0.1	0.4	0.0	0.2	0.0	6.7	0.9	1.3	11.2	0.0	0.0	0.0	0.3	10.2	0.3	0.0	0.0	0.0	0.0	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.6	2.5	2.1	1.4	1.8	3.6	2.4	3.9	2.6	2.8	5.5	0.1	0.0	0.0	0.3	0.0	12.1	0.0	2.4	0.0	0.1	0.1	0.4	1.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.2	0.0	0.0	0.1	0.0	1.1	10.8	0.0	0.0	4.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	4.1	0.0	0.8	0.2	0.6	0.0	21.4	0.0	0.0	3.9	0.0	0.0	2.5	0.4	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.3	0.0	1.8	6.6	0.1	0.9	0.9	4.7	1.4	1.1	0.0	0.0	0.0
ASPA	"ACY2, ASP"	ENSG00000108381	Aspartoacylase	P45381	17	3472374-3503405	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Hydrolase	"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.0;kidney: 38.2"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 49.7;Melanocytes: 46.2;Oligodendrocytes: 217.0;Peritubular cells: 48.2;Proximal enterocytes: 37.5;Proximal tubular cells: 74.8"	"Cancer enhanced"	"Detected in some"		"renal cancer: 7.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.4;ASC TERT1: 4.1;CACO-2: 3.8;HSkMC: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022142, HPA022145"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA022142: AB_1845102, HPA022145: AB_1845103"	"unprognostic (4.42e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.36e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.43e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.07e-4)"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.49e-1)"	13.9	4.3	25.9	1.8	46.4	1.8	4.1	27.6	40.9	7.5	14.2	4.3	11.2	4.5	6.0	4.9	5.5	3.6	2.7	25.8	27.7	38.2	15.0	3.5	1.5	30.4	35.4	2.9	1.0	0.8	0.8	3.5	29.5	4.1	4.9	2.8	1.8	5.0	11.9	5.2	15.6	3.1	24.7	5.4	4.4	6.6	42.4	0.6	2.1	15.0	0.7	6.3	4.3	69.0	0.2	0.1	0.5	0.5	5.4	4.1	0.3	0.2	0.1	0.2	0.1	3.8	0.2	0.6	0.2	0.7	0.3	0.3	0.3	0.1	0.2	2.0	0.1	0.4	0.7	0.2	0.5	0.4	0.4	7.5	0.3	0.4	0.1	0.1	0.1	0.4	0.3	1.1	0.2	0.2	0.2	0.6	0.4	0.2	0.3	0.3	0.3	0.6	0.2	1.1	0.4	0.3	1.1	0.3	0.9	0.4	0.3	0.2	0.4	0.6	0.4	0.4	0.3	0.7	0.4	0.4	0.2	0.4	0.5	1.1	0.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.7	0.3	0.1	0.2	0.1	0.0	25.9	46.4	27.6	40.9	25.8	27.7	30.4	35.4	29.5	24.7	42.4	69.0	5.1	9.6	1.5	12.1	0.1	5.2	1.5	1.6	6.2	5.5	2.1	0.8	1.3	2.8	1.0	25.8	0.0	0.0	0.0	0.3	7.9	0.2	5.0	0.1	4.1	1.1	2.4	2.7	0.6	0.2	0.1	15.0	2.0	0.2	0.0	0.1	3.9	11.5	0.2	8.4	0.4	0.8	2.0	0.8	1.5	2.5	49.7	0.8	46.2	3.7	0.0	4.1	0.0	1.5	217.0	0.0	2.5	48.2	0.2	0.4	37.5	74.8	0.1	0.5	0.0	8.5	11.6	11.1	0.6	0.7	1.7	0.1	0.4	28.3	1.8	2.7
BICC1		ENSG00000122870	"BicC family RNA binding protein 1"	Q9H694	10	58512872-58831435	"Disease related genes, Predicted intracellular proteins"		"Developmental protein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 28.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 120.5;Cholangiocytes: 158.7;Collecting duct cells: 86.5;Ductal cells: 98.5;Fibroblasts: 79.6;Microglial cells: 165.8;Proximal tubular cells: 148.2"	"Group enriched"	"Detected in all"	4	"pancreatic cancer: 9.2;renal cancer: 25.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"basophil: 6.2"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"A549: 59.1;BJ hTERT+: 61.4;CACO-2: 93.1;RPTEC TERT1: 140.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070797			Approved	Centrosome,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol	Centrosome	"HPA070797: "	"unprognostic (1.27e-1)"	"unprognostic (1.57e-3)"	"unprognostic (3.61e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.72e-1)"	"unprognostic (9.98e-3)"	"unprognostic (1.79e-2)"	"unprognostic (6.69e-2)"	"unprognostic (4.56e-2)"	"unprognostic (4.40e-3)"	"unprognostic (7.16e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.37e-3)"	"unprognostic (4.19e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.94e-2)"	10.6	6.1	0.3	4.0	0.5	0.3	8.7	0.0	1.6	5.8	1.9	4.5	1.2	4.9	4.0	3.5	7.5	11.6	10.5	0.6	1.0	28.6	2.4	5.8	2.4	1.2	0.6	13.9	16.9	0.8	3.6	3.6	0.2	3.8	4.1	1.4	4.3	4.2	7.6	6.1	2.7	4.7	1.2	2.9	2.7	3.1	0.7	1.4	4.6	6.2	2.7	5.5	5.6	0.7	0.0	59.1	0.8	0.0	17.9	23.0	0.0	38.5	61.4	34.4	40.4	93.1	12.3	0.0	39.8	39.3	8.8	0.8	6.1	7.0	47.4	0.1	5.9	0.0	7.4	0.1	11.5	0.0	0.0	36.0	2.2	26.9	28.6	42.3	0.1	0.0	0.0	0.2	13.4	0.1	0.0	0.0	0.5	0.0	3.8	0.0	14.3	0.0	140.8	7.1	0.2	7.3	0.1	0.4	3.4	2.4	0.0	0.6	0.0	8.2	7.7	1.4	5.0	0.0	0.0	0.1	23.8	0.0	7.8	6.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.2	0.5	0.1	0.0	0.3	0.5	0.0	1.6	0.6	1.0	1.2	0.6	0.2	1.2	0.7	0.7	4.1	0.0	0.5	120.5	1.5	7.1	1.3	1.3	0.6	0.6	1.1	4.3	3.3	158.7	1.7	86.5	0.0	0.4	0.1	0.3	78.2	98.5	5.2	43.8	14.4	1.4	3.6	0.0	70.4	3.5	0.2	79.6	0.5	7.2	0.0	4.2	3.3	1.4	3.5	0.0	37.2	1.2	0.0	0.6	18.5	3.2	71.1	1.7	21.4	165.8	1.1	10.1	0.0	25.6	2.7	35.3	1.2	50.0	0.3	2.4	0.0	148.2	14.1	0.2	6.6	40.0	9.8	0.1	3.9	0.3	4.7	4.1	1.5	8.7	1.6	0.1
BMP4	BMP2B	ENSG00000125378	"Bone morphogenetic protein 4"	P12644	14	53949736-53958761	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"	"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 47.3;Fibroblasts: 65.2;Hepatic stellate cells: 52.8;Pancreatic endocrine cells: 40.1;Skeletal myocytes: 51.0;Syncytiotrophoblasts: 34.8"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 28.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	12	"monocytes: 1.9;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 120.1;CAPAN-2: 298.6;Hep G2: 326.0;OE19: 219.1;SuSa: 168.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006863, HPA066235"	Uncertain				"Secreted to blood"	NA	NA	162000000		"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 50: Fibroblasts - ECM organization"			"CAB006863: , HPA066235: AB_2685641"	"unprognostic (1.30e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.20e-3)"	"unprognostic (3.39e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.11e-1)"	"unprognostic (3.45e-3)"	"unprognostic (7.67e-2)"	"unprognostic (2.45e-3)"	"unprognostic (7.06e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.24e-1)"	14.0	13.4	3.0	6.1	3.2	0.1	13.4	7.0	4.5	21.0	32.4	25.6	17.0	8.9	2.5	12.9	9.7	14.4	16.3	3.1	2.8	9.0	4.2	13.4	9.6	3.6	3.3	23.8	3.4	2.7	4.7	44.4	3.9	21.9	28.9	2.7	10.5	18.7	11.5	15.3	19.2	9.0	3.2	6.5	23.8	2.0	3.9	3.4	8.5	17.7	4.2	27.4	23.5	4.7	15.6	40.0	2.1	1.8	0.5	0.4	0.6	7.9	34.0	20.1	15.5	120.1	298.6	0.0	97.2	0.1	2.2	73.2	8.6	1.0	10.7	4.1	5.9	0.2	8.3	326.0	19.4	0.0	1.0	0.0	2.8	9.5	0.5	61.1	59.3	6.8	0.0	0.3	9.7	6.9	5.3	0.3	13.9	219.1	3.4	0.2	10.5	0.3	28.5	1.3	0.1	0.3	0.0	1.1	0.9	168.2	38.8	1.5	2.9	0.6	87.1	0.3	1.4	0.2	0.1	1.0	0.1	0.1	4.3	0.0	0.6	0.0	0.1	1.1	0.0	0.0	0.9	0.2	0.1	0.0	1.3	0.4	0.0	0.0	1.9	0.0	0.0	0.3	3.0	3.2	7.0	4.5	3.1	2.8	3.6	3.3	3.9	3.2	3.9	4.7	7.6	9.6	7.3	1.0	0.6	27.5	4.0	16.1	47.3	0.3	8.0	10.4	5.7	14.3	6.0	5.5	0.0	29.3	0.1	1.0	3.9	5.5	2.5	0.7	18.9	18.2	0.0	2.7	1.3	0.2	18.9	65.2	0.5	0.7	1.3	0.9	52.8	2.0	3.7	0.0	0.4	5.3	2.0	0.6	5.9	1.0	10.5	0.4	3.6	1.9	0.0	0.5	0.0	1.0	0.3	40.1	4.0	1.5	0.1	2.3	0.6	2.4	5.8	1.5	0.0	51.0	10.5	1.4	2.2	7.5	17.5	34.8	1.0	1.4	4.0	1.4
C16orf89	MGC45438	ENSG00000153446	"Chromosome 16 open reading frame 89"	Q6UX73	16	5044122-5066110	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 108.3;thyroid gland: 228.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 44.8;Alveolar cells type 2: 268.1;Club cells: 70.4;Distal tubular cells: 113.5;Fibroblasts: 43.8"	"Group enriched"	"Detected in many"	14	"lung cancer: 64.7;thyroid cancer: 145.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 2.3;Hep G2: 2.5;HHSteC: 1.3;NTERA-2: 1.7;U-2197: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA013613, HPA016934"	Enhanced				"Secreted to blood"	NA	NA		1400000	"Cluster 38: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"			"HPA013613: AB_1845584, HPA016934: AB_2732417"	"unprognostic (1.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.29e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.23e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.39e-2)"	"unprognostic (3.25e-2)"	"unprognostic (6.64e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.54e-2)"	"unprognostic (8.48e-3)"	17.8	4.2	20.0	6.0	21.6	0.2	12.8	18.8	28.3	20.2	15.0	6.3	17.6	3.5	87.1	6.7	12.4	45.0	18.8	19.4	19.9	16.8	0.3	108.3	0.9	19.9	18.5	2.8	5.4	0.1	5.7	0.9	19.0	4.2	5.0	0.5	35.0	1.1	0.2	0.6	7.9	4.9	19.6	0.6	82.4	1.2	22.6	2.8	228.8	3.9	2.2	14.4	3.2	22.7	0.0	0.1	0.0	0.2	2.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.6	2.5	1.3	0.1	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.1	0.7	0.3	1.7	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.5	0.3	0.1	0.0	0.0	0.2	0.1	2.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.2	0.0	0.1	0.0	0.0	20.0	21.6	18.8	28.3	19.4	19.9	19.9	18.5	19.0	19.6	22.6	22.7	0.9	44.8	268.1	23.2	0.0	0.4	1.8	0.3	0.6	0.5	23.6	18.0	2.8	0.0	70.4	0.0	0.0	0.1	0.1	0.1	113.5	0.0	1.7	3.7	0.4	1.3	0.0	0.0	0.9	7.8	0.1	43.8	17.3	0.3	5.1	0.0	0.0	0.0	6.0	0.0	0.7	0.6	6.1	0.0	0.4	2.7	9.3	0.7	0.0	11.2	0.0	0.3	0.0	1.0	1.6	0.7	0.4	14.7	0.0	5.0	0.0	1.5	16.9	0.2	0.0	1.9	1.9	0.8	0.1	0.6	0.3	0.3	0.6	0.0	0.7	5.0
C1QL1	"C1QRF, C1QTNF14, CRF, CTRP14"	ENSG00000131094	"Complement C1q like 1"	O75973	17	44959693-44968303	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 134.0"	"Cell type enriched"	"Detected in some"	7	"Horizontal cells: 673.0"	"Cancer enriched"	"Detected in all"	7	"glioma: 116.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 34.8;SH-SY5Y: 24.8;U-2 OS: 89.0;U-251 MG: 28.1;U-87 MG: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (6.37e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.65e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.34e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.49e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (1.31e-8)"	"unprognostic (2.67e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.04e-1)"	7.7	0.7	18.5	0.4	17.2	0.0	0.9	26.6	32.1	3.0	16.2	4.9	2.0	13.0	0.3	1.8	4.4	0.3	4.1	15.5	21.4	21.0	0.7	0.2	0.0	134.0	41.9	0.7	4.6	0.0	2.1	0.0	24.9	7.3	0.3	8.1	0.7	0.0	0.1	0.5	6.2	0.6	32.4	0.1	3.9	0.8	21.6	0.1	0.3	0.2	0.0	6.4	1.2	24.3	4.6	5.1	1.1	17.8	0.3	0.0	0.3	0.8	0.7	0.5	1.6	0.7	0.6	0.2	3.0	0.4	5.3	0.6	2.8	0.2	0.2	12.7	7.5	0.0	7.9	0.1	2.1	0.0	2.2	0.4	0.0	0.7	0.2	6.2	0.0	3.1	0.1	0.2	0.5	1.1	4.0	0.1	3.1	0.5	10.7	6.7	0.2	0.3	0.1	0.4	34.8	24.8	15.6	1.3	1.3	0.9	4.1	0.2	0.1	1.4	89.0	0.9	28.1	1.0	0.0	0.1	27.8	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	17.2	26.6	32.1	15.5	21.4	134.0	41.9	24.9	32.4	21.6	24.3	0.1	0.0	0.0	4.2	0.0	0.3	0.2	1.0	0.0	22.3	0.4	3.2	1.1	5.7	0.0	0.0	10.4	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.5	0.4	5.3	0.0	0.5	0.0	0.1	1.9	0.0	0.5	0.0	0.3	1.1	0.1	0.0	673.0	11.7	0.0	0.0	0.3	0.0	0.2	0.3	0.1	0.0	1.0	0.0	17.6	0.0	84.4	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.5	0.0	0.0	0.7	0.2	1.0	0.2	0.0	0.0	0.2	0.1	0.0	0.1
C7		ENSG00000112936	"Complement C7"	P10643	5	40909497-40984643	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 735.4"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 578.4;Hepatic stellate cells: 662.5;Leydig cells: 1058.5;Sertoli cells: 309.0;Theca cells: 503.1"	"Cancer enriched"	"Detected in all"	4	"pancreatic cancer: 73.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 116.5;HHSteC: 155.1;HSkMC: 212.1;SH-SY5Y: 146.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"spinal cord: 13.7"	HPA001465	Approved				"Secreted to blood"	NA	NA		48000000000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA001465: AB_1078554"	"unprognostic (5.01e-2)"	"unprognostic (3.74e-2)"	"unprognostic (7.40e-2)"	"unprognostic (4.68e-3)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-3)"	"prognostic favorable (5.89e-4)"	"unprognostic (6.67e-2)"	"unprognostic (3.45e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.24e-2)"	"unprognostic (6.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.06e-3)"	470.9	607.7	2.6	21.7	3.5	0.2	46.4	2.6	9.6	118.5	13.6	165.3	19.3	124.6	163.6	52.9	377.3	211.7	558.7	2.8	2.5	298.1	110.6	206.7	99.2	4.4	2.7	735.4	149.8	15.0	23.1	359.2	3.0	101.6	32.5	1.5	18.0	105.7	4.3	12.6	139.8	256.3	4.3	138.2	120.2	28.0	3.0	32.2	105.1	1.6	22.5	122.1	118.3	3.0	0.0	0.0	0.0	0.0	116.5	16.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	155.1	0.0	0.0	212.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	146.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.6	3.5	2.6	9.6	2.8	2.5	4.4	2.7	3.0	4.3	3.0	3.0	7.9	6.4	4.1	0.0	1.4	0.6	0.5	0.0	1.8	2.1	1.2	0.3	56.7	7.2	2.5	0.0	0.0	0.2	0.1	0.4	0.0	0.2	4.7	0.5	7.9	127.6	54.8	26.7	0.1	1.3	0.1	578.4	0.0	0.2	1.3	2.7	662.5	8.3	0.5	43.7	0.3	1.3	0.0	14.5	4.2	29.8	1058.5	1.5	0.0	58.1	0.6	3.7	0.0	0.0	0.0	0.9	0.9	18.0	1.0	1.3	0.2	0.1	0.0	0.9	309.0	2.2	23.7	2.6	2.5	6.5	0.6	0.3	1.2	503.1	3.0	0.8
CA3	"CAIII, Car3"	ENSG00000164879	"Carbonic anhydrase 3"	P07451	8	85373436-85449040	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 5273.7"	"Group enriched"	"Detected in many"	8	"Erythroid cells: 221.3;Skeletal myocytes: 304.0"	"Group enriched"	"Detected in many"	7	"glioma: 23.1;prostate cancer: 9.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HEL: 47.3;RH-30: 78.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004967, HPA021775, HPA026700"	Enhanced					NA	NA		53000000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"			"CAB004967: AB_437014, HPA021775: AB_1845990, HPA026700: AB_1845991"	"prognostic favorable (4.24e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-3)"	"unprognostic (4.71e-2)"	"unprognostic (8.43e-3)"	"unprognostic (3.56e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.19e-1)"	43.4	3.8	2.4	0.3	2.3	9.9	6.4	2.7	3.7	5.1	1.4	1.7	1.8	8.3	2.1	64.8	9.8	2.2	19.5	2.3	2.8	3.7	2.4	24.6	0.4	2.9	2.3	1.4	1.3	1.0	3.8	0.3	2.0	89.5	1.1	5.5	15.4	2.7	5273.7	5.2	4.4	19.1	2.5	0.8	4.1	2.9	2.5	1.4	3.0	1018.8	0.6	1.5	5.5	2.8	2.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.1	0.0	0.1	0.0	0.1	0.2	0.3	0.3	0.0	0.5	0.2	47.3	0.0	1.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	78.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	2.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	2.4	2.3	2.7	3.7	2.3	2.8	2.9	2.3	2.0	2.5	2.5	2.8	0.3	3.2	4.2	2.3	0.1	0.5	1.7	0.6	1.2	0.0	14.5	0.6	1.0	5.7	0.6	0.0	6.2	1.1	0.4	0.4	0.0	0.6	24.1	0.4	0.2	2.2	0.0	221.3	2.2	0.2	0.2	9.1	0.0	0.7	0.0	0.2	2.5	0.3	0.4	0.0	2.5	0.4	0.0	0.3	0.4	7.0	0.3	2.5	0.0	0.0	0.0	29.6	0.0	1.5	0.7	0.2	1.7	0.0	0.0	0.5	8.5	0.6	1.0	1.6	0.0	304.0	5.1	0.6	1.3	0.2	1.0	1.6	1.4	0.3	0.9	0.3
CCDC80	"CL2, DRO1, LINC01279, SSG1, TCONS_00006930, URB"	ENSG00000091986	"Coiled-coil domain containing 80"	Q76M96	3	112596797-112649530	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 450.8;Fibroblasts: 921.6;Late spermatids: 353.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 521.4;fHDF/TERT166: 1281.3;hTERT-RPE1: 2404.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002266	Approved				"Secreted to extracellular matrix"	NA	NA		510000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA002266: AB_1078423"	"unprognostic (1.26e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.30e-3)"	"unprognostic (1.99e-3)"	"unprognostic (8.40e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (2.86e-5)"	"unprognostic (5.97e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.55e-1)"	"prognostic unfavorable (1.26e-4)"	244.9	15.0	6.4	83.5	6.9	1.1	218.3	9.6	8.6	305.3	24.4	74.5	8.7	276.5	76.8	92.4	82.2	234.0	218.8	6.8	10.2	17.7	6.6	74.0	18.5	12.2	11.4	62.2	28.7	12.4	10.8	26.0	9.3	67.8	73.4	9.4	34.7	78.7	13.4	79.1	25.1	360.3	11.1	34.8	47.5	42.7	9.2	17.1	87.5	34.9	30.8	194.4	131.8	13.5	26.1	11.0	127.6	5.8	521.4	411.2	6.9	359.0	108.5	118.6	171.8	2.9	2.1	1.2	13.5	1281.3	11.4	33.5	5.3	4.8	123.7	24.3	1.2	0.7	27.7	0.7	109.5	1.0	0.5	409.7	14.4	174.9	11.0	2404.9	27.8	0.6	0.4	1.0	352.7	0.5	0.3	0.7	31.6	0.7	4.2	0.3	14.0	0.6	3.3	0.5	0.4	2.5	53.5	2.3	1.8	23.0	2.1	1.0	141.7	345.6	56.6	66.6	160.1	1.6	0.8	1.2	102.4	0.7	56.8	0.9	0.3	0.2	0.3	0.1	0.3	0.4	0.3	0.3	0.1	0.6	0.4	0.4	0.3	0.3	0.2	0.7	0.2	0.0	6.4	6.9	9.6	8.6	6.8	10.2	12.2	11.4	9.3	11.1	9.2	13.5	104.5	6.4	15.9	13.1	1.5	60.9	4.2	44.7	26.7	1.1	5.9	59.7	22.5	10.0	62.7	5.5	0.0	57.9	1.0	0.3	1.9	23.7	450.8	95.4	93.2	43.9	0.0	0.0	1.0	1.2	101.5	921.6	16.8	18.4	1.3	44.3	53.6	0.9	9.4	0.0	0.3	0.8	30.5	2.2	121.5	353.6	77.0	9.7	144.1	3.7	2.0	101.4	0.0	0.0	0.0	13.5	0.0	34.6	5.8	3.6	0.0	0.1	112.4	2.5	19.7	177.7	198.4	6.9	4.9	11.9	51.7	27.9	9.0	23.0	0.1	1.9
CD248	"CD164L1, TEM1"	ENSG00000174807	"CD248 molecule"	Q9HCU0	11	66314494-66317044	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 237.3;breast: 155.5"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 155.4;Fibroblasts: 166.9;Leydig cells: 74.9;Smooth muscle cells: 59.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"naive CD8 T-cell: 21.8"	"Lineage enriched"	"Detected in single"	144	"T-cells: 21.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 492.4;ASC TERT1: 481.9;BJ: 222.2;BJ hTERT+: 330.1;fHDF/TERT166: 451.1;HSkMC: 516.8;U-2197: 794.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		43000000	"Cluster 32: T-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Nucleoplasm	"HPA051856: AB_2681640"	"unprognostic (2.26e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.82e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (2.69e-7)"	"unprognostic (1.90e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.30e-2)"	237.3	12.9	2.3	39.3	2.4	0.4	155.5	2.2	4.0	87.2	1.5	31.7	7.8	52.2	6.9	19.6	60.8	32.3	30.3	2.2	2.2	18.7	3.6	36.5	6.2	2.4	2.6	23.9	11.7	3.3	8.8	67.4	2.2	17.8	7.4	0.4	18.2	19.4	15.8	51.0	27.2	26.5	2.0	7.2	26.3	5.0	3.9	5.3	35.0	6.5	2.6	63.4	61.5	2.0	0.0	0.0	4.9	0.0	492.4	481.9	0.3	222.2	330.1	16.3	15.1	0.1	0.0	0.0	5.8	451.1	0.0	0.0	0.2	0.2	3.5	0.0	0.0	0.0	0.1	3.3	97.5	0.0	0.0	516.8	0.0	21.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.4	3.2	2.5	0.0	1.4	9.5	0.0	0.2	0.0	0.0	2.8	7.6	0.0	1.2	0.0	13.4	0.5	0.4	0.1	0.0	0.8	794.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	0.0	0.0	2.6	0.0	0.1	3.1	21.8	0.0	0.0	0.0	0.0	0.0	2.5	2.3	2.4	2.2	4.0	2.2	2.2	2.4	2.6	2.2	2.0	3.9	2.0	15.0	0.0	0.0	1.3	1.3	12.5	0.0	0.0	0.6	0.1	1.2	1.5	2.2	0.0	0.0	0.0	0.0	2.7	0.5	0.0	0.0	0.2	0.3	5.3	155.4	5.8	0.0	0.0	0.0	0.0	2.5	166.9	13.3	3.1	0.0	0.0	2.5	0.0	6.0	0.0	0.0	0.0	0.0	0.3	14.4	2.3	74.9	1.6	12.4	1.9	0.6	2.9	1.0	0.0	0.0	0.3	0.0	20.3	0.1	0.0	0.0	0.1	0.0	0.1	32.9	5.5	59.3	0.1	0.1	0.8	8.2	4.4	6.9	1.1	0.0	0.1
CFD	"ADN, DF, PFD"	ENSG00000197766	"Complement factor D"	P00746	19	859664-863641	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1496.7;breast: 993.2"	"Group enriched"	"Detected in many"	6	"Fibroblasts: 9365.5;Leydig cells: 5032.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 297.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 297.6"	"Group enriched"	"Detected in many"	5	"ASC diff: 197.4;THP-1: 342.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	732000000	4400000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (3.00e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.22e-3)"	"unprognostic (6.92e-2)"	"unprognostic (5.28e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.46e-2)"	"unprognostic (8.10e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (9.53e-2)"	"prognostic unfavorable (7.09e-4)"	"unprognostic (1.23e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.92e-2)"	"unprognostic (9.75e-2)"	1496.7	33.3	1.5	9.6	1.6	10.7	993.2	1.2	2.4	597.4	3.7	324.8	23.5	58.4	2.4	212.8	258.0	9.6	854.2	1.7	2.3	18.1	8.7	363.3	2.1	3.3	2.3	74.3	41.4	1.7	9.0	14.5	3.6	277.8	10.9	0.6	247.3	6.3	197.0	488.6	248.4	4.0	2.6	28.6	263.8	51.8	2.9	3.6	332.3	26.9	0.8	848.3	729.8	5.8	3.9	5.2	0.6	2.2	197.4	26.2	9.5	0.8	0.0	0.0	0.0	0.8	0.4	0.2	5.7	0.0	0.5	3.0	1.8	0.5	0.0	5.7	14.5	0.5	12.3	3.8	3.6	2.5	4.9	8.7	0.2	0.1	0.0	0.8	0.0	4.5	11.9	0.9	0.0	2.6	0.6	49.2	1.0	4.5	16.1	1.3	0.5	5.2	0.3	1.2	1.8	1.8	5.5	1.9	0.5	0.6	7.5	342.2	0.4	0.2	5.1	2.9	0.6	7.8	4.7	0.4	0.2	20.8	0.2	297.6	41.2	127.8	8.4	55.5	13.2	5.7	4.2	10.2	14.5	1.4	9.7	9.7	112.0	1.3	57.3	1.8	4.7	37.8	1.5	1.6	1.2	2.4	1.7	2.3	3.3	2.3	3.6	2.6	2.9	5.8	857.8	9.6	23.3	0.0	19.2	785.5	49.0	10.1	17.1	2.9	107.3	120.1	55.5	21.5	30.9	18.4	2.1	36.6	40.0	33.1	11.7	7.7	27.1	23.1	593.3	114.8	4.2	8.2	0.2	0.0	32.9	9365.5	113.6	15.9	17.1	0.9	30.4	2.6	272.4	1.7	0.4	8.7	0.0	424.7	1145.2	89.6	5032.4	442.5	642.1	4.7	303.6	1.3	21.6	0.0	0.1	2.9	64.8	283.2	41.0	19.7	4.3	3.4	28.4	6.5	0.0	414.3	530.2	11.4	21.3	28.6	735.9	34.3	82.8	1.2	21.0	233.2
CHN1	"ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2"	ENSG00000128656	"Chimerin 1"	P15882	2	174798809-175005381	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	Neurogenesis	"GTPase activation"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 772.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 195.2;Excitatory neurons: 596.4;Inhibitory neurons: 111.7;Microglial cells: 97.4;Oligodendrocyte precursor cells: 149.8"	"Cancer enhanced"	"Detected in all"		"glioma: 18.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory CD4 T-cell: 6.5;memory CD8 T-cell: 2.1;T-reg: 8.0"	"Lineage enriched"	"Detected in single"	18	"T-cells: 8.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 186.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036111			Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA036111: AB_10671241"	"unprognostic (3.18e-3)"	"unprognostic (4.19e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (7.31e-3)"	"unprognostic (4.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.46e-2)"	11.8	13.3	368.6	7.3	445.9	0.8	10.5	194.0	772.6	9.2	170.6	10.2	3.3	7.9	38.3	6.9	6.5	11.1	15.1	492.6	241.5	4.7	2.1	19.6	21.5	210.2	225.4	5.8	4.2	43.4	36.3	38.6	210.5	17.0	5.1	39.5	3.2	9.6	2.7	3.8	7.5	13.1	192.4	5.5	7.1	21.3	239.1	3.1	10.2	3.7	18.7	8.7	6.7	422.8	0.4	17.4	57.6	16.3	14.7	67.4	0.4	45.6	186.7	65.1	97.0	0.3	5.4	0.5	1.6	71.8	39.9	2.0	68.0	1.9	30.3	1.3	32.9	11.1	20.1	3.8	34.4	6.4	1.7	53.6	1.9	31.6	11.1	16.1	33.6	30.0	0.7	1.9	57.2	11.8	29.3	2.5	71.7	2.6	23.7	8.2	70.3	0.8	0.9	0.6	71.3	76.3	41.3	0.5	7.3	36.0	3.2	2.2	10.1	26.8	3.9	9.8	20.6	6.4	33.7	0.7	6.7	0.4	6.6	0.4	0.1	0.1	0.3	0.1	0.8	0.2	6.5	2.1	0.0	0.1	1.3	0.4	0.4	0.2	0.2	0.3	8.0	1.0	368.6	445.9	194.0	772.6	492.6	241.5	210.2	225.4	210.5	192.4	239.1	422.8	15.4	3.2	1.9	195.2	1.6	4.5	0.3	0.0	0.0	85.1	7.3	1.4	6.2	1.5	2.6	3.7	27.1	1.2	0.5	0.1	0.0	0.3	24.1	5.3	5.6	17.9	2.4	0.0	596.4	0.6	1.1	28.4	2.0	3.6	0.0	5.1	10.4	0.5	2.7	77.4	111.7	0.0	0.0	0.0	4.0	23.2	3.1	0.9	7.2	97.4	0.0	59.1	0.0	149.8	88.1	0.6	0.0	5.3	1.3	0.6	0.0	0.3	1.0	14.1	13.1	23.8	27.3	17.8	23.6	0.1	3.7	2.1	12.5	5.1	0.2	0.3
CLMP	"ACAM, ASAM, FLJ22415"	ENSG00000166250	"CXADR like membrane protein"	Q9H6B4	11	123069872-123195248	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 63.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 75.7;Fibroblasts: 95.1;Inhibitory neurons: 31.9;Peritubular cells: 57.9;Skeletal myocytes: 65.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 124.8;BJ: 171.8;BJ hTERT+: 160.3;fHDF/TERT166: 126.6;hTEC/SVTERT24-B: 129.1;hTERT-HME1: 155.6;U-138 MG: 232.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		310000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (1.63e-2)"	"unprognostic (6.65e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.46e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-3)"	"unprognostic (9.66e-3)"	"unprognostic (3.25e-2)"	"unprognostic (4.02e-3)"	"unprognostic (3.87e-2)"	"unprognostic (9.78e-8)"	"unprognostic (3.88e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.69e-2)"	63.2	6.5	0.9	14.7	0.8	0.4	24.5	7.8	2.7	20.5	3.6	41.1	7.3	30.3	4.3	10.1	18.4	23.1	12.9	5.3	0.4	6.0	0.4	8.1	7.4	4.2	2.1	9.1	2.0	0.2	1.9	26.3	1.8	7.4	10.6	0.9	5.4	8.5	1.7	6.5	17.3	36.3	2.0	8.1	16.0	2.6	2.1	0.8	2.4	3.4	5.0	16.7	14.0	5.2	3.0	3.3	7.5	15.2	124.8	108.1	45.5	171.8	160.3	23.9	43.8	7.4	0.2	0.0	0.4	126.6	82.4	0.1	0.3	45.5	27.3	0.9	0.3	0.0	7.1	0.1	40.7	0.0	0.1	61.0	30.6	129.1	155.6	59.7	11.7	0.1	0.0	0.4	33.3	0.1	0.0	0.2	17.4	0.0	20.2	0.1	2.5	0.1	12.6	0.0	20.5	50.3	0.0	0.4	0.1	3.2	0.6	0.0	43.3	232.7	2.3	96.0	21.6	0.1	0.0	0.1	63.1	0.0	7.5	0.3	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.9	0.8	7.8	2.7	5.3	0.4	4.2	2.1	1.8	2.0	2.1	5.2	2.3	0.0	3.9	2.0	0.2	1.5	0.3	2.4	0.0	3.8	1.2	14.6	5.1	0.0	0.4	0.0	0.0	9.8	0.3	0.1	0.0	1.9	0.7	2.4	75.7	1.4	6.7	0.0	26.5	1.3	20.4	95.1	0.0	1.4	0.0	5.3	2.2	0.0	3.6	1.7	31.9	0.5	0.0	0.0	1.9	0.7	20.8	0.9	0.0	4.7	0.0	0.5	0.0	1.0	3.6	0.9	0.0	57.9	0.6	2.0	0.1	0.1	0.2	1.1	0.0	65.0	8.5	0.1	0.1	0.4	1.0	10.4	1.1	2.2	0.3	0.5
CMTM3	"BNAS2, CKLFSF3, FLJ31762"	ENSG00000140931	"CKLF like MARVEL transmembrane domain containing 3"	Q96MX0	16	66603874-66613892	"Predicted intracellular proteins, Predicted membrane proteins"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 222.1;Granulosa cells: 140.8;Hofbauer cells: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"REH: 164.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013870, HPA072695"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA013870: AB_1847003, HPA072695: AB_2732210"	"unprognostic (1.59e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.21e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.80e-3)"	"unprognostic (6.65e-3)"	"unprognostic (7.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.22e-2)"	"unprognostic (7.38e-2)"	"prognostic unfavorable (4.42e-6)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.81e-2)"	49.3	16.6	15.5	25.0	14.3	20.0	32.8	15.6	28.1	40.2	9.5	16.8	7.1	30.4	16.6	10.4	25.5	32.7	26.2	15.6	18.0	19.7	10.7	35.4	32.3	24.9	15.8	38.9	7.9	29.4	10.1	44.4	19.3	23.4	12.1	3.0	17.4	16.7	6.4	22.2	18.8	27.7	17.0	36.1	11.9	59.7	19.1	35.5	16.1	13.0	20.9	34.3	26.7	20.4	6.7	33.8	93.4	66.2	68.4	42.6	59.2	17.5	78.6	34.4	34.0	18.6	21.0	0.2	47.7	49.0	59.7	7.8	63.7	57.4	27.3	34.6	23.2	21.5	4.4	53.5	92.2	65.8	77.4	85.5	4.5	36.6	7.7	141.3	78.9	59.5	34.6	0.7	42.8	7.8	53.1	108.9	45.0	0.5	31.8	164.7	65.6	3.3	16.4	0.8	9.9	33.9	8.5	0.3	58.5	59.9	0.7	59.3	54.0	48.7	58.8	12.0	21.1	4.4	0.7	21.8	30.5	50.0	53.7	7.9	14.2	9.9	9.2	13.9	12.9	2.6	10.3	10.5	12.3	0.9	8.0	9.8	8.0	8.6	8.9	24.9	15.7	5.8	15.5	14.3	15.6	28.1	15.6	18.0	24.9	15.8	19.3	17.0	19.1	20.4	38.0	0.0	7.1	0.3	12.9	14.7	33.5	10.0	6.8	0.5	12.3	25.7	2.0	4.3	6.4	5.5	0.0	10.7	101.2	0.4	0.0	28.1	2.8	4.9	56.0	50.4	12.5	12.8	0.6	6.4	222.1	62.6	2.6	6.2	91.3	140.8	44.3	1.3	119.8	0.0	0.3	0.7	8.2	74.7	77.9	9.4	39.4	78.0	28.4	10.3	61.5	10.0	82.4	8.0	0.2	41.0	0.1	24.5	5.7	40.8	0.1	4.4	3.1	0.8	6.6	26.3	36.1	4.9	8.1	1.1	8.7	9.4	68.9	10.5	0.2	21.6
CNPY4	"MGC40499, PRAT4B"	ENSG00000166997	"Canopy FGF signaling regulator 4"	Q8N129	7	100119634-100125508	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 35.3;Leydig cells: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014166, HPA025240"	Uncertain		Approved	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA014166: AB_1853895, HPA025240: AB_2082630"	"unprognostic (9.64e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.09e-3)"	"unprognostic (8.44e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.71e-1)"	"prognostic unfavorable (3.99e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.16e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.59e-5)"	"unprognostic (6.92e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.35e-2)"	13.7	16.8	13.3	9.6	13.9	6.1	11.0	14.3	14.9	24.6	14.7	14.1	6.4	21.2	14.8	5.7	15.4	16.7	13.1	13.1	13.7	10.4	6.6	9.2	10.8	14.2	13.8	24.5	4.5	12.8	16.6	21.3	14.1	10.8	9.9	17.2	5.7	15.9	5.1	8.3	9.7	21.4	13.8	13.6	7.8	6.8	13.6	14.3	10.4	7.1	9.8	12.4	14.8	14.3	7.9	13.5	33.2	59.6	76.0	36.5	16.6	29.0	31.2	14.9	27.8	7.5	7.0	17.2	32.9	52.5	10.9	7.9	13.0	14.2	15.6	16.2	13.4	7.1	23.3	10.4	21.5	12.1	12.8	33.4	3.8	13.7	6.2	32.7	52.4	8.2	6.0	11.1	21.5	22.9	25.8	15.9	17.1	5.0	19.2	7.5	24.9	9.2	15.4	2.0	8.3	16.9	27.8	22.4	15.4	21.4	11.3	6.7	42.9	47.5	28.5	20.2	13.3	9.4	16.3	15.3	27.8	18.4	19.7	11.8	5.1	8.6	15.1	11.2	19.8	3.9	15.6	19.0	7.2	2.9	12.7	19.0	2.3	12.3	13.9	4.6	13.8	6.7	13.3	13.9	14.3	14.9	13.1	13.7	14.2	13.8	14.1	13.8	13.6	14.3	15.2	6.4	2.6	4.2	3.4	3.6	2.3	7.9	2.8	6.9	3.4	6.2	3.4	5.7	4.0	12.9	2.1	35.3	5.2	3.7	1.9	6.4	0.5	5.1	20.2	15.0	2.4	11.8	3.4	2.5	10.3	28.4	1.1	4.2	9.5	16.1	18.2	1.3	14.0	8.4	4.0	1.9	4.1	2.5	2.4	2.2	35.1	4.7	16.0	2.8	5.1	26.6	8.2	2.0	2.8	2.4	2.8	31.6	1.9	0.5	2.8	3.3	4.4	15.8	13.1	12.7	15.5	1.1	4.5	2.1	3.8	18.3	8.6	30.5	2.3	1.0
CNRIP1	"C2orf32, CRIP1, CRIP1a, CRIP1b, DKFZP566K1924"	ENSG00000119865	"Cannabinoid receptor interacting protein 1"	Q96F85	2	68284171-68320051	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 72.2;Erythroid cells: 116.2;granulocytes: 122.9"	"Cancer enhanced"	"Detected in all"		"glioma: 14.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	109	"basophil: 12.2"	"Lineage enriched"	"Detected in single"	109	"granulocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"HEL: 158.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035337			Approved	Cytosol		NA	NA		54000	"Cluster 38: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"HPA035337: AB_10601359"	"unprognostic (1.23e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.51e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (1.04e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.38e-3)"	27.4	6.4	59.0	5.9	62.3	6.1	20.2	50.9	71.6	30.1	29.6	17.1	3.5	22.4	6.1	5.3	24.2	8.5	16.0	65.1	51.8	10.3	2.9	18.3	5.1	40.4	45.1	31.2	3.0	1.8	15.4	12.1	44.3	15.1	4.6	29.6	5.8	8.9	6.6	8.1	10.9	9.3	44.7	10.2	10.6	2.6	52.7	2.7	8.9	7.0	2.9	20.7	19.2	51.8	0.0	1.1	9.0	0.0	34.1	24.6	0.1	34.5	26.6	30.6	22.3	0.0	0.0	0.0	1.2	33.2	22.6	0.0	0.7	0.2	32.6	0.0	8.1	158.7	2.3	0.0	34.7	0.1	21.7	22.1	0.0	20.0	11.5	18.7	47.8	0.0	0.2	0.1	23.4	0.1	0.0	0.4	16.3	0.0	15.6	0.0	13.2	0.0	0.0	0.0	45.8	47.8	2.2	0.0	28.3	0.1	0.0	1.7	51.4	21.1	12.9	18.5	51.0	0.0	0.0	0.1	16.9	0.0	15.5	12.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	59.0	62.3	50.9	71.6	65.1	51.8	40.4	45.1	44.3	44.7	52.7	51.8	50.2	0.0	4.3	15.0	0.6	12.9	0.4	0.0	4.6	72.2	0.6	1.7	2.1	0.0	0.6	0.0	22.9	1.2	0.1	0.0	0.0	0.4	0.7	1.9	30.4	60.6	0.0	116.2	48.8	0.2	9.3	44.4	0.5	0.6	122.9	1.3	36.4	0.8	56.3	28.6	39.5	0.0	0.0	25.7	40.9	2.6	45.4	13.9	37.4	16.9	2.5	42.0	0.0	24.1	19.6	0.5	0.0	42.5	0.5	1.2	0.0	0.1	0.0	54.3	46.0	18.7	41.9	0.7	0.5	0.7	10.7	2.1	3.8	27.3	0.0	1.0
CNTN4	BIG-2	ENSG00000144619	"Contactin 4"	Q8IWV2	3	2098813-3057959	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 411.7;Excitatory neurons: 960.7;Inhibitory neurons: 1048.5;Oligodendrocyte precursor cells: 248.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 8.3;CACO-2: 9.0;HEK 293: 5.5;SH-SY5Y: 16.5;WM-115: 5.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		170000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.64e-1)"	"unprognostic (7.17e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.60e-2)"	"unprognostic (7.38e-3)"	"unprognostic (2.41e-2)"	"prognostic favorable (1.00e-4)"	"unprognostic (1.22e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.13e-1)"	3.4	0.5	2.2	1.1	6.4	0.0	2.5	13.5	12.3	8.7	0.0	4.6	1.8	8.3	1.9	3.1	4.2	5.1	2.5	1.8	2.7	4.2	2.9	2.4	1.1	0.5	5.4	1.0	1.6	22.6	1.9	7.9	1.2	4.3	3.3	19.8	0.9	5.6	0.7	0.7	4.1	4.5	4.2	1.0	3.6	13.4	7.7	2.2	10.3	4.0	2.6	3.6	1.7	4.0	0.0	0.0	1.1	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	16.5	0.0	0.0	0.1	1.2	0.1	0.2	0.0	0.0	1.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	6.4	13.5	12.3	1.8	2.7	0.5	5.4	1.2	4.2	7.7	4.0	0.4	9.6	3.6	26.8	0.1	0.8	1.3	0.0	1.8	96.5	2.0	1.8	1.4	7.2	5.6	0.0	0.0	0.1	0.0	1.8	0.0	4.4	411.7	0.3	9.1	1.9	7.8	0.0	960.7	0.0	0.1	18.1	0.0	0.3	0.0	6.9	0.7	0.4	0.3	101.0	1048.5	2.0	0.0	0.3	0.7	156.3	5.0	0.4	1.8	31.9	0.0	27.5	0.0	248.3	14.7	0.0	1.6	5.3	0.4	0.4	3.7	3.7	0.0	5.9	6.6	0.5	8.3	4.5	4.9	0.9	0.0	0.3	0.1	0.1	3.5	0.2
CPEB1	"CPEB, FLJ13203"	ENSG00000214575	"Cytoplasmic polyadenylation element binding protein 1"	Q9BZB8	15	82543201-82648861	"Predicted intracellular proteins"	"mRNA processing, Translation regulation"	"Activator, Repressor, Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.6;testis: 32.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 70.0;Inhibitory neurons: 44.3;Oligodendrocytes: 196.5;Spermatocytes: 34.1;Spermatogonia: 62.3"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 14.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 37.9;U-2197: 106.0;U-87 MG: 39.1"									HPA040396			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Cytosol"		"HPA040396: AB_2676960"	"unprognostic (3.97e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (7.51e-3)"	"unprognostic (1.97e-3)"	"unprognostic (9.50e-3)"	"unprognostic (8.17e-2)"	"unprognostic (2.05e-2)"	"unprognostic (5.37e-4)"	2.8	5.0	10.4	1.3	18.6	0.2	2.5	20.3	18.6	9.3	4.5	6.8	1.2	4.2	7.9	3.6	8.3	4.0	2.9	12.7	17.0	1.2	0.2	1.6	0.5	21.3	21.7	14.3	1.3	0.8	21.8	0.3	24.0	2.3	2.4	4.5	1.5	3.7	2.4	1.9	2.5	3.4	15.0	0.6	2.5	32.4	20.4	0.4	2.3	10.5	0.5	7.7	6.1	33.6	0.1	3.6	0.3	0.4	2.6	0.2	0.1	2.8	0.3	1.8	1.4	0.2	0.1	0.0	6.3	1.1	19.5	0.1	5.1	0.0	0.4	0.0	4.2	0.1	0.1	0.1	1.8	0.1	2.3	1.4	0.0	3.5	0.0	0.2	0.0	7.6	8.9	0.2	1.3	0.2	0.6	0.1	8.2	0.1	1.0	0.0	0.2	0.1	0.0	0.1	10.5	2.4	9.2	0.5	37.9	11.2	0.1	1.1	0.1	18.9	7.5	106.0	6.0	5.3	14.3	1.4	39.1	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.5	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	10.4	18.6	20.3	18.6	12.7	17.0	21.3	21.7	24.0	15.0	20.4	33.6	0.3	0.0	0.0	19.6	0.1	0.8	0.3	0.0	0.0	11.5	0.6	0.3	1.9	0.0	0.0	0.0	10.4	0.0	0.1	0.1	0.0	0.1	12.6	0.5	1.4	0.2	0.0	0.0	70.0	0.0	0.0	5.9	0.5	0.1	1.3	0.3	0.4	0.0	0.3	11.8	44.3	0.0	0.0	0.0	0.8	20.0	4.1	0.4	5.4	10.3	0.1	5.2	0.0	10.1	196.5	0.1	0.0	2.2	0.2	0.5	0.0	0.4	2.2	4.3	6.6	1.9	1.8	34.1	62.3	0.0	0.6	0.1	0.4	0.0	0.0	0.1
CPVL		ENSG00000106066	"Carboxypeptidase vitellogenic like"	Q9H3G5	7	28995235-29195451	"Enzymes, Predicted intracellular proteins"		"Carboxypeptidase, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 219.0"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 306.1;Kupffer cells: 290.3;Langerhans cells: 531.0;Macrophages: 266.2;monocytes: 176.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 61.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 1136.9;intermediate monocyte: 953.5;myeloid DC: 1319.5"	"Group enriched"	"Detected in all"	52	"dendritic cells: 1319.5;monocytes: 1136.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 190.8;RPTEC TERT1: 801.1;U-266/84: 205.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB003697, HPA045715, HPA056466"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		760000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"		"CAB003697: AB_425990, HPA045715: AB_2679429, HPA056466: AB_2683140"	"unprognostic (4.72e-2)"	"unprognostic (7.08e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (1.63e-1)"	"unprognostic (2.49e-2)"	"unprognostic (6.85e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.07e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.21e-1)"	"unprognostic (7.46e-3)"	"prognostic unfavorable (4.99e-4)"	44.0	23.5	7.5	66.3	8.7	59.8	24.9	48.9	12.0	28.5	39.6	28.9	32.8	17.1	34.6	25.4	19.8	42.1	79.3	6.8	9.9	96.7	52.9	57.6	92.9	15.2	11.4	18.1	7.9	5.4	10.1	84.9	15.4	17.9	25.7	0.9	5.3	21.3	12.5	19.3	46.5	34.1	11.8	219.0	15.5	34.4	8.8	66.7	128.4	8.3	35.8	50.6	15.8	23.4	1.5	0.2	20.3	0.1	0.1	0.0	190.8	0.0	0.0	1.9	0.4	59.8	0.1	0.0	90.3	0.8	94.4	3.2	51.8	4.2	0.6	0.4	47.9	67.0	1.2	144.5	0.0	0.0	0.3	0.3	5.9	0.7	1.6	0.0	0.6	27.5	45.5	0.1	1.6	0.0	63.4	0.4	31.6	0.1	16.0	0.3	0.0	0.6	801.1	22.8	11.9	9.4	53.6	125.5	101.7	97.0	15.1	49.6	0.0	0.4	0.8	0.5	12.0	17.5	205.5	1.0	0.2	25.0	20.8	19.5	1136.9	5.7	2.6	953.5	3.4	1.8	1.3	1.9	1319.5	1.2	1.2	1.2	23.4	5.8	327.8	34.8	1.5	1142.7	7.5	8.7	48.9	12.0	6.8	9.9	15.2	11.4	15.4	11.8	8.8	23.4	12.3	6.4	16.0	3.3	7.2	12.5	1.3	0.7	5.7	0.0	2.6	3.4	69.1	10.0	2.5	71.7	0.0	138.0	2.1	0.2	35.2	0.5	24.7	3.7	0.3	21.1	1.8	34.1	3.7	15.6	118.3	29.4	1.1	0.6	5.1	2.3	6.8	1.1	306.1	0.0	1.7	1.2	0.0	290.3	531.0	7.6	9.3	266.2	10.6	45.9	176.8	0.2	2.1	2.0	1.3	0.8	0.4	3.0	2.9	0.5	0.4	30.6	1.5	0.4	0.0	31.0	3.0	27.1	92.8	27.2	8.8	118.5	3.3	3.6	1.2	0.9
CYBRD1	"CYB561A2, DCYTB, FLJ23462, FRRS3"	ENSG00000071967	"Cytochrome b reductase 1"	Q53TN4	2	171522247-171558129	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport"	"Oxidoreductase, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 221.2;Fibroblasts: 243.4;Leydig cells: 202.0;Peritubular cells: 221.5;Proximal enterocytes: 689.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.4;intermediate monocyte: 17.7;myeloid DC: 16.8;neutrophil: 9.8;non-classical monocyte: 13.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 16.8;granulocytes: 9.8;monocytes: 17.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1064.0;ASC TERT1: 453.8;BJ hTERT+: 408.2;HSkMC: 327.3;hTERT-RPE1: 276.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014757	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA014757: AB_1847374"	"unprognostic (1.35e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.44e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-2)"	166.7	97.5	32.6	24.4	38.8	18.3	148.7	33.9	34.1	140.0	32.6	68.7	197.7	100.2	49.7	70.6	88.2	153.7	128.6	28.2	45.9	32.0	21.7	129.9	33.8	45.2	38.7	180.9	21.6	12.0	26.1	38.1	40.5	70.6	39.0	22.2	63.7	76.7	23.3	85.0	233.4	87.9	35.6	30.6	53.3	23.8	35.9	27.9	231.0	82.8	30.1	84.3	90.4	43.0	24.8	18.1	10.1	19.2	1064.0	453.8	1.3	88.3	408.2	45.0	56.4	1.1	33.8	0.0	14.8	214.2	46.2	12.2	8.4	7.2	53.2	18.9	2.2	20.7	26.1	0.4	222.7	22.0	1.9	327.3	68.8	70.5	13.7	276.3	29.6	12.4	7.0	0.2	128.3	0.0	7.1	20.4	5.1	0.0	4.6	2.5	125.3	1.5	7.0	1.4	1.3	4.7	104.2	0.2	56.5	3.6	35.8	13.5	59.5	101.0	14.4	96.1	38.3	0.3	0.4	0.2	49.5	18.3	55.6	0.0	17.4	0.8	1.6	17.7	0.3	0.0	0.3	0.2	16.8	0.0	0.0	0.0	9.8	3.6	13.7	0.7	0.0	7.5	32.6	38.8	33.9	34.1	28.2	45.9	45.2	38.7	40.5	35.6	35.9	43.0	37.6	221.2	109.0	45.1	0.9	121.2	47.3	20.3	38.7	0.0	54.7	48.0	18.4	37.1	34.7	25.8	0.0	1.9	3.4	16.1	0.0	1.0	1.5	4.2	35.6	33.9	0.0	85.0	0.9	6.4	2.3	243.4	13.3	8.3	2.5	1.6	73.5	2.4	48.5	0.0	1.5	22.2	2.0	60.7	92.0	6.1	202.0	28.4	44.4	36.5	29.3	27.9	4.1	12.1	54.2	1.8	16.2	221.5	2.2	22.5	689.4	0.3	6.9	1.5	19.7	89.6	49.9	1.2	1.2	7.0	60.1	1.4	5.9	2.8	27.6	18.2
CYGB	"HGB, STAP"	ENSG00000161544	Cytoglobin	Q8WWM9	17	76527356-76551175	"Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 104.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 94.3;Fibroblasts: 87.6;Leydig cells: 95.7;Melanocytes: 78.2;Sertoli cells: 92.1;Smooth muscle cells: 95.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 34.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 79.6;Hep G2: 61.7;HHSteC: 120.7;HSkMC: 95.4;SH-SY5Y: 129.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017757, HPA061642"	Approved	Approved	Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"	Cytosol	"HPA017757: AB_1847410, HPA061642: AB_2684573"	"unprognostic (6.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.97e-2)"	"prognostic favorable (2.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.76e-2)"	79.6	20.8	10.1	12.0	10.7	1.7	55.1	20.6	13.6	27.7	14.1	27.1	21.1	19.6	4.6	12.8	20.4	13.2	104.4	9.5	15.8	12.4	19.0	27.8	7.2	17.5	26.0	13.8	12.8	11.7	10.9	8.9	26.8	29.9	9.3	77.6	14.2	11.0	19.3	19.5	26.6	5.9	10.1	12.2	22.9	5.3	14.3	5.3	50.1	9.6	2.6	50.7	25.6	9.8	0.2	1.1	1.8	0.4	79.6	23.1	26.1	0.7	2.0	0.3	0.9	0.0	0.3	0.2	24.1	2.4	0.3	0.7	0.1	33.7	0.1	0.1	0.2	0.4	0.4	61.7	120.7	0.0	0.0	95.4	7.2	2.5	2.5	0.4	0.3	0.8	0.3	0.1	1.2	0.8	0.2	0.4	0.3	0.0	1.4	0.5	0.3	0.2	0.4	0.1	0.6	129.8	0.1	0.0	2.7	5.9	0.2	0.6	0.2	3.1	1.6	0.3	0.0	1.2	0.3	0.3	0.2	0.3	9.9	0.0	0.1	0.1	0.2	0.1	0.1	1.6	0.1	0.0	0.1	2.2	0.2	0.5	0.9	1.0	0.0	0.0	0.2	0.2	10.1	10.7	20.6	13.6	9.5	15.8	17.5	26.0	26.8	10.1	14.3	9.8	94.3	3.2	2.0	2.0	3.5	10.8	1.3	17.3	3.4	38.5	1.4	5.7	6.1	0.0	6.7	0.0	0.0	1.4	1.9	0.1	0.0	0.8	0.7	2.9	4.2	23.1	0.0	0.0	2.4	0.2	0.6	87.6	1.5	0.7	0.0	0.2	2.2	1.2	0.4	8.4	12.3	0.0	0.0	0.0	13.3	2.5	95.7	2.6	78.2	3.7	0.0	22.1	0.0	1.0	1.0	0.1	0.0	23.3	0.6	0.8	0.0	0.2	21.1	12.9	92.1	21.8	95.6	1.6	1.4	0.7	6.7	2.9	2.6	9.2	0.0	1.0
DKK3	"REIC, RIG"	ENSG00000050165	"Dickkopf WNT signaling pathway inhibitor 3"	Q9UBP4	11	11956207-12009769	"Plasma proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 1224.0"	"Group enriched"	"Detected in many"	7	"Cardiomyocytes: 884.3;Muller glia cells: 1960.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 6.2;memory CD8 T-cell: 3.8"	"Lineage enriched"	"Detected in single"	62	"T-cells: 6.2"	"Cell line enhanced"	"Detected in many"		"BJ: 418.9;BJ hTERT+: 643.0;fHDF/TERT166: 614.4;hTERT-RPE1: 370.2;TIME: 349.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011868, CAB024949"	Approved		Supported	"Nuclear bodies,Vesicles,Cytosol"	"Secreted in other tissues"	No	No		18000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles	"Nuclear bodies, Cytosol"	"CAB024949: , HPA011868: AB_1847716"	"unprognostic (4.24e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (6.31e-5)"	"unprognostic (7.41e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.02e-3)"	31.2	79.1	110.7	10.0	183.6	0.2	26.0	12.6	135.2	89.7	104.8	53.2	14.6	47.0	16.7	29.7	23.0	67.0	1224.0	147.7	80.2	17.0	5.6	123.7	8.5	95.1	54.3	38.1	18.2	34.2	38.2	25.0	46.8	59.4	13.0	204.1	30.9	78.1	7.8	29.7	24.6	43.1	83.9	33.2	31.7	30.9	99.9	4.7	16.4	18.8	5.4	40.9	48.3	121.6	1.5	13.1	18.1	0.1	15.3	29.7	0.6	418.9	643.0	182.4	205.5	9.6	3.2	0.0	44.8	614.4	96.8	64.4	1.5	181.9	69.5	0.1	0.5	0.0	1.7	0.0	113.6	0.0	0.3	45.3	60.0	61.9	151.3	370.2	195.3	0.0	0.2	0.4	256.4	0.0	0.1	0.4	8.6	0.0	0.5	0.1	1.2	0.1	62.5	0.6	0.5	53.2	2.0	0.0	0.2	47.9	0.2	0.5	349.7	107.5	82.8	11.2	110.3	0.1	0.0	0.3	18.1	0.0	103.5	0.0	0.0	0.0	0.5	0.0	6.2	0.0	0.6	3.8	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	110.7	183.6	12.6	135.2	147.7	80.2	95.1	54.3	46.8	83.9	99.9	121.6	5.8	3.2	3.0	94.3	0.1	45.6	59.5	70.3	93.4	31.6	3.2	103.2	884.3	0.0	12.8	0.0	12.5	0.5	0.4	0.0	0.0	0.8	104.3	0.7	8.4	32.9	1.8	0.0	90.4	0.2	0.8	106.1	7.1	0.6	1.3	17.0	66.8	0.4	20.4	13.5	83.7	0.1	0.0	1.3	12.5	88.5	20.5	1.4	64.0	38.4	0.0	1960.4	0.0	27.6	14.7	1.1	0.1	57.6	1.7	32.8	0.0	0.2	2.9	67.5	190.7	12.7	83.4	1.2	3.2	5.8	14.8	0.8	4.1	0.5	0.3	3.0
DMC1	LIM15	ENSG00000100206	"DNA meiotic recombinase 1"	Q14565	22	38518948-38570204	"Predicted intracellular proteins"	"Cell cycle, Meiosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 12.3"	"Group enriched"	"Detected in many"	5	"Spermatocytes: 109.3;Spermatogonia: 36.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 25.5;hTEC/SVTERT24-B: 17.4;U-266/84: 21.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA001232, CAB015397"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"CAB015397: AB_629406, HPA001232: AB_1078683"	"unprognostic (1.29e-2)"	"unprognostic (3.11e-3)"	"unprognostic (4.48e-3)"	"unprognostic (5.71e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.22e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.99e-3)"	"unprognostic (7.40e-3)"	"unprognostic (1.00e-2)"	"unprognostic (2.16e-4)"	"unprognostic (3.94e-1)"	"unprognostic (2.79e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.99e-1)"	0.7	0.2	0.4	1.3	0.4	2.3	0.9	1.2	0.7	1.0	0.4	0.9	0.2	2.5	0.9	0.9	0.8	0.4	2.3	0.4	0.2	0.5	0.3	0.4	2.8	0.5	0.2	1.2	0.5	0.3	0.4	0.7	0.5	1.2	1.1	0.8	0.3	0.7	1.3	1.6	0.7	0.7	0.1	0.5	0.6	12.3	0.1	3.4	0.3	0.5	3.1	0.6	0.7	0.5	7.1	2.6	5.0	0.1	0.4	2.1	0.2	7.4	1.0	11.7	8.1	0.2	0.8	3.5	0.3	2.0	0.0	1.2	2.0	0.3	13.1	25.5	0.5	13.6	2.0	0.2	0.2	1.2	2.7	0.5	0.0	17.4	0.0	0.1	0.9	11.2	10.5	3.5	4.1	3.9	2.8	10.3	9.0	3.5	0.2	6.2	0.0	5.2	1.5	0.9	9.7	0.5	12.5	1.1	0.1	1.1	2.1	2.9	0.3	0.1	0.8	0.1	0.1	9.8	21.4	6.4	2.0	2.8	0.9	0.4	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.4	0.5	0.1	0.1	0.1	0.1	0.4	0.4	1.2	0.7	0.4	0.2	0.5	0.2	0.5	0.1	0.1	0.5	0.6	0.0	2.3	3.6	0.7	2.3	1.0	0.4	1.8	0.7	2.7	2.4	2.5	0.0	2.7	3.7	0.0	1.9	0.4	1.3	1.9	0.2	2.9	0.9	0.8	0.8	0.0	11.8	1.1	0.0	1.7	1.4	0.0	1.3	1.3	1.1	0.4	0.1	1.0	0.0	1.4	1.6	0.0	0.0	1.2	3.0	1.5	1.1	0.0	1.9	0.1	4.8	1.0	2.5	0.6	0.1	0.5	1.5	3.8	0.2	0.1	0.4	0.9	0.2	13.1	1.3	0.9	109.3	36.0	0.3	0.6	0.8	0.9	0.3	2.5	0.5
DOK5	"C20orf180, dJ805C22.1"	ENSG00000101134	"Docking protein 5"	Q9P104	20	54475593-54651169	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 46.0;tongue: 24.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 110.7;Distal tubular cells: 39.2;Excitatory neurons: 49.7;Horizontal cells: 38.7;Inhibitory neurons: 79.6;Muller glia cells: 63.9;Oligodendrocyte precursor cells: 58.3"	"Group enriched"	"Detected in many"	6	"glioma: 18.0;ovarian cancer: 29.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 32.9;ASC diff: 13.1;ASC TERT1: 11.0;hTEC/SVTERT24-B: 13.7;U-138 MG: 51.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054460, HPA065235"	Uncertain		Approved	"Focal adhesion sites"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Focal adhesion sites"		"HPA054460: AB_2682495, HPA065235: AB_2685441"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (8.99e-7)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-4)"	"unprognostic (5.12e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.49e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.99e-2)"	2.9	1.9	14.6	1.7	14.2	0.0	1.9	13.4	15.6	1.1	13.0	1.4	0.3	1.7	0.3	1.7	12.2	9.8	18.4	15.4	16.9	5.2	2.3	1.0	0.6	15.9	14.7	0.9	1.2	0.2	1.1	1.8	18.6	0.9	0.7	11.7	1.4	0.8	46.0	0.5	0.7	2.8	13.9	0.3	0.8	1.7	15.3	0.4	5.1	24.3	0.4	4.7	0.9	13.3	0.0	0.0	32.9	0.0	13.1	11.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	5.7	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	4.3	0.0	13.7	0.0	0.6	1.7	0.0	0.0	4.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	3.6	7.0	0.0	8.6	0.0	0.0	0.1	0.4	1.9	0.0	0.0	0.0	51.3	3.2	1.4	0.0	0.0	0.0	0.1	2.3	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	14.2	13.4	15.6	15.4	16.9	15.9	14.7	18.6	13.9	15.3	13.3	4.8	0.0	0.0	110.7	0.3	0.3	2.3	0.0	0.0	12.3	6.7	6.2	7.3	12.8	0.0	11.0	6.2	0.3	0.1	0.0	39.2	17.7	2.3	0.4	1.5	3.3	0.0	0.0	49.7	1.2	0.6	14.4	0.0	10.6	0.0	28.6	17.5	0.0	29.0	38.7	79.6	0.0	0.0	0.6	2.5	4.5	2.5	0.6	0.0	9.4	14.5	63.9	0.0	58.3	2.1	2.2	0.0	1.2	0.1	2.0	0.0	0.2	0.0	8.1	0.0	2.8	5.3	3.7	1.5	0.0	0.4	0.8	0.2	1.6	0.0	0.9
DPT		ENSG00000143196	Dermatopontin	Q07507	1	168695468-168729206	"Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 424.7"	"Group enriched"	"Detected in many"	5	"Fibroblasts: 457.5;Leydig cells: 231.8;Peritubular cells: 123.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"ASC diff: 143.3;fHDF/TERT166: 59.9"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"midbrain: 1.0"	HPA065548			Approved	Vesicles	"Secreted to extracellular matrix"	NA	NA		610000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA065548: AB_2685511"	"unprognostic (1.49e-1)"	"unprognostic (7.62e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.64e-2)"	"unprognostic (3.78e-3)"	"unprognostic (4.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (4.74e-5)"	"unprognostic (2.12e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.98e-3)"	334.6	39.6	0.4	28.6	0.5	0.0	251.3	0.5	1.0	177.6	0.5	424.7	18.8	63.2	60.8	86.0	129.1	78.0	241.4	0.5	0.4	13.2	29.0	48.6	58.6	0.5	0.4	30.3	84.8	4.9	2.1	37.5	0.6	55.2	58.2	0.0	72.0	52.7	37.1	39.2	94.2	138.5	0.5	0.9	108.5	15.4	0.5	48.0	75.0	209.3	70.1	103.3	166.9	0.7	0.0	0.0	0.0	0.0	143.3	0.6	0.2	0.1	6.7	7.2	7.4	0.0	0.0	0.0	0.0	59.9	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	4.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	7.6	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.5	1.0	0.5	0.4	0.5	0.4	0.6	0.5	0.5	0.7	18.7	3.2	1.7	0.3	0.3	31.9	0.1	0.0	1.8	0.0	2.2	2.3	7.4	0.0	0.6	0.0	0.0	0.6	0.4	0.1	0.0	0.1	1.2	0.3	10.7	6.9	0.0	0.0	4.8	0.2	0.8	457.5	3.1	0.2	0.0	0.0	8.9	0.0	0.6	0.0	3.4	0.0	0.0	0.0	45.6	4.4	231.8	4.0	39.2	1.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	123.8	0.5	0.5	0.0	0.1	0.0	0.0	0.0	24.4	18.5	0.5	0.3	3.1	32.0	0.4	5.0	2.2	0.0	0.6
DZIP1	"DZIP, KIAA0996"	ENSG00000134874	"DAZ interacting zinc finger protein 1"	Q86YF9	13	95578202-95644706	"Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Early spermatids: 384.1;Late spermatids: 774.5;Spermatocytes: 222.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054891, HPA057272"	Uncertain		Supported	Nucleoplasm,Centrosome		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Centrosome"		"HPA054891: AB_2682631, HPA057272: AB_2683390"	"unprognostic (6.74e-3)"	"unprognostic (7.65e-2)"	"unprognostic (1.94e-1)"	"unprognostic (4.64e-3)"	"unprognostic (4.82e-2)"	"unprognostic (5.52e-3)"	"unprognostic (6.34e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.34e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.89e-3)"	5.0	3.4	8.6	2.5	8.5	0.1	4.4	6.9	9.4	12.4	5.7	10.7	1.0	12.6	7.2	3.2	12.4	5.1	4.3	7.7	8.7	11.4	1.1	4.6	2.2	7.0	8.1	16.3	9.9	0.4	10.3	2.5	6.1	6.4	1.8	4.0	2.3	6.2	1.3	1.6	4.0	6.1	5.6	1.5	4.7	14.8	11.5	0.8	2.4	2.1	1.7	7.9	7.1	7.1	1.1	4.2	17.5	15.5	14.5	16.2	3.6	11.0	13.2	12.7	15.2	0.2	0.0	0.0	2.5	9.4	5.5	0.0	11.7	3.8	14.8	1.1	9.6	15.6	4.4	11.0	9.2	0.1	0.0	11.7	0.4	4.2	5.8	23.1	9.1	1.1	0.0	0.1	11.4	0.0	0.0	0.0	8.6	0.0	0.4	0.0	10.1	0.0	15.4	1.8	4.2	9.9	8.3	0.0	0.6	22.4	0.0	7.3	1.3	12.3	5.3	1.8	8.8	0.0	0.0	0.0	3.5	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.6	8.5	6.9	9.4	7.7	8.7	7.0	8.1	6.1	5.6	11.5	7.1	2.4	0.0	0.0	63.6	0.0	0.6	1.1	3.1	4.6	18.7	0.6	3.4	3.5	2.8	3.9	1.8	4.2	4.5	0.0	0.0	7.9	20.8	384.1	37.2	34.1	2.5	0.0	0.0	86.8	0.2	2.6	19.0	0.5	2.7	0.0	3.1	2.9	0.4	0.7	6.7	95.7	0.0	4.1	0.3	1.5	774.5	38.8	1.2	3.6	19.7	2.0	8.3	0.0	106.6	5.1	0.6	0.0	43.6	0.0	0.8	0.0	24.4	19.4	1.5	19.7	18.2	15.8	222.8	12.6	1.2	1.0	1.8	0.5	20.8	0.0	0.3
EGFLAM	"AGRINL, AGRNL, FLJ39155, PIKA"	ENSG00000164318	"EGF like, fibronectin type III and laminin G domains"	Q63HQ2	5	38258409-38465480	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"tongue: 121.2"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 120.9;Early spermatids: 50.7;Late spermatids: 49.1;Leydig cells: 155.4;Sertoli cells: 85.5;Smooth muscle cells: 70.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 10.2;HBEC3-KT: 12.6;hTERT-HME1: 16.4;HUVEC TERT2: 16.1;LHCN-M2: 37.0;U-2 OS: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA066577	Approved				"Secreted - unknown location"	NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA066577: "	"unprognostic (2.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.38e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.63e-3)"	"unprognostic (6.31e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.80e-2)"	"prognostic unfavorable (4.47e-5)"	"unprognostic (7.02e-6)"	"unprognostic (2.60e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.04e-2)"	41.7	19.8	2.0	2.8	2.5	0.2	47.1	1.9	2.3	15.6	3.5	6.1	1.9	5.6	6.8	4.0	8.2	4.9	26.2	1.5	2.4	6.9	4.7	2.9	14.2	3.2	4.2	23.7	3.1	4.0	5.8	51.6	3.6	14.2	3.2	66.7	6.9	20.6	72.0	5.9	4.7	6.7	1.6	9.8	3.4	15.0	3.6	20.4	9.0	121.2	9.1	7.7	13.0	2.5	3.2	0.0	6.5	0.2	0.8	0.2	0.0	2.9	0.0	0.5	0.1	0.0	0.0	0.1	10.2	0.1	0.1	0.0	0.0	12.6	0.0	0.0	1.6	0.0	6.1	0.0	2.8	0.0	0.1	5.4	0.0	0.1	16.4	0.0	16.1	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	3.9	0.0	3.7	0.1	1.3	0.0	0.2	0.0	0.1	15.6	0.6	0.2	0.0	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.5	1.9	2.3	1.5	2.4	3.2	4.2	3.6	1.6	3.6	2.5	11.4	0.0	0.0	0.3	0.0	2.7	0.3	0.0	0.0	1.3	2.4	9.8	2.6	0.0	0.0	0.0	120.9	0.3	0.4	0.0	3.9	0.5	50.7	0.2	3.2	5.4	0.0	0.0	0.6	1.0	0.5	17.8	0.0	0.3	0.0	1.6	1.4	0.0	0.7	0.0	0.9	0.0	0.0	0.0	4.2	49.1	155.4	0.6	5.4	1.9	0.0	3.4	0.0	1.0	0.1	1.3	0.0	30.9	0.0	0.2	0.0	6.5	0.0	33.1	85.5	22.0	70.9	9.8	3.3	0.3	2.0	0.5	0.4	23.5	0.0	0.3
ELN	"SVAS, WBS, WS"	ENSG00000049540	Elastin	P15502	7	74027789-74069907	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 70.4;Fibroblasts: 115.9;Leydig cells: 110.6;Peritubular cells: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 97.6;BJ: 143.7;fHDF/TERT166: 205.6;U-2197: 817.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010750, HPA018111, HPA056941"	Supported		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		2900000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: AB_2683280"	"unprognostic (1.51e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.72e-2)"	"unprognostic (3.70e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (3.90e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (1.62e-3)"	147.2	21.6	11.6	40.8	14.3	0.1	94.2	19.9	17.6	100.2	24.3	57.6	8.8	73.6	18.4	53.0	70.7	76.7	184.1	13.1	15.3	12.8	13.4	214.1	14.5	15.4	20.1	37.0	90.9	2.8	24.9	58.9	13.8	106.4	11.3	2.8	66.9	35.1	17.9	91.3	40.6	90.0	14.9	40.9	63.2	13.1	14.0	5.1	48.4	16.9	4.5	85.3	84.3	17.9	0.0	2.0	0.8	0.0	97.6	0.6	0.6	143.7	0.1	0.0	0.0	0.6	0.1	0.0	0.0	205.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.5	0.1	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.9	0.0	0.6	0.6	8.3	0.8	0.8	0.4	58.0	1.0	0.0	0.0	28.0	68.9	0.0	1.2	0.1	10.0	0.6	0.0	0.0	0.2	0.3	817.9	0.0	0.2	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.6	14.3	19.9	17.6	13.1	15.3	15.4	20.1	13.8	14.9	14.0	17.9	34.6	0.0	6.4	34.9	0.1	11.0	13.5	33.9	4.0	2.8	0.9	1.1	9.7	2.8	4.3	7.3	2.1	0.1	0.3	0.2	0.0	0.3	3.5	3.5	70.4	28.4	1.8	0.0	4.6	3.9	0.3	115.9	7.1	2.3	0.0	0.2	47.2	4.2	0.5	6.7	8.1	1.3	0.0	0.6	20.4	7.5	110.6	1.2	14.2	23.4	0.0	15.9	0.0	14.1	18.5	1.1	0.2	148.2	0.4	1.4	0.0	0.1	3.0	0.8	0.0	12.2	34.1	1.1	1.2	2.1	10.9	0.1	1.2	0.6	0.2	1.1
ENPEP	"CD249, gp160"	ENSG00000138792	"Glutamyl aminopeptidase"	Q07075	4	110365733-110565285	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"		"Aminopeptidase, Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 163.6;kidney: 90.0"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 663.2;Proximal tubular cells: 177.6;Sertoli cells: 157.8"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 41.0"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HEK 293: 7.5;MOLT-4: 1.8;SuSa: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA005128	Enhanced					NA	NA		55000000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"			"HPA005128: AB_1844795"	"unprognostic (2.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.47e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-3)"	11.6	2.2	0.4	1.5	0.5	0.1	4.8	0.4	2.5	1.6	1.8	1.2	36.6	12.9	4.1	1.7	2.3	4.4	4.3	0.6	0.5	90.0	29.0	4.6	0.8	0.9	0.8	1.2	1.3	45.2	1.2	15.5	0.7	1.8	0.8	0.0	1.1	1.2	2.3	0.7	163.6	10.6	0.5	9.2	1.2	0.5	0.4	4.4	5.0	8.9	0.3	2.6	1.6	0.8	0.0	0.2	0.0	0.0	0.1	0.1	2.7	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.8	0.3	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.1	0.0	1.3	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	2.5	0.6	0.5	0.9	0.8	0.7	0.5	0.4	0.8	10.7	0.0	2.0	1.6	1.1	1.7	0.1	0.0	0.0	0.0	0.2	0.1	3.9	0.0	0.3	11.0	0.0	37.0	0.0	1.5	17.6	0.0	0.5	3.1	40.7	2.2	1.8	0.0	7.3	0.0	3.5	15.4	0.0	2.3	0.0	0.0	1.4	31.4	2.7	0.0	2.9	28.4	2.0	1.0	1.9	0.2	0.6	1.1	0.0	1.0	0.0	0.0	1.0	0.0	0.8	0.0	31.6	0.4	0.1	0.2	663.2	177.6	1.7	0.0	157.8	0.8	54.1	0.0	0.2	0.1	1.0	58.6	1.9	0.5	42.1	0.1
EPHA7	Hek11	ENSG00000135333	"EPH receptor A7"	Q15375	6	93240020-93419687	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 24.6;parathyroid gland: 69.9"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 138.6;Inhibitory neurons: 172.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 12.0;HEK 293: 35.1;RH-30: 31.7;THP-1: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010496	Approved				"Intracellular and membrane"	NA	NA		660000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB010496: AB_2099673"	"unprognostic (3.34e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.62e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.82e-2)"	0.3	0.0	1.2	0.4	3.4	0.0	1.2	3.4	5.1	1.4	0.0	24.6	1.5	0.9	0.2	0.2	0.5	2.2	3.6	4.9	2.6	5.9	0.0	0.2	0.0	1.2	2.2	1.9	0.1	69.9	1.2	0.4	1.5	9.7	2.5	1.8	5.4	0.9	0.1	0.2	4.4	2.1	0.4	3.9	10.3	0.9	0.6	0.0	0.1	0.1	0.0	8.2	1.8	1.2	0.0	0.5	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	35.1	0.0	3.0	0.0	0.0	0.0	0.0	0.5	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.6	0.0	1.0	5.4	31.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	32.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.4	3.4	5.1	4.9	2.6	1.2	2.2	1.5	0.4	0.6	1.2	0.2	0.0	0.0	4.2	0.0	0.4	0.4	0.0	0.6	18.5	3.1	1.8	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	13.1	1.3	1.4	1.8	0.0	0.0	138.6	0.0	0.0	5.9	0.0	3.8	0.0	3.7	0.0	0.0	0.1	11.8	172.0	0.0	0.0	0.0	0.4	3.3	0.9	0.1	0.0	11.2	0.0	0.4	0.0	4.5	8.3	0.1	0.0	0.0	0.0	0.4	0.0	11.8	0.0	1.0	0.0	0.2	0.5	0.2	1.1	0.2	1.0	0.0	0.2	0.9	0.0	0.1
FAM171B	"FLJ34104, KIAA1946"	ENSG00000144369	"Family with sequence similarity 171 member B"	Q6P995	2	186694060-186765959	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 258.6;Bipolar cells: 141.4;Excitatory neurons: 126.5;Inhibitory neurons: 114.2;Oligodendrocyte precursor cells: 102.1;Oligodendrocytes: 78.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 15.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 43.7;U-138 MG: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010639, HPA013434"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Mitochondria"		"HPA010639: AB_1852447, HPA013434: AB_2262499"	"unprognostic (2.52e-1)"	"unprognostic (7.75e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-2)"	"unprognostic (4.03e-2)"	"unprognostic (9.43e-2)"	"unprognostic (6.78e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (9.51e-7)"	"unprognostic (4.63e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.03e-4)"	2.9	14.4	36.1	1.5	52.2	0.5	3.4	8.3	54.8	6.6	0.0	1.8	1.0	7.5	2.1	1.9	2.7	4.9	1.4	52.8	33.0	1.2	0.3	1.4	1.2	15.0	16.9	10.2	1.0	7.6	10.7	3.3	17.6	2.7	2.0	24.1	23.0	2.3	0.7	3.7	1.4	4.4	17.2	1.5	2.0	0.9	28.3	2.8	2.2	3.6	1.1	2.2	2.2	30.1	4.2	4.9	7.2	22.6	20.9	15.7	0.1	4.5	8.0	5.5	7.8	13.6	21.9	0.0	1.6	12.9	9.3	0.5	9.9	4.3	7.8	0.0	5.7	5.1	2.1	0.0	1.6	1.5	1.7	20.2	1.8	4.2	3.4	7.1	12.1	3.9	0.0	43.7	10.5	2.9	3.0	0.0	9.6	0.0	4.9	0.0	13.9	1.0	8.5	15.8	22.4	12.2	2.3	1.4	6.1	4.2	1.7	1.0	7.1	29.7	3.9	0.5	2.9	11.5	12.0	0.0	9.2	0.0	4.2	0.2	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.4	0.2	0.2	0.0	0.0	36.1	52.2	8.3	54.8	52.8	33.0	15.0	16.9	17.6	17.2	28.3	30.1	9.1	0.0	0.0	258.6	0.1	8.9	2.8	1.2	4.0	141.4	10.7	5.7	0.8	5.7	5.7	0.0	14.6	11.4	0.5	0.0	0.0	1.0	1.3	1.5	13.0	14.4	4.8	1.3	126.5	0.4	0.8	14.1	2.6	4.7	0.0	0.8	6.8	0.1	2.0	23.5	114.2	0.0	4.1	0.3	2.8	4.0	7.8	1.0	3.6	18.7	0.7	16.2	0.0	102.1	78.5	0.7	0.0	13.9	0.2	1.4	0.0	0.2	2.6	17.0	0.0	8.6	4.5	0.4	1.5	0.6	5.3	8.2	0.9	2.6	0.0	1.1
FBLN5	"ARMD3, DANCE, EVEC, UP50"	ENSG00000140092	"Fibulin 5"	Q9UBX5	14	91869411-91947987	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"		"Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Fibroblasts: 209.4;Leydig cells: 626.6;Peritubular cells: 794.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 6.6"	"Group enriched"	"Detected in many"	19	"granulocytes: 6.6;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 457.1;ASC TERT1: 234.6;BJ: 202.0;BJ hTERT+: 202.5;fHDF/TERT166: 394.6;HSkMC: 216.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000848, HPA000868, CAB025843"	Supported		Uncertain	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		12000000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619"	"unprognostic (5.53e-3)"	"unprognostic (1.14e-1)"	"unprognostic (7.78e-2)"	"unprognostic (9.29e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.73e-2)"	"prognostic favorable (6.75e-4)"	"unprognostic (5.21e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.74e-2)"	"unprognostic (1.90e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.18e-2)"	"unprognostic (3.17e-3)"	182.2	73.4	10.7	17.7	12.8	7.5	110.4	7.4	12.5	124.9	15.7	80.3	19.1	178.4	40.0	26.8	143.0	130.2	211.1	9.4	8.6	108.4	29.3	164.8	25.5	15.5	10.9	107.3	46.4	16.8	14.5	67.0	14.2	49.0	20.6	0.6	55.8	70.9	30.4	66.9	52.7	88.7	13.1	130.9	68.9	35.6	12.7	21.8	79.5	36.0	15.7	117.5	93.3	7.5	0.0	1.6	0.2	0.0	457.1	234.6	22.5	202.0	202.5	5.8	4.5	4.7	0.0	0.0	4.2	394.6	0.6	0.1	9.8	1.0	1.0	0.0	2.3	0.4	4.7	0.0	74.2	0.0	0.1	216.6	0.4	3.9	14.1	2.8	10.4	0.1	0.0	0.1	25.3	0.4	0.5	0.5	0.5	0.0	0.5	0.4	30.2	0.2	1.2	0.1	0.2	0.1	12.3	0.7	2.6	7.0	2.9	0.3	1.9	3.2	6.6	3.8	0.1	0.1	0.0	0.2	0.4	0.0	0.0	6.6	0.1	2.2	0.8	0.2	0.5	0.0	0.3	0.1	0.0	0.1	1.1	1.8	2.5	0.0	0.2	0.0	0.1	0.4	10.7	12.8	7.4	12.5	9.4	8.6	15.5	10.9	14.2	13.1	12.7	7.5	31.4	83.3	13.1	0.0	2.1	9.2	2.4	7.1	1.8	0.0	11.2	9.3	5.2	0.0	11.5	5.5	0.0	2.5	2.5	0.1	5.9	4.7	5.9	13.3	67.4	15.2	0.0	0.4	2.6	4.7	2.5	209.4	2.0	12.0	2.5	1.8	34.2	0.4	7.8	0.0	3.6	0.1	18.3	2.5	18.4	27.5	626.6	5.8	21.4	15.9	1.6	0.0	8.2	5.0	2.3	2.2	0.0	794.8	0.7	1.3	0.0	32.5	21.4	0.0	6.6	28.0	14.5	3.0	2.8	1.3	8.7	3.7	15.5	3.5	0.4	1.2
FLRT2		ENSG00000185070	"Fibronectin leucine rich transmembrane protein 2"	O43155	14	85530144-85654428	"Predicted membrane proteins"	"Cell adhesion"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 29.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 279.5;Excitatory neurons: 549.6;Inhibitory neurons: 321.3;Leydig cells: 219.0;Microglial cells: 432.8;Oligodendrocyte precursor cells: 212.1"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"basal ganglia: 2.1;cerebral cortex: 8.2;hippocampal formation: 4.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 60.1;HUVEC TERT2: 38.7;TIME: 55.3;U-138 MG: 58.8;U-2197: 43.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA		17000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.59e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.46e-2)"	"unprognostic (4.75e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (5.34e-2)"	"unprognostic (8.02e-6)"	"unprognostic (1.98e-3)"	"unprognostic (8.03e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.50e-5)"	9.2	4.5	0.8	4.5	2.1	0.1	2.9	0.0	8.2	11.0	2.3	2.7	0.9	6.1	3.0	3.5	6.4	9.1	3.8	4.7	0.0	1.4	1.2	2.3	3.5	0.0	0.0	29.6	21.7	1.3	1.9	1.2	0.0	5.1	3.1	3.1	1.9	3.3	7.3	6.1	1.7	5.2	0.0	3.0	2.2	4.6	0.2	1.2	4.9	3.1	2.6	5.3	4.2	0.0	0.0	0.2	8.9	0.0	7.9	14.5	0.0	9.7	6.3	9.0	8.4	0.0	0.0	0.0	0.0	28.5	0.9	2.0	13.6	18.6	21.8	0.0	7.8	0.0	5.3	0.0	25.2	2.1	0.0	8.0	10.6	7.5	60.1	2.7	38.7	0.0	0.0	0.0	21.8	0.0	0.0	0.0	4.2	0.0	0.2	0.0	10.8	0.0	0.0	0.0	2.1	0.0	2.3	0.0	3.2	11.8	0.0	0.1	55.3	58.8	9.9	43.0	17.8	0.0	0.0	0.0	18.5	0.0	5.8	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	2.1	0.0	8.2	4.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.9	0.0	1.3	279.5	0.1	21.4	1.7	5.2	6.2	7.0	3.9	4.4	4.0	10.0	0.4	1.8	0.0	0.4	0.1	0.1	0.0	66.2	3.1	2.2	65.1	15.9	0.0	0.0	549.6	42.8	0.2	34.3	0.5	1.6	0.0	39.9	66.0	0.2	2.4	10.1	321.3	0.0	0.0	1.3	6.6	7.7	219.0	1.2	1.8	432.8	0.6	13.2	0.0	212.1	9.0	20.4	0.0	124.8	0.0	1.1	0.0	0.2	1.7	1.4	13.1	3.2	8.5	1.1	0.6	1.0	24.0	0.8	0.8	32.3	0.0	0.2
FRZB	"FRE, FRITZ, FRP-3, FRZB-1, FRZB-PEN, FRZB1, FZRB, hFIZ, SFRP3, SRFP3"	ENSG00000162998	"Frizzled related protein"	Q92765	2	182833275-182866637	"Disease related genes, Predicted secreted proteins"	"Differentiation, Wnt signaling pathway"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 336.9"	"Cell type enriched"	"Detected in many"	13	"Muller glia cells: 3633.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 19.2;ASC diff: 9.4;NTERA-2: 7.4;SH-SY5Y: 6.5"	"Region enhanced"	"Detected in all"		"olfactory bulb: 56.9"	"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA		44000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (5.39e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.64e-2)"	"unprognostic (2.38e-2)"	"unprognostic (4.67e-2)"	"unprognostic (8.58e-2)"	"unprognostic (5.41e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (8.97e-6)"	"unprognostic (3.53e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.04e-2)"	"unprognostic (3.21e-1)"	10.4	5.7	10.4	6.1	12.8	0.7	12.6	11.0	18.6	20.3	52.2	16.2	14.4	17.2	11.4	12.4	7.1	39.0	19.9	10.3	11.2	16.3	3.3	9.1	18.7	14.1	10.9	13.5	7.1	6.7	18.6	30.5	15.4	12.9	19.9	336.9	4.7	16.6	26.6	10.4	14.5	31.1	11.9	88.9	21.9	14.2	11.3	4.9	10.8	116.2	11.9	10.3	12.3	10.3	0.0	0.0	19.2	0.2	9.4	0.2	0.2	0.0	0.9	3.2	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.4	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.8	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	7.4	0.0	0.0	0.6	0.8	0.0	0.0	0.0	1.0	6.5	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	12.8	11.0	18.6	10.3	11.2	14.1	10.9	15.4	11.9	11.3	10.3	13.8	0.0	0.5	1.0	0.8	8.2	0.4	0.2	0.6	39.8	7.8	18.7	2.9	0.0	1.4	0.0	33.3	5.3	0.5	2.1	0.0	0.1	0.3	0.5	1.4	18.5	1.2	0.0	2.7	8.2	3.8	97.8	9.7	0.9	0.0	0.5	3.6	1.0	7.8	26.9	7.7	137.4	0.0	0.8	3.7	2.8	3.7	0.5	245.5	25.3	0.0	3633.8	0.0	8.5	1.7	0.2	0.8	14.7	5.8	1.8	1.3	0.2	0.2	124.4	276.1	41.9	157.1	0.2	0.1	0.6	3.1	12.4	1.5	22.9	3.4	0.6
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138824-35143109	"Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1381.3;tongue: 838.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 225.1;Hepatocytes: 651.7;Leydig cells: 430.3;Muller glia cells: 343.4;Skeletal myocytes: 188.7;Smooth muscle cells: 205.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 11.0"	"Group enriched"	"Detected in many"	4	"B-cells: 11.0;T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 46.7;ASC TERT1: 13.5;HSkMC: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	141.4	26.1	496.5	9.6	528.9	2.2	125.1	506.1	637.3	291.9	616.5	168.3	14.3	173.3	62.1	70.7	187.3	56.3	557.7	487.5	503.4	28.6	558.7	85.8	6.6	568.0	515.0	144.7	19.2	3.8	39.8	29.3	494.8	116.0	25.6	35.9	37.2	73.5	1381.3	48.3	67.2	104.5	511.1	20.8	72.6	12.1	560.2	8.2	38.0	838.7	6.7	80.0	194.9	498.6	1.1	0.0	0.0	0.2	46.7	13.5	1.3	5.7	0.1	0.0	0.0	0.0	0.3	3.8	1.5	0.0	0.1	1.0	1.1	0.7	0.0	3.4	1.3	0.7	0.0	1.9	5.2	0.3	0.4	19.3	0.0	0.1	0.5	0.5	0.2	0.1	1.0	3.7	0.1	0.0	0.1	0.8	0.2	2.8	0.6	0.0	0.2	1.1	0.0	0.0	0.3	0.2	0.7	0.2	1.8	0.3	0.2	6.1	0.5	0.1	0.5	0.4	0.0	0.1	0.0	0.4	0.9	0.6	7.7	1.6	0.3	0.0	1.3	0.7	0.8	11.0	3.6	1.5	0.3	6.9	0.7	0.9	0.5	2.1	0.8	0.6	6.9	0.6	496.5	528.9	506.1	637.3	487.5	503.4	568.0	515.0	494.8	511.1	560.2	498.6	46.1	0.0	0.0	44.4	15.8	29.4	3.7	2.7	8.0	1.8	4.4	18.0	0.3	11.5	0.8	25.8	4.2	1.2	9.5	42.2	0.0	0.1	1.9	2.2	47.4	13.3	0.0	8.4	3.7	4.9	1.6	225.1	2.0	1.2	0.0	0.1	36.0	651.7	4.4	0.0	0.4	0.8	2.0	14.4	49.0	12.0	430.3	5.3	53.4	2.8	1.0	343.4	1.0	1.5	0.5	1.1	5.3	128.2	2.5	3.3	0.4	0.2	12.6	8.6	118.3	188.7	205.7	10.7	21.7	3.0	27.3	2.9	18.8	0.1	0.7	2.5
FXYD6		ENSG00000137726	"FXYD domain containing ion transport regulator 6"	Q9H0Q3	11	117836976-117877486	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 163.9;Leydig cells: 237.9;Muller glia cells: 128.7;Peritubular cells: 363.8;Sertoli cells: 355.0;Theca cells: 141.8"	"Cancer enriched"	"Detected in all"	6	"glioma: 71.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"classical monocyte: 37.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 37.7"	"Cell line enhanced"	"Detected in some"		"AF22: 136.0;HAP1: 92.9;RH-30: 57.1;SCLC-21H: 204.5;SH-SY5Y: 114.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041334, HPA042284"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA041334: AB_10970752, HPA042284: AB_2677931"	"unprognostic (2.18e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.31e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (3.44e-2)"	"prognostic favorable (4.38e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.60e-4)"	58.4	116.3	230.8	30.1	258.5	9.8	39.5	82.5	293.2	112.3	28.1	371.1	22.2	321.5	61.0	29.8	181.6	93.1	117.1	244.3	187.3	70.6	32.8	86.6	30.0	91.8	173.6	281.1	30.1	9.8	175.0	16.7	149.5	107.8	35.9	47.1	29.5	73.2	37.3	22.2	104.6	197.6	71.4	151.9	98.9	86.6	136.4	31.2	66.5	78.3	18.9	202.9	80.4	179.3	0.3	0.9	136.0	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.6	0.1	4.8	0.7	92.9	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.3	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.2	2.6	0.0	1.7	6.3	0.5	27.2	0.0	0.0	0.1	57.1	1.0	3.5	0.1	204.5	114.0	0.0	0.5	5.1	36.9	2.4	2.4	0.0	0.0	30.0	0.5	0.0	0.4	0.3	0.1	1.0	0.4	0.4	0.0	37.7	0.0	0.0	9.4	0.6	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.9	0.0	0.1	0.6	0.0	9.9	230.8	258.5	82.5	293.2	244.3	187.3	91.8	173.6	149.5	71.4	136.4	179.3	72.2	6.4	2.2	0.0	1.1	6.6	2.4	1.1	0.6	3.5	2.1	21.5	9.3	1.5	0.7	0.0	2.1	0.8	1.0	0.0	1.9	6.4	3.6	0.6	23.9	71.8	12.5	10.7	0.0	0.4	1.1	78.6	0.5	1.0	0.0	29.7	163.9	1.6	72.7	1.7	0.0	0.2	6.1	32.4	9.6	14.3	237.9	18.7	16.0	0.0	9.8	128.7	1.0	0.0	0.0	0.4	0.0	363.8	1.2	4.9	0.0	0.1	1.7	4.4	355.0	49.6	79.6	4.6	3.5	1.4	3.8	1.4	1.4	141.8	0.0	1.7
GATA6		ENSG00000141448	"GATA binding protein 6"	Q92908	18	22169589-22202528	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 57.8;ovary: 73.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 97.6;Gastric mucus-secreting cells: 100.9;Granulosa cells: 52.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 26.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	23	"basophil: 4.0"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 4.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 54.8;CACO-2: 69.7;hTERT-RPE1: 25.5;OE19: 37.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011581, HPA066629"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB011581: AB_732529, HPA066629: AB_2685695"	"unprognostic (1.90e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.43e-2)"	"unprognostic (4.36e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.61e-1)"	"unprognostic (8.45e-3)"	"prognostic unfavorable (1.92e-9)"	"unprognostic (8.75e-3)"	"unprognostic (2.07e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-2)"	22.2	57.8	0.0	2.5	0.2	0.0	3.8	0.0	0.3	4.9	2.8	11.4	22.8	19.8	1.2	0.8	28.9	11.1	43.9	0.1	0.0	3.0	12.6	14.8	1.9	0.1	0.0	73.0	22.7	0.3	0.6	6.5	0.0	5.5	11.0	0.1	0.8	0.7	0.8	1.5	20.7	9.5	0.2	15.0	49.6	6.3	0.1	0.4	5.3	0.6	0.2	23.0	3.2	0.0	10.1	1.4	0.0	0.0	2.1	1.0	54.8	0.3	0.4	0.8	1.0	69.7	3.8	0.0	3.2	1.2	3.4	10.8	0.4	4.5	1.4	0.0	13.6	0.0	4.3	6.1	14.3	0.6	0.6	0.4	8.9	12.1	9.1	25.5	9.5	0.0	0.5	0.0	0.0	1.5	0.0	0.2	0.1	37.6	9.8	0.0	1.1	0.2	0.4	2.8	0.9	0.1	10.7	6.1	3.0	2.7	1.7	0.0	0.7	1.4	1.6	11.4	1.7	0.0	0.0	0.0	6.2	0.3	9.9	4.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	7.3	44.8	30.2	0.0	0.0	0.9	4.0	4.6	1.8	0.0	3.4	2.7	97.6	30.0	6.1	0.0	0.0	0.9	0.9	50.0	0.0	28.4	44.7	6.3	6.3	11.5	26.0	2.7	0.1	19.6	11.2	24.4	100.9	16.6	5.1	52.9	28.5	11.1	1.6	0.0	0.1	45.8	2.0	0.6	0.9	8.8	3.4	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.2	36.8	27.7	10.1	0.2	4.1	43.3	0.0	3.9	0.0	32.9	0.4	8.6	1.4	1.4	0.9	0.9	1.9	1.3	11.4	47.2	2.9
GLIS2	NPHP7	ENSG00000126603	"GLIS family zinc finger 2"	Q9BZE0	16	4314761-4339597	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Ciliopathy, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Leydig cells: 22.1;Peritubular cells: 33.8;Proximal tubular cells: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-2197: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062755, HPA065406"			Enhanced	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA062755: , HPA065406: "	"unprognostic (2.86e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.96e-2)"	"prognostic unfavorable (1.59e-5)"	"unprognostic (3.76e-1)"	"unprognostic (5.15e-2)"	"unprognostic (8.13e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.37e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (8.06e-6)"	"unprognostic (1.59e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.40e-3)"	16.3	23.4	4.4	2.5	4.1	0.1	11.4	5.2	3.9	22.3	3.3	19.2	1.5	20.9	0.7	4.9	17.3	5.6	30.9	3.1	3.8	41.5	3.2	30.6	1.6	5.6	5.6	27.5	13.2	2.3	18.9	4.4	4.3	21.7	0.4	0.7	9.8	4.0	3.0	7.1	7.4	3.3	4.4	4.5	11.9	5.3	5.5	0.2	19.4	0.4	0.5	20.2	11.4	2.5	6.1	12.3	2.0	4.8	1.5	7.2	4.3	6.1	5.3	2.3	1.6	3.2	5.1	0.0	10.8	6.0	2.2	3.7	1.2	5.6	0.1	8.9	0.3	0.0	10.9	1.9	6.9	0.0	0.9	4.1	1.2	1.9	0.9	2.6	1.9	0.1	0.5	2.0	1.3	4.0	0.0	1.2	4.6	0.7	2.2	11.7	2.6	6.7	0.4	0.0	0.9	4.6	6.1	2.9	1.7	0.6	8.2	1.0	3.2	3.2	6.0	36.8	1.9	1.4	0.9	1.5	1.4	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	4.1	5.2	3.9	3.1	3.8	5.6	5.6	4.3	4.4	5.5	2.5	4.8	16.0	9.8	8.5	0.0	5.6	5.4	8.7	1.8	10.6	3.5	2.4	5.9	15.7	5.6	12.9	4.2	0.9	0.1	0.0	19.6	11.8	0.2	1.8	9.0	6.9	0.0	0.0	2.1	8.3	0.9	18.3	0.5	2.1	0.0	2.6	6.8	0.7	0.4	6.7	3.2	0.2	2.0	0.3	6.1	0.9	22.1	0.8	3.6	5.6	1.0	10.4	0.0	4.0	1.3	10.3	0.0	33.8	0.0	5.1	0.0	21.7	3.1	7.3	0.0	8.2	14.6	0.2	3.4	0.7	2.8	1.1	0.7	0.1	0.0	2.8
GPM6B	"M6B, MGC17150, MGC54284"	ENSG00000046653	"Glycoprotein M6B"	Q13491	X	13770939-13938638	"Predicted membrane proteins"	"Differentiation, Neurogenesis, Osteogenesis, Protein transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 743.2;choroid plexus: 180.7;retina: 207.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 633.3;Excitatory neurons: 361.3;Melanocytes: 357.5;Muller glia cells: 1722.4;Oligodendrocyte precursor cells: 408.1;Oligodendrocytes: 1476.6"	"Cancer enriched"	"Detected in many"	5	"glioma: 192.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	220	"plasmacytoid DC: 77.7"	"Lineage enriched"	"Detected in single"	268	"dendritic cells: 77.7"	"Cell line enhanced"	"Detected in many"		"AF22: 154.8;AN3-CA: 150.1;ASC TERT1: 74.2;HSkMC: 110.0;SK-MEL-30: 154.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002913	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA002913: AB_2263553"	"unprognostic (1.56e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (2.12e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.27e-2)"	"prognostic favorable (2.67e-4)"	"unprognostic (1.79e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.38e-3)"	"unprognostic (8.34e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-1)"	7.5	9.3	418.4	6.0	518.8	1.1	26.4	540.4	521.1	27.1	180.7	33.8	5.0	6.3	12.1	11.5	6.5	5.9	15.8	447.8	463.6	7.7	1.1	16.8	2.8	596.3	459.3	4.4	3.2	0.6	17.2	1.3	580.5	21.8	7.8	207.7	14.8	35.2	2.5	13.9	9.2	5.4	533.4	14.5	11.7	3.5	419.9	0.8	5.0	7.5	1.9	9.1	19.7	743.2	0.4	0.4	154.8	150.1	41.6	74.2	0.4	0.9	6.9	0.1	0.0	0.4	0.5	0.7	0.3	0.0	0.6	1.3	7.6	0.8	0.0	0.6	25.2	0.4	10.0	0.4	1.5	0.5	0.9	110.0	0.9	0.0	1.9	0.6	0.0	3.0	0.4	6.8	1.5	0.6	3.4	0.7	48.5	0.1	2.5	2.0	13.7	23.9	0.0	0.5	7.8	4.4	0.8	4.4	154.4	41.9	0.7	3.6	0.3	1.0	1.3	0.3	2.0	0.5	0.3	0.3	1.4	0.3	12.4	0.2	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.2	0.1	77.7	0.1	0.7	418.4	518.8	540.4	521.1	447.8	463.6	596.3	459.3	580.5	533.4	419.9	743.2	13.8	0.0	5.1	633.3	15.8	33.0	22.7	5.9	6.8	74.4	37.1	47.1	1.3	1.5	7.8	22.0	87.6	5.0	50.7	3.0	0.0	5.4	1.5	45.8	32.7	12.5	1.2	5.3	361.3	3.7	3.7	54.2	0.0	30.4	4.5	19.7	10.8	0.4	1.2	26.9	144.0	5.0	8.2	1.9	33.5	3.2	24.2	3.7	357.5	40.3	4.6	1722.4	50.4	408.1	1476.6	2.3	6.0	32.0	7.3	26.5	6.1	1.1	11.0	151.4	46.0	137.7	43.6	9.6	13.3	7.0	17.0	13.7	20.5	8.6	3.2	14.8
GXYLT2	GLT8D4	ENSG00000172986	"Glucoside xylosyltransferase 2"	A0PJZ3	3	72888046-72998138	"Enzymes, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 47.9;Endometrial stromal cells: 45.4;Fibroblasts: 23.0;Late spermatids: 27.1;Oligodendrocytes: 61.3;Skeletal myocytes: 40.0;Theca cells: 22.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 22.3;JURKAT: 22.1;MOLT-4: 36.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA068429	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Midbody ring"		Yes	No			"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Cytokinetic bridge, Midbody ring"	"HPA068429: AB_2685988"	"unprognostic (9.43e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.90e-1)"	"unprognostic (4.77e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.04e-2)"	"unprognostic (4.79e-3)"	"unprognostic (5.29e-2)"	"unprognostic (5.25e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (3.22e-3)"	"unprognostic (4.70e-1)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (2.42e-5)"	6.0	3.8	2.6	5.2	5.3	1.8	4.0	4.3	3.2	5.7	2.6	3.7	0.6	5.6	2.5	3.2	5.1	10.1	13.6	2.0	2.4	0.9	0.3	3.8	1.5	6.2	5.8	16.5	4.2	2.4	1.9	4.0	4.1	3.3	2.0	0.4	5.3	4.0	0.8	1.7	1.2	5.5	5.3	0.7	1.3	5.8	4.6	6.7	8.8	1.5	1.0	5.7	3.6	6.9	0.2	1.8	0.1	11.2	9.9	19.3	1.7	1.8	4.2	4.0	9.8	0.5	1.2	0.0	3.1	4.9	22.3	0.1	1.0	2.2	3.8	0.0	1.3	0.0	7.2	12.4	12.6	4.9	0.0	18.8	1.1	9.7	1.6	6.0	0.0	22.1	5.8	0.1	2.4	2.7	36.5	0.1	6.6	0.1	2.2	0.2	9.5	0.0	1.3	1.7	1.1	5.0	9.8	0.5	1.3	2.0	3.7	1.5	0.1	4.3	13.5	13.3	6.5	1.0	0.1	0.2	11.1	2.3	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.3	0.0	2.6	5.3	4.3	3.2	2.0	2.4	6.2	5.8	4.1	5.3	4.6	6.9	1.6	3.2	2.6	7.2	0.1	1.9	1.9	5.3	0.0	0.6	1.5	7.6	14.6	2.8	2.3	0.0	0.0	0.2	1.5	1.4	0.0	0.1	47.9	5.7	45.4	0.6	3.5	0.0	8.3	1.1	0.3	23.0	0.0	7.5	0.0	8.0	0.7	0.0	0.4	0.0	9.0	2.9	0.0	0.0	4.0	27.1	8.1	0.5	0.0	12.2	0.0	2.5	0.0	3.0	61.3	0.8	0.4	7.2	0.0	2.0	0.6	0.5	2.1	0.4	0.0	40.0	3.9	2.5	4.2	0.2	0.4	0.8	0.4	22.9	1.6	0.4
HS6ST2		ENSG00000171004	"Heparan sulfate 6-O-sulfotransferase 2"	Q96MM7	X	132626016-132961395	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Transferase	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.5;kidney: 13.9;ovary: 14.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 35.7;Excitatory neurons: 37.5;Inhibitory neurons: 44.2;Leydig cells: 62.7;Oligodendrocyte precursor cells: 54.3;Peritubular cells: 35.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 46.2;HeLa: 28.1;RH-30: 66.1;RT4: 33.7;SH-SY5Y: 82.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA034625	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA034625: AB_10612119"	"unprognostic (7.62e-3)"	"unprognostic (4.89e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.39e-5)"	"unprognostic (1.36e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.54e-1)"	"prognostic favorable (6.03e-4)"	0.2	2.4	12.4	0.6	10.0	0.0	2.0	1.2	7.4	1.0	0.0	0.6	0.1	3.5	2.4	3.9	1.8	0.3	0.2	9.6	10.7	13.9	0.0	0.7	0.1	6.3	22.5	14.1	5.3	0.3	1.1	8.4	7.3	2.8	0.8	1.5	0.9	0.8	6.2	0.2	0.1	1.5	4.9	0.0	0.9	2.9	20.3	0.6	0.4	0.9	0.5	2.5	0.7	2.6	10.7	0.1	14.5	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	17.0	0.0	0.0	15.2	0.0	0.0	0.5	21.7	0.1	0.0	0.0	46.2	0.1	28.1	0.0	0.0	0.0	0.0	0.7	20.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	7.8	0.3	0.1	11.8	7.2	0.6	0.0	66.1	0.0	13.3	33.7	1.8	82.0	14.8	0.0	0.1	23.7	0.0	0.1	0.0	0.0	2.6	9.6	23.8	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.4	10.0	1.2	7.4	9.6	10.7	6.3	22.5	7.3	4.9	20.3	2.6	0.0	0.0	0.0	1.6	0.0	0.3	0.2	1.8	6.8	0.2	4.3	2.4	0.8	0.0	5.5	3.7	0.0	35.7	0.2	0.3	5.9	0.0	0.5	0.3	0.6	0.5	0.0	0.0	37.5	2.0	2.6	2.6	0.0	0.1	0.0	0.1	0.0	0.0	3.4	0.0	44.2	0.2	2.0	0.0	0.0	1.1	62.7	0.2	0.0	10.3	0.0	5.3	0.0	54.3	1.4	0.8	0.2	35.3	0.0	1.3	0.0	0.1	9.8	0.4	0.0	17.9	0.3	0.3	1.1	11.1	0.3	17.4	0.1	0.3	0.2	1.8
HTRA1	"ARMD7, HtrA, IGFBP5-protease, PRSS11"	ENSG00000166033	"HtrA serine peptidase 1"	Q92743	10	122458551-122514907	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding, Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 269.3;Granulosa cells: 731.6;Horizontal cells: 625.9;Muller glia cells: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 2417.8;ASC TERT1: 889.4;fHDF/TERT166: 862.3;HSkMC: 1581.4;LHCN-M2: 1238.2;U-87 MG: 1004.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036655	Approved		Supported	"Plasma membrane"	"Secreted to blood"	NA	NA	24800000	7600000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"		"HPA036655: AB_10671966"	"unprognostic (3.84e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.71e-3)"	"unprognostic (2.33e-2)"	"unprognostic (3.83e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (7.90e-7)"	"unprognostic (7.12e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (5.62e-6)"	246.0	81.3	382.1	37.0	436.6	0.5	202.8	422.6	595.7	352.1	316.2	154.8	20.8	197.1	247.1	57.8	122.9	301.2	114.7	377.7	411.4	230.9	226.4	69.9	39.9	427.1	447.0	425.5	55.9	111.8	184.1	281.9	425.3	85.7	51.8	243.6	101.1	114.5	31.1	130.5	73.5	152.3	382.1	54.2	87.3	19.5	423.6	21.2	78.8	80.9	27.3	137.3	188.3	464.2	0.3	45.6	19.4	5.7	2417.8	889.4	0.8	108.3	196.8	44.4	23.6	0.2	0.6	0.0	29.0	862.3	68.6	12.8	7.6	124.4	6.2	0.1	4.9	0.1	65.4	0.3	123.7	0.1	0.9	1581.4	444.6	25.8	205.3	503.6	207.1	0.0	0.1	1.5	1238.2	22.3	0.1	0.7	20.9	0.2	67.6	0.2	1.3	0.4	282.6	2.2	1.2	3.9	272.1	0.2	122.2	91.4	8.6	0.2	136.0	309.9	4.5	141.3	94.1	0.2	0.1	0.3	1004.6	0.2	148.5	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	382.1	436.6	422.6	595.7	377.7	411.4	427.1	447.0	425.3	382.1	423.6	464.2	55.1	22.4	6.9	116.5	0.9	44.1	32.5	10.8	23.9	53.3	5.4	31.2	26.4	14.3	0.9	64.4	54.2	30.9	1.3	0.0	0.0	2.0	3.5	11.3	76.5	107.0	0.0	2.7	2.2	4.6	164.6	269.3	4.6	14.4	1.3	731.6	57.8	157.8	51.3	625.9	31.2	0.3	8.2	18.1	59.9	4.2	31.7	22.0	46.2	86.2	8.5	373.8	0.0	193.0	112.5	2.7	1.3	77.5	1.9	8.7	0.2	22.6	10.1	150.3	6.6	63.3	140.5	0.2	0.7	7.0	30.5	87.7	7.2	2.5	0.6	11.9
IGDCC4	"LOC57722, NOPE"	ENSG00000103742	"Immunoglobulin superfamily DCC subclass member 4"	Q8TDY8	15	65381484-65422947	"Plasma proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.3;skeletal muscle: 10.6;tongue: 14.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 18.6;Cone photoreceptor cells: 31.3;Fibroblasts: 14.7;Leydig cells: 34.8;Microglial cells: 14.0;Oligodendrocyte precursor cells: 17.6;Skeletal myocytes: 29.8"	"Cancer enhanced"	"Detected in many"		"glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.4;AF22: 9.4;CAPAN-2: 8.1;EFO-21: 4.5;HSkMC: 5.2;NTERA-2: 7.2;SuSa: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008510, HPA008576"	Approved	Approved	Approved	Nucleoplasm,Cytosol		NA	NA		64000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA008510: , HPA008576: AB_1079496"	"unprognostic (1.16e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.75e-3)"	"unprognostic (9.94e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.36e-2)"	"unprognostic (1.83e-8)"	"unprognostic (3.30e-2)"	"unprognostic (4.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.32e-3)"	0.9	2.5	5.6	2.4	6.9	0.0	0.5	5.8	2.5	3.4	0.0	0.8	0.5	1.4	4.2	1.6	1.7	4.2	0.9	2.9	7.2	0.1	0.0	0.2	0.6	11.2	9.4	8.5	0.1	0.3	0.9	5.6	6.8	0.4	0.6	0.8	0.5	0.4	10.6	0.8	0.8	1.0	6.9	0.2	1.1	0.6	11.3	0.7	1.9	14.0	0.6	2.1	2.0	4.5	0.0	4.4	9.4	0.0	0.0	1.0	0.0	0.4	0.0	0.0	0.3	0.5	8.1	0.0	4.5	0.3	0.0	0.0	2.3	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.3	0.0	0.0	5.2	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.8	7.2	0.0	0.0	0.0	2.3	0.0	3.3	0.0	0.0	0.1	0.0	0.0	0.4	5.4	0.0	0.0	0.0	3.7	2.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	6.9	5.8	2.5	2.9	7.2	11.2	9.4	6.8	6.9	11.3	4.5	0.2	0.0	0.0	18.6	0.0	2.3	0.0	0.0	0.0	7.7	0.2	0.5	2.2	0.0	0.0	3.7	31.3	0.4	0.1	0.0	0.0	0.4	0.4	0.0	2.1	0.3	0.0	0.0	0.9	0.0	0.6	14.7	1.1	0.0	0.0	8.8	0.0	0.0	0.7	0.0	6.3	0.0	0.0	0.0	2.5	1.4	34.8	0.3	5.4	14.0	0.0	1.0	1.0	17.6	1.0	0.3	0.0	4.1	0.1	0.1	0.0	0.7	0.0	12.2	6.6	29.8	1.0	0.8	2.6	0.1	1.1	0.8	0.3	7.0	0.0	0.0
IGF2	"C11orf43, FLJ44734, IGF-II"	ENSG00000167244	"Insulin like growth factor 2"	P01344	11	2129112-2141238	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins"	"Carbohydrate metabolism, Glucose metabolism, Osteogenesis"	"Growth factor, Hormone, Mitogen"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 2749.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 1104.3;Extravillous trophoblasts: 3196.3;Leydig cells: 3007.5;Peritubular cells: 643.9;Syncytiotrophoblasts: 1612.9"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 86.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 862.0;Hep G2: 600.5;LHCN-M2: 333.7;RH-30: 408.5;SH-SY5Y: 495.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007556, HPA007993"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol	"Secreted to blood"	NA	NA	609000000	1200000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Nucleoplasm, Cytosol"	"HPA007556: AB_2667860, HPA007993: AB_1851474"	"unprognostic (1.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.59e-1)"	"prognostic favorable (7.12e-4)"	"unprognostic (7.92e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.98e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.78e-2)"	99.7	58.4	5.5	9.2	32.6	0.9	41.8	12.6	86.0	75.5	236.8	22.3	4.7	75.2	52.7	18.8	128.4	34.8	91.7	6.5	7.1	31.8	305.9	9.8	3.4	20.2	6.6	117.8	37.5	5.2	25.4	2749.2	10.1	14.5	4.8	0.5	11.6	15.2	82.1	8.4	10.9	14.7	13.0	14.4	11.9	23.7	10.9	3.4	12.4	114.0	4.7	24.2	23.6	9.0	0.0	2.8	0.3	0.6	0.2	0.3	1.8	112.8	1.3	3.6	0.4	862.0	0.4	0.1	8.4	0.0	2.1	0.1	0.9	7.0	7.9	0.1	0.5	0.2	0.2	600.5	143.4	0.7	0.0	174.7	0.5	0.7	0.2	0.1	1.4	0.0	0.3	0.0	333.7	2.2	0.1	0.8	1.2	0.2	1.5	0.1	408.5	0.9	0.0	0.9	32.7	495.6	0.7	0.1	0.0	83.0	4.2	0.0	0.4	0.2	20.1	0.2	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	32.6	12.6	86.0	6.5	7.1	20.2	6.6	10.1	13.0	10.9	9.0	40.6	3.2	3.1	0.0	2.6	5.4	0.5	0.5	0.6	0.4	0.0	0.0	6.5	8.6	0.9	3.7	0.0	1104.3	0.0	0.0	0.0	0.0	13.1	0.0	0.0	498.4	0.0	16.0	0.0	0.0	3196.3	334.2	0.0	0.0	0.0	0.0	171.4	494.9	218.2	0.0	0.0	0.0	0.0	11.6	5.5	91.1	3007.5	3.4	3.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	643.9	0.0	1.1	0.0	0.0	0.9	0.5	65.7	33.5	37.5	3.8	6.3	1.5	4.1	1612.9	1.8	0.0	0.0	0.4
IL17D	"FLJ30846, IL-17D, IL-27, IL27"	ENSG00000172458	"Interleukin 17D"	Q8TAD2	13	20702127-20723098	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 79.8;skeletal muscle: 131.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 64.0;Early spermatids: 19.3;Excitatory neurons: 17.5;Late spermatids: 35.0;Muller glia cells: 20.2;Oligodendrocyte precursor cells: 20.6"	"Group enriched"	"Detected in many"	9	"glioma: 10.8;melanoma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 27.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	25000		"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (1.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.26e-2)"	"unprognostic (3.86e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.93e-2)"	"unprognostic (5.97e-2)"	8.4	5.7	71.9	1.6	79.7	0.4	6.4	68.7	58.7	15.2	21.6	5.6	9.4	6.5	1.1	8.9	5.0	5.1	11.6	66.0	70.9	2.6	0.8	6.2	1.2	79.1	62.2	9.3	5.9	0.4	8.9	1.6	61.8	5.5	0.5	10.6	4.3	1.6	131.1	5.4	5.7	1.2	79.6	0.9	4.4	3.9	68.2	0.2	7.6	24.5	0.3	5.4	9.9	79.8	16.5	2.2	3.5	7.6	8.1	4.6	18.3	4.5	1.1	0.4	0.8	7.6	8.7	11.0	0.8	0.4	5.3	8.5	1.5	0.1	0.2	4.0	12.2	0.8	0.7	9.1	1.0	12.2	2.4	6.3	0.1	0.6	0.0	6.9	5.0	15.3	4.5	0.0	3.0	15.9	13.6	10.0	10.7	19.2	2.6	17.8	8.6	1.3	0.2	14.1	20.7	6.7	2.6	3.8	18.3	6.1	9.6	10.4	27.1	1.7	3.0	1.4	5.7	2.0	1.7	2.9	4.0	5.7	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	71.9	79.7	68.7	58.7	66.0	70.9	79.1	62.2	61.8	79.6	68.2	79.8	0.7	0.0	0.0	64.0	0.2	2.4	0.3	0.0	1.2	1.2	0.4	0.4	1.0	0.0	0.0	0.0	0.0	1.1	0.3	0.7	0.0	0.1	19.3	0.2	1.6	0.6	0.0	0.4	17.5	0.2	7.4	7.6	0.0	0.7	0.0	0.9	1.4	0.0	0.4	0.0	12.2	0.1	0.0	0.3	1.9	35.0	11.5	0.2	8.8	2.8	0.0	20.2	0.0	20.6	12.5	0.2	0.1	1.2	0.0	0.5	0.2	0.2	0.0	4.9	0.0	9.4	2.0	8.6	0.6	0.0	2.0	1.1	0.3	0.1	0.3	0.2
KCNT2	"KCa4.2, SLICK, SLO2.1"	ENSG00000162687	"Potassium sodium-activated channel subfamily T member 2"	Q6UVM3	1	196225779-196609225	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ovary: 3.8"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 220.2;Inhibitory neurons: 240.5;Oligodendrocyte precursor cells: 310.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 3.2;hTERT-RPE1: 9.0;SCLC-21H: 7.5;SH-SY5Y: 5.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051218	Uncertain		Approved	Vesicles		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA051218: AB_2681392"	"unprognostic (5.06e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.10e-6)"	"unprognostic (1.22e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.18e-1)"	"unprognostic (9.56e-3)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.67e-5)"	"unprognostic (3.30e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.72e-3)"	1.0	0.6	0.9	0.1	2.0	0.0	0.4	0.0	2.0	0.4	0.3	0.5	0.2	0.3	0.4	1.0	0.5	1.4	1.8	2.5	3.3	0.3	2.8	1.8	0.1	0.0	0.2	3.8	0.1	0.0	0.9	0.2	0.0	1.0	0.5	0.1	0.5	0.6	0.1	0.3	0.4	0.5	0.6	0.2	0.5	1.1	1.0	0.1	1.1	0.8	0.1	0.8	0.4	0.5	0.0	0.1	1.8	0.0	0.2	0.2	0.0	0.0	1.0	0.1	1.8	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.9	0.0	3.2	0.0	0.0	1.2	0.0	0.4	0.1	9.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	2.4	0.0	0.1	0.0	0.1	0.0	0.0	0.5	7.5	5.6	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.0	2.0	2.5	3.3	0.0	0.2	0.0	0.6	1.0	0.5	0.8	41.7	1.1	6.8	0.0	0.4	0.2	0.0	0.6	0.0	0.0	0.1	1.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.2	0.8	0.0	0.0	220.2	0.0	0.0	9.3	0.0	0.0	0.0	6.1	2.5	6.2	0.0	0.0	240.5	0.0	0.0	0.0	0.7	3.3	6.5	0.0	1.8	58.1	0.0	0.0	0.0	310.7	6.1	0.0	0.0	4.9	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.4	4.0	0.6	0.2	0.0	0.0	0.0	0.0	3.9	0.0	0.2
LIN7A	"LIN-7A, MALS-1, TIP-33, VELI1"	ENSG00000111052	"Lin-7 homolog A, crumbs cell polarity complex component"	O14910	12	80792520-80937934	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.9;retina: 26.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 77.3;Early spermatids: 107.2;Excitatory neurons: 135.5;Inhibitory neurons: 93.1;Late spermatids: 76.9;Spermatocytes: 61.3"	"Cancer enhanced"	"Detected in many"		"renal cancer: 8.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 18.8;eosinophil: 15.8;neutrophil: 29.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 29.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 21.3;ASC TERT1: 31.4;HAP1: 25.2;HDLM-2: 29.6;HL-60: 29.1;NB-4: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071562	Approved					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA071562: AB_2732181"	"unprognostic (7.11e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.52e-3)"	"unprognostic (3.04e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.83e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.41e-1)"	"prognostic favorable (1.63e-11)"	"unprognostic (5.01e-5)"	"unprognostic (7.79e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.69e-2)"	5.0	3.1	5.5	2.4	6.5	27.9	5.4	22.2	8.0	7.9	1.0	1.9	0.5	8.5	0.5	0.9	3.7	4.0	6.3	6.4	6.0	8.7	17.7	5.1	2.6	1.9	6.9	3.7	0.5	0.9	6.0	5.3	3.1	1.8	0.6	26.6	0.8	0.7	1.0	0.7	2.1	4.6	2.3	4.6	1.1	7.1	6.9	0.7	4.2	2.5	1.2	3.9	4.6	3.6	0.0	0.6	5.0	0.0	21.3	31.4	0.0	12.8	5.9	5.1	1.1	9.9	0.0	0.0	0.0	4.9	0.1	0.0	25.2	0.0	1.5	29.6	7.8	0.0	0.2	15.6	2.6	29.1	0.2	7.8	0.0	0.5	0.5	1.2	4.1	0.0	0.0	0.0	2.3	0.3	0.0	27.0	4.7	0.3	0.1	0.0	18.7	0.0	2.9	4.1	10.2	0.0	0.0	0.0	0.1	0.3	1.1	15.5	0.0	4.0	1.5	2.1	0.1	4.4	0.0	0.0	0.4	0.0	0.2	18.8	5.2	15.8	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	29.8	0.0	0.2	0.0	0.1	1.2	5.5	6.5	22.2	8.0	6.4	6.0	1.9	6.9	3.1	2.3	6.9	3.6	4.8	22.4	5.8	18.6	0.0	0.8	4.8	0.0	0.0	77.3	10.8	3.4	22.8	8.6	0.6	25.8	2.1	0.4	0.2	0.3	9.8	1.3	107.2	1.9	8.9	1.9	1.8	0.4	135.5	0.2	0.1	4.9	0.0	3.5	0.0	0.1	1.8	21.5	2.5	30.3	93.1	0.5	0.0	5.2	0.7	76.9	4.7	4.2	0.0	9.4	6.5	42.6	0.0	23.1	2.7	0.0	1.2	1.5	0.4	2.0	20.1	26.5	0.7	11.2	13.1	5.0	19.2	61.3	1.3	0.0	0.4	0.7	0.6	3.5	1.1	1.8
LINGO2	"LERN3, LRRN6C"	ENSG00000174482	"Leucine rich repeat and Ig domain containing 2"	Q7L985	9	27948078-28670286	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"endometrium 1: 7.5;smooth muscle: 8.8"	"Group enriched"	"Detected in some"	29	"Excitatory neurons: 1591.2;Inhibitory neurons: 988.0"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.8"	"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	9	"NK-cell: 1.0"	"Lineage enriched"	"Detected in single"	9	"NK-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.2;hTERT-HME1: 1.5;SH-SY5Y: 9.1;U-87 MG: 1.6;WM-115: 4.1"	"Low region specificity"	"Detected in all"							"HPA016633, CAB025361"	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB025361: , HPA016633: AB_1853362"	"unprognostic (1.27e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.98e-4)"	"unprognostic (9.86e-4)"	"unprognostic (7.55e-3)"		"unprognostic (2.67e-6)"	"unprognostic (1.08e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.74e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.95e-4)"	0.0	0.4	0.5	0.0	0.8	0.2	0.0	0.0	3.3	0.6	0.0	0.1	0.0	7.5	0.9	0.0	0.4	0.9	0.0	2.9	3.0	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.8	0.6	1.7	0.0	0.6	0.0	2.4	0.0	1.5	0.0	0.1	0.0	8.8	0.1	0.1	0.6	1.7	0.4	0.2	2.9	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.2	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.0	9.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.5	0.8	0.0	3.3	2.9	3.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	34.6	0.0	0.0	0.0	0.0	0.0	8.8	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	17.5	0.4	4.6	0.2	1.8	0.0	1591.2	0.0	0.1	1.4	0.0	0.9	1.3	29.6	0.0	0.0	0.2	0.0	988.0	0.0	0.0	0.0	0.0	16.4	0.0	0.1	0.0	43.1	0.1	0.9	5.2	17.6	20.0	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.3	2.8	1.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0
LRP1	"A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A"	ENSG00000123384	"LDL receptor related protein 1"	Q07954	12	57128483-57213361	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Endocytosis	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 109.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 273.4;Hepatocytes: 188.4;Leydig cells: 233.3;Peritubular cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 4.3;intermediate monocyte: 2.2;myeloid DC: 1.6;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	21	"dendritic cells: 1.6;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 484.8;ASC TERT1: 488.4;fHDF/TERT166: 222.2;HSkMC: 318.5;hTERT-RPE1: 248.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004182, CAB018621, HPA022903"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		180000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426"	"unprognostic (1.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.33e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.29e-5)"	109.2	14.1	21.3	29.0	36.3	8.2	40.0	30.2	19.7	32.3	8.0	24.1	23.2	36.9	6.2	19.3	30.3	31.5	35.5	16.7	21.9	5.7	35.0	34.0	4.9	46.0	31.5	71.0	10.7	7.8	10.2	39.8	27.9	13.8	11.2	9.9	20.3	20.2	13.0	20.4	18.4	28.9	27.1	13.6	15.1	7.3	48.9	5.6	17.6	23.5	2.7	25.5	29.3	27.6	7.7	14.5	30.4	24.2	484.8	488.4	91.2	85.3	109.0	27.5	26.7	26.9	12.4	0.4	10.4	222.2	6.0	33.6	5.3	8.7	9.7	0.7	1.3	0.4	17.9	56.4	66.5	0.5	14.6	318.5	3.1	61.8	7.2	248.7	1.7	1.1	0.4	1.3	87.2	1.7	0.2	0.4	34.8	11.0	8.8	3.2	171.0	1.6	1.9	2.2	1.4	16.4	19.0	0.6	13.2	42.0	2.9	1.2	1.2	96.0	35.0	53.9	5.2	1.1	0.1	0.2	167.4	0.1	18.7	0.0	4.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	1.6	21.3	36.3	30.2	19.7	16.7	21.9	46.0	31.5	27.9	27.1	48.9	27.6	24.6	12.8	8.4	113.6	3.2	24.0	11.9	28.7	19.9	29.2	4.9	19.3	14.8	15.7	14.7	1.8	0.0	87.5	1.1	81.7	0.0	7.4	1.9	9.7	111.4	13.0	4.2	0.8	39.3	1.8	53.0	273.4	49.5	4.2	6.3	36.9	11.0	188.4	73.8	8.4	41.6	14.1	6.1	145.3	28.6	8.4	233.3	102.9	28.4	89.9	48.8	154.7	1.0	173.4	6.6	14.7	27.2	184.3	4.4	5.5	86.0	2.1	15.1	7.3	39.5	129.7	77.0	1.6	2.4	35.4	16.1	125.9	4.2	11.4	25.0	12.3
LRRC34	MGC27085	ENSG00000171757	"Leucine rich repeat containing 34"	Q8IZ02	3	169793003-169812986	"Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 12.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 137.9;Respiratory ciliated cells: 129.6;Spermatocytes: 104.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 8.1;HL-60: 8.9;JURKAT: 7.1;NTERA-2: 7.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA035747	Approved		Approved	"Cell Junctions,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"	"Cell Junctions, Microtubules"	"Cytokinetic bridge, Mitotic spindle"	"HPA035747: AB_10670120"	"unprognostic (1.04e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.67e-2)"	"unprognostic (5.64e-2)"	"unprognostic (9.74e-3)"	"unprognostic (5.46e-2)"	"unprognostic (9.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (6.39e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.79e-1)"	1.5	0.4	1.6	0.6	2.1	1.4	1.1	1.6	2.7	0.9	2.8	0.5	0.2	0.7	0.3	0.2	5.5	0.3	1.1	1.2	2.1	0.7	0.2	1.0	0.8	2.1	2.5	0.8	0.2	0.3	2.8	0.2	2.2	0.6	0.1	5.6	0.3	0.7	0.4	0.5	0.4	0.2	2.1	0.7	0.4	12.8	1.9	0.6	0.9	0.4	0.3	0.4	0.4	1.8	2.3	0.4	0.5	0.0	0.9	3.0	0.0	0.9	1.9	2.4	2.1	0.1	0.0	1.5	0.1	0.6	3.1	0.0	1.8	0.0	0.8	0.4	5.6	8.1	0.2	0.0	0.6	8.9	1.8	0.9	0.4	0.8	0.0	0.1	1.6	7.1	0.2	0.0	0.9	0.0	0.8	1.1	7.7	0.0	2.6	4.0	0.0	0.4	2.1	0.2	4.0	3.1	0.5	0.3	0.0	0.2	0.0	4.2	0.5	0.4	0.0	0.3	0.1	0.1	0.1	1.9	3.5	0.1	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.1	1.6	2.1	1.6	2.7	1.2	2.1	2.1	2.5	2.2	2.1	1.9	1.8	3.9	3.2	2.6	8.5	1.5	0.4	0.9	5.3	0.0	6.9	0.4	0.9	3.2	0.0	12.9	5.5	37.5	0.2	1.6	0.1	1.9	0.5	137.9	33.8	5.8	3.0	4.2	4.2	15.1	0.2	0.3	5.0	0.5	1.0	1.3	1.0	10.4	0.3	2.4	11.8	12.5	0.4	6.1	0.8	1.2	36.3	10.5	1.2	0.0	3.7	3.8	7.4	0.0	9.5	3.6	0.3	0.0	10.5	0.7	0.4	0.0	3.6	129.6	18.8	0.0	3.6	3.7	104.4	9.2	0.1	0.3	0.5	0.9	1.9	0.2	0.4
LRRN3	"FIGLER5, FLJ11129, NLRR3"	ENSG00000173114	"Leucine rich repeat neuronal 3"	Q9H3W5	7	111091006-111125454	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.2;thyroid gland: 19.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 47.0;Bipolar cells: 29.2;Cardiomyocytes: 24.8;Excitatory neurons: 81.2;Inhibitory neurons: 46.5;Leydig cells: 56.2;Oligodendrocyte precursor cells: 61.3"	"Group enriched"	"Detected in many"	7	"glioma: 17.5;thyroid cancer: 4.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"naive CD4 T-cell: 32.5;naive CD8 T-cell: 30.9"	"Lineage enriched"	"Detected in single"	70	"T-cells: 32.5"	"Cell line enhanced"	"Detected in some"		"AF22: 24.7;BJ: 14.7;BJ hTERT+: 31.0;GAMG: 15.6;SH-SY5Y: 43.9;SuSa: 13.6;T-47d: 24.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043820, HPA046792"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA043820: AB_2678687, HPA046792: AB_2679810"	"unprognostic (4.93e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.85e-3)"	"unprognostic (1.08e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-2)"	"unprognostic (7.23e-2)"	7.2	23.2	11.9	1.2	12.8	0.6	1.7	10.4	14.7	2.5	4.3	0.9	0.4	0.5	2.3	1.3	0.7	1.0	8.0	11.9	10.4	0.4	2.2	7.5	3.0	6.8	8.5	6.3	0.9	0.2	3.0	5.8	8.6	2.6	1.0	6.3	1.2	4.9	4.1	0.3	1.4	0.4	7.7	1.4	0.4	14.9	13.2	10.5	19.6	0.5	3.6	0.8	0.9	8.9	0.0	0.1	24.7	3.1	11.2	4.8	0.1	14.7	31.0	1.4	1.2	0.0	0.0	0.1	0.0	0.0	15.6	0.1	1.5	0.0	3.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.3	0.1	0.0	0.1	0.1	6.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.0	43.9	0.0	0.0	0.0	13.6	24.3	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.4	2.7	2.0	0.0	0.1	32.5	30.9	0.2	0.0	0.1	0.0	0.4	6.1	11.9	12.8	10.4	14.7	11.9	10.4	6.8	8.5	8.6	7.7	13.2	8.9	0.8	0.0	4.3	47.0	0.8	0.0	0.0	0.0	0.0	29.2	0.6	0.8	24.8	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	1.1	0.3	0.5	1.2	1.8	0.0	81.2	0.0	0.5	13.3	1.5	0.5	1.3	0.0	1.1	0.0	0.8	3.3	46.5	0.0	0.0	0.0	0.4	4.4	56.2	0.2	1.8	7.5	0.8	11.0	1.0	61.3	7.0	0.0	0.0	16.1	0.0	0.0	0.0	0.1	0.0	3.8	0.0	1.6	1.7	1.1	0.4	0.0	0.1	0.4	10.3	0.5	0.0	0.2
LRRN4CL		ENSG00000177363	"LRRN4 C-terminal like"	Q8ND94	11	62686406-62689530	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 62.1;Leydig cells: 27.1;Melanocytes: 33.8;Peritubular cells: 17.3;Skeletal myocytes: 33.0"	"Cancer enriched"	"Detected in many"	5	"melanoma: 26.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 7.7;ASC TERT1: 25.3;HHSteC: 19.8;HSkMC: 10.6;LHCN-M2: 13.4"	"Low region specificity"	"Detected in many"							HPA050317	Enhanced		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	"Nuclear bodies"	"HPA050317: AB_2681084"	"unprognostic (1.28e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.84e-1)"	"unprognostic (9.95e-3)"	"unprognostic (2.61e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-7)"	"unprognostic (2.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (4.53e-3)"	"unprognostic (1.86e-2)"	23.3	6.6	0.4	2.5	0.4	0.5	16.0	1.5	1.3	22.4	2.6	15.1	1.8	29.7	3.7	4.5	18.2	3.6	7.2	0.6	0.6	1.0	0.1	3.5	0.5	0.5	0.3	21.0	1.1	0.3	1.7	0.7	0.4	6.1	2.1	0.4	5.5	5.8	4.8	10.6	7.2	9.1	0.2	0.2	8.2	1.5	0.5	0.4	4.2	5.6	0.3	9.7	16.1	0.7	0.0	0.1	0.2	0.3	7.7	25.3	0.3	2.8	4.0	0.3	1.4	0.2	0.1	0.2	0.3	4.6	0.1	0.3	0.1	0.0	0.4	0.2	0.2	0.5	0.2	0.2	19.8	0.2	0.2	10.6	0.1	0.6	0.0	0.2	0.1	0.4	0.3	0.1	13.4	0.1	0.3	0.6	0.6	0.1	0.1	0.1	1.7	0.3	0.0	0.2	0.8	0.3	0.4	0.3	0.8	0.1	0.2	0.3	0.3	2.4	0.2	2.7	0.1	0.2	0.2	0.3	1.5	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.0	0.4	0.4	1.5	1.3	0.6	0.6	0.5	0.3	0.4	0.2	0.5	0.7	4.0	0.0	1.8	0.0	0.1	6.6	2.1	0.0	0.0	2.1	0.5	0.8	1.5	0.0	0.6	0.0	2.1	0.1	0.2	0.0	0.0	0.0	1.0	0.5	11.0	3.7	1.2	0.0	0.1	0.0	0.2	62.1	0.5	0.4	1.3	0.2	1.4	0.1	0.4	1.7	0.3	0.3	0.0	0.6	8.3	0.5	27.1	1.1	33.8	1.9	0.1	0.2	1.0	0.0	0.1	0.0	0.1	17.3	0.4	1.4	0.1	0.3	0.0	1.0	0.0	33.0	2.8	0.4	0.3	0.5	7.0	0.1	1.1	1.2	0.1	1.3
LTBP3	LTBP2	ENSG00000168056	"Latent transforming growth factor beta binding protein 3"	Q9NS15	11	65538559-65558930	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor binding"	"Amelogenesis imperfecta, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 61.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 293.8;U-87 MG: 157.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA		2200000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (3.35e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.50e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.24e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.04e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.24e-2)"	65.4	80.1	44.0	21.4	46.1	11.2	68.0	42.0	56.1	120.0	42.2	103.7	16.8	130.8	36.7	36.7	112.6	39.9	131.2	37.6	41.4	84.5	48.8	72.2	24.7	57.0	49.0	155.5	70.1	44.7	111.0	25.5	45.4	109.0	8.5	12.8	64.2	56.3	54.6	39.6	55.8	35.7	51.7	58.1	62.0	20.3	46.9	17.6	114.0	31.0	12.1	84.9	88.0	54.0	16.5	65.9	8.7	43.2	60.7	97.0	8.5	64.7	43.6	8.2	5.3	25.3	85.5	2.0	53.6	64.2	20.4	71.9	11.8	12.2	3.7	9.5	26.4	15.9	25.2	26.2	40.3	2.2	13.4	109.9	4.9	12.1	1.5	293.8	31.9	5.2	4.9	12.7	6.0	39.4	10.9	5.9	7.6	14.6	81.2	29.3	1.1	32.1	6.7	5.5	2.9	41.8	17.3	24.9	35.3	3.7	46.0	5.8	107.0	24.8	32.2	42.5	17.6	13.9	27.1	1.4	157.8	2.6	52.3	0.2	7.3	2.9	8.8	11.2	14.1	61.2	12.6	10.4	8.9	47.6	10.5	11.2	2.9	10.8	13.2	17.8	14.2	7.8	44.0	46.1	42.0	56.1	37.6	41.4	57.0	49.0	45.4	51.7	46.9	54.0	47.1	12.8	11.7	64.0	26.8	73.8	27.7	22.0	50.7	55.7	42.2	43.1	16.7	35.8	16.2	40.5	2.1	24.7	24.4	19.7	21.5	28.1	1.1	19.3	37.5	29.8	30.6	11.2	21.3	12.0	10.5	86.1	14.8	25.3	24.1	92.5	37.5	61.6	20.7	28.6	17.9	15.1	8.2	11.0	34.4	4.3	86.6	14.6	30.2	17.8	11.5	71.4	24.7	29.7	20.2	18.1	15.0	123.8	20.9	35.8	25.3	15.7	8.2	14.3	39.5	89.4	44.0	9.5	37.5	46.9	79.3	16.3	24.4	26.0	20.4	26.5
MB21D2	C3orf59	ENSG00000180611	"Mab-21 domain containing 2"	Q8IYB1	3	192796815-192917856	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 63.8;Inhibitory neurons: 53.0;Langerhans cells: 85.0;Oligodendrocyte precursor cells: 68.9;Syncytiotrophoblasts: 110.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 4.2;T-reg: 3.9"	"Lineage enriched"	"Detected in single"	9	"T-cells: 4.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 114.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044026	Approved		Approved	Cytosol		NA	Yes			"Cluster 13: T-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA044026: AB_10962840"	"unprognostic (3.52e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (3.74e-5)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (2.76e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.30e-3)"	"unprognostic (5.94e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.80e-2)"	"unprognostic (3.28e-2)"	3.7	4.2	2.5	3.2	2.8	1.3	3.4	3.3	3.1	2.8	1.6	3.0	8.8	5.1	1.9	2.0	3.6	4.7	4.0	2.8	2.3	4.2	1.5	3.6	1.2	2.1	2.0	4.1	1.9	2.3	3.5	13.3	1.8	1.9	2.9	2.0	1.5	1.9	2.7	4.7	9.3	5.6	1.5	2.2	3.5	7.1	1.9	1.4	1.7	1.6	1.7	8.8	2.4	2.3	26.6	3.7	6.3	19.0	3.9	5.8	11.2	18.8	17.5	33.4	19.9	17.0	4.2	0.0	11.0	46.6	13.8	11.5	14.6	4.8	36.2	114.8	8.1	3.3	1.8	2.0	7.4	0.4	1.6	7.6	7.4	9.4	5.8	2.7	6.6	3.3	0.2	1.5	5.8	19.8	0.3	0.0	13.1	14.4	45.9	0.6	10.5	5.6	7.8	15.1	9.8	5.0	4.1	12.8	1.9	12.9	19.9	0.4	2.1	6.3	18.4	11.1	36.3	48.1	41.0	0.0	4.4	4.0	8.6	0.0	0.2	0.0	0.2	0.3	1.9	0.1	4.2	1.0	0.4	0.0	2.6	0.7	0.0	0.0	0.0	0.0	3.9	0.9	2.5	2.8	3.3	3.1	2.8	2.3	2.1	2.0	1.8	1.5	1.9	2.3	2.9	6.4	0.5	16.6	1.2	9.2	0.9	2.0	1.2	10.9	4.6	3.2	1.8	1.5	3.2	0.0	2.1	63.8	0.3	2.4	0.0	6.5	0.2	12.4	2.0	7.7	10.2	0.0	28.6	0.2	9.5	5.9	1.5	15.9	0.0	5.8	9.7	0.2	5.6	8.4	53.0	2.8	4.1	3.8	85.0	1.4	3.1	10.4	14.2	17.8	13.4	1.1	0.0	68.9	30.6	2.2	6.1	6.0	4.2	0.8	15.4	9.6	2.8	1.3	13.1	3.3	4.5	1.8	16.5	1.8	8.7	110.4	3.3	5.4	3.7	2.6
MFAP2	"MAGP, MAGP-1"	ENSG00000117122	"Microfibril associated protein 2"	P55001	1	16974502-16980632	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 81.8"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 197.8;Fibroblasts: 75.8;Granulosa cells: 93.3;Leydig cells: 53.7;Peritubular cells: 63.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 249.4;ASC TERT1: 249.6;HUVEC TERT2: 263.1;SH-SY5Y: 212.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA007354	Enhanced				"Secreted to extracellular matrix"	NA	NA		210000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA007354: AB_1079365"	"unprognostic (5.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.92e-2)"	"unprognostic (4.86e-1)"	"unprognostic (1.53e-3)"	"unprognostic (3.72e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (9.45e-3)"	"unprognostic (9.12e-2)"	"prognostic unfavorable (2.52e-8)"	"unprognostic (2.18e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.93e-1)"	"unprognostic (5.66e-3)"	36.6	4.2	0.4	13.3	0.6	0.1	22.7	0.5	1.1	81.8	1.6	15.0	5.0	61.4	22.1	6.1	19.0	73.2	13.8	0.5	0.6	9.4	1.6	20.1	4.2	0.7	0.9	35.8	18.8	4.5	13.2	42.4	0.7	22.1	4.8	4.9	16.5	12.1	2.6	27.6	12.1	30.6	0.5	2.7	8.3	11.2	0.7	1.6	9.5	3.0	2.3	22.5	36.7	0.6	0.0	0.2	93.2	0.3	249.4	249.6	6.2	26.3	102.5	39.7	73.7	24.1	1.1	0.0	82.6	89.7	0.1	0.1	7.2	7.7	15.9	0.1	78.0	0.0	37.1	2.1	23.4	0.1	0.1	104.4	18.8	109.4	42.7	113.1	263.1	0.0	0.2	16.2	19.2	12.5	0.1	0.1	108.8	0.5	0.8	1.5	0.0	4.0	0.9	0.3	5.0	212.1	9.0	36.6	9.6	71.1	11.9	13.0	75.6	65.6	128.4	51.7	2.8	0.1	0.3	0.2	53.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.5	1.1	0.5	0.6	0.7	0.9	0.7	0.5	0.7	0.6	5.5	0.0	1.7	0.0	0.1	6.6	7.8	28.7	8.0	0.2	2.1	3.9	0.9	2.8	10.7	3.7	0.0	4.5	0.0	0.1	0.0	1.3	12.9	5.6	28.7	7.1	10.1	0.0	0.0	0.8	197.8	75.8	2.0	8.3	0.0	93.3	1.4	0.0	7.4	0.0	0.0	0.4	12.2	0.0	7.7	7.6	53.7	0.6	17.8	2.8	0.0	27.7	0.0	0.0	0.0	1.9	0.0	63.9	0.5	1.5	0.0	0.0	1.9	0.8	0.0	3.3	14.7	3.2	8.7	0.6	6.3	29.0	0.9	0.5	0.2	1.2
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387190	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Fibroblasts: 903.5;Peritubular cells: 240.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 1.0;intermediate monocyte: 1.8;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	15	"granulocytes: 1.0;monocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 394.8;ASC TERT1: 597.9;fHDF/TERT166: 284.0;HHSteC: 275.4;HSkMC: 417.8;MOLT-4: 375.8;SH-SY5Y: 350.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		110000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA054097: AB_2682378"	"unprognostic (3.02e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.39e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.80e-2)"	"prognostic favorable (3.51e-4)"	"unprognostic (2.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.87e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.83e-7)"	"unprognostic (1.07e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (7.12e-4)"	271.8	81.9	6.5	74.0	10.0	2.7	197.7	7.0	9.5	326.1	13.1	287.5	102.0	237.3	289.0	293.2	227.5	646.2	273.2	6.1	8.3	61.4	45.6	634.7	65.7	7.7	9.0	325.8	71.3	7.0	87.5	156.7	6.6	226.7	139.1	17.3	108.1	129.8	41.6	144.7	187.6	262.7	6.9	59.8	176.1	31.8	8.1	42.4	114.5	249.7	78.6	488.8	244.6	6.9	0.3	0.7	0.6	0.1	394.8	597.9	0.8	44.8	160.0	4.6	3.2	0.2	0.0	0.2	0.1	284.0	0.1	0.2	0.1	0.0	0.8	0.3	1.2	0.0	0.3	0.0	275.4	14.4	0.2	417.8	0.0	2.6	0.1	4.7	0.0	3.9	0.1	0.0	0.4	0.0	375.8	33.8	7.1	0.1	0.4	26.4	24.9	0.7	0.0	0.2	35.8	350.2	0.4	0.2	0.3	2.4	0.4	82.4	0.2	50.9	3.3	2.3	0.1	0.4	0.5	0.1	48.9	15.4	0.1	0.0	0.1	1.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	6.5	10.0	7.0	9.5	6.1	8.3	7.7	9.0	6.6	6.9	8.1	6.9	35.1	3.2	12.1	0.0	0.3	47.5	0.7	0.2	5.7	0.7	2.3	4.2	10.7	0.0	3.1	1.8	0.0	7.2	1.3	0.0	0.0	0.2	0.7	0.3	21.4	15.9	0.0	0.0	0.0	0.0	3.6	903.5	6.1	0.4	1.3	0.1	15.4	0.2	9.4	0.0	0.0	0.0	0.0	0.0	62.9	6.3	78.3	3.9	67.6	14.0	0.0	80.2	0.0	0.5	0.1	0.1	0.0	240.0	2.6	2.2	0.0	0.0	2.9	3.3	19.7	38.6	103.1	0.4	0.5	8.8	41.1	19.4	6.9	0.2	0.0	2.2
MRC2	"CD280, CLEC13E, ENDO180, KIAA0709"	ENSG00000011028	"Mannose receptor C type 2"	Q9UBG0	17	62627670-62693597	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	Endocytosis	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 93.9;Endometrial stromal cells: 65.2;Fibroblasts: 141.6;Late spermatids: 82.8;Leydig cells: 71.7;Peritubular cells: 102.3;Theca cells: 71.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 210.9;fHDF/TERT166: 164.9;HSkMC: 148.6;hTERT-RPE1: 150.6;U-138 MG: 216.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041991	Enhanced					NA	NA		36000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA041991: AB_10794166"	"unprognostic (3.22e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.45e-2)"	"unprognostic (2.59e-2)"	"unprognostic (4.29e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.39e-2)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (7.70e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (5.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.93e-2)"	24.5	8.6	4.8	13.7	7.9	5.3	16.2	5.6	5.3	39.3	22.5	12.3	6.6	31.3	9.6	21.2	26.3	32.4	45.2	4.3	5.1	18.1	2.8	35.0	4.5	9.3	9.1	45.8	7.5	1.2	17.4	9.6	8.9	25.7	3.2	0.7	9.0	20.8	12.2	28.8	10.9	21.3	9.9	16.3	9.0	16.2	6.0	4.5	7.0	6.5	2.0	17.9	28.2	11.2	0.1	35.1	23.3	29.7	64.1	115.4	3.1	210.9	138.8	34.3	40.8	2.1	0.4	0.0	15.2	164.9	15.1	17.8	4.0	19.0	8.8	26.7	5.4	17.6	27.2	0.0	97.2	22.9	0.2	148.6	9.5	29.6	3.4	150.6	15.4	10.6	9.3	0.0	47.8	6.3	6.6	70.6	4.9	0.0	2.4	22.3	15.4	0.2	3.2	0.4	2.9	52.2	14.1	0.4	0.3	14.3	0.6	97.1	68.5	216.6	83.9	36.2	43.6	0.2	0.0	0.0	66.8	22.6	34.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.8	7.9	5.6	5.3	4.3	5.1	9.3	9.1	8.9	9.9	6.0	11.2	8.6	3.2	35.9	5.9	0.4	11.3	5.8	20.7	25.0	11.1	1.6	11.4	4.4	0.0	2.3	1.8	0.0	0.7	0.6	0.1	0.0	0.3	93.9	22.6	65.2	5.2	0.0	28.4	3.3	0.2	2.7	141.6	2.0	2.9	2.5	13.8	5.3	0.0	6.8	0.0	0.9	0.1	0.0	9.2	11.1	82.8	71.7	7.0	5.4	57.1	0.6	0.8	1.0	3.5	0.9	0.6	0.0	102.3	0.3	2.1	0.0	0.0	1.4	0.6	0.0	31.4	23.3	11.7	9.3	34.6	7.7	1.9	2.7	71.0	0.2	1.4
NAP1L3	"MB20, MGC26312, NPL3"	ENSG00000186310	"Nucleosome assembly protein 1 like 3"	Q99457	X	93670930-93673578	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 103.4;retina: 40.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 41.8;Excitatory neurons: 27.9;Horizontal cells: 62.2;Inhibitory neurons: 57.1"	"Cancer enhanced"	"Detected in many"		"glioma: 12.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 4.1"	"Group enriched"	"Detected in many"	25	"NK-cells: 3.1;T-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"AF22: 13.6;HAP1: 13.2;NTERA-2: 24.0;SuSa: 20.7;U-2197: 16.1"	"Low region specificity"	"Detected in all"							HPA026075			Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA026075: AB_1854301"	"unprognostic (7.18e-2)"	"unprognostic (1.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (4.83e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.31e-2)"	"unprognostic (9.29e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.23e-4)"	2.5	13.4	65.2	2.8	53.3	1.2	2.6	46.9	103.4	19.3	11.2	3.2	1.5	12.1	5.6	1.3	10.0	5.4	11.3	50.5	62.9	3.3	1.3	1.8	2.5	45.3	62.7	16.7	1.3	1.0	18.1	1.5	54.4	4.4	2.4	40.9	1.4	5.3	0.4	1.7	2.0	8.2	40.6	4.6	1.4	16.6	46.9	1.1	5.6	1.2	1.3	3.5	2.8	47.5	0.0	0.2	13.6	9.9	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	2.0	7.6	0.3	0.1	13.2	0.0	0.0	0.0	0.3	6.4	0.0	0.2	0.7	0.0	0.4	6.1	0.0	0.6	6.2	0.0	0.0	6.8	0.0	0.0	0.7	0.0	0.0	0.0	24.0	0.0	5.7	0.0	10.5	0.0	0.4	0.1	0.1	1.4	0.0	0.0	0.2	20.7	0.0	0.7	0.0	7.5	10.9	16.1	0.7	10.2	4.5	0.0	4.2	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.7	0.0	2.6	0.9	0.0	0.0	4.1	2.9	0.1	3.1	0.0	0.0	0.8	0.9	65.2	53.3	46.9	103.4	50.5	62.9	45.3	62.7	54.4	40.6	46.9	47.5	0.8	0.0	0.0	11.8	0.3	0.6	0.3	0.0	0.0	41.8	0.2	1.9	8.3	0.0	0.6	0.0	6.2	0.2	0.8	0.0	17.6	0.1	1.2	0.3	9.9	1.4	0.0	1.3	27.9	0.0	0.2	7.6	0.0	0.3	5.7	7.4	1.1	0.0	0.4	62.2	57.1	0.0	0.0	0.0	0.9	2.2	11.8	0.3	5.4	9.4	0.2	16.6	0.0	16.6	21.2	0.2	0.0	19.5	0.1	0.0	0.0	0.5	1.5	12.9	0.0	6.6	4.0	5.7	7.4	0.0	0.4	0.3	1.6	16.4	0.0	0.0
NIPSNAP3B	FLJ11275	ENSG00000165028	"Nipsnap homolog 3B"	Q9BS92	9	104764129-104777764	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 20.4;tongue: 19.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 11.8;Cardiomyocytes: 21.6;Excitatory neurons: 10.7;Microglial cells: 16.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"REH: 3.0;SH-SY5Y: 2.1;THP-1: 2.2;U-266/70: 2.3"									HPA042491	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 14: REH - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA042491: AB_2678023"	"unprognostic (1.72e-2)"	"unprognostic (1.47e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.41e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.25e-5)"	"unprognostic (1.44e-1)"	"unprognostic (3.72e-2)"	"unprognostic (5.61e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.81e-2)"	6.6	5.1	1.8	1.1	1.9	0.7	4.3	1.2	2.2	2.3	1.6	1.1	0.5	3.1	3.4	1.0	1.9	1.3	12.8	1.9	2.0	1.5	0.5	1.4	1.5	1.5	1.5	3.3	1.9	1.0	2.7	3.0	1.6	2.7	0.9	2.5	1.4	3.6	20.4	1.3	1.2	1.6	1.2	2.0	1.1	1.0	1.8	0.8	2.0	19.5	1.8	0.9	1.5	1.5	0.0	0.3	0.4	0.1	0.4	0.4	0.7	0.1	0.2	0.2	0.1	0.3	0.3	0.8	0.1	0.2	0.0	0.0	0.2	0.1	0.2	0.0	0.5	1.4	1.2	0.1	0.4	0.2	0.4	0.4	0.1	0.3	0.0	0.5	0.1	0.7	1.2	0.0	0.0	0.2	0.6	1.2	0.2	0.0	0.2	3.0	0.0	0.1	0.1	0.0	0.9	2.1	1.2	0.0	0.1	0.2	1.1	2.2	0.1	0.2	0.4	0.2	0.1	2.3	0.8	0.2	0.0	0.2	0.0	2.8	0.0	0.6	0.0	0.1	0.1	0.7	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	1.8	1.9	1.2	2.2	1.9	2.0	1.5	1.5	1.6	1.2	1.8	1.5	11.8	0.0	1.1	2.0	8.5	0.4	1.5	0.8	1.2	4.0	0.9	1.7	21.6	0.0	0.3	3.7	0.0	0.8	0.1	0.0	5.9	0.7	0.0	2.2	2.0	3.4	1.2	5.9	10.7	0.2	0.2	3.9	2.6	1.2	1.3	2.5	6.1	0.3	6.2	0.0	9.8	0.3	4.1	0.9	3.9	0.9	2.5	3.0	0.0	16.9	4.1	1.2	0.0	4.5	1.1	0.2	0.0	6.8	2.3	0.3	0.0	0.4	3.2	0.5	0.0	2.0	3.7	0.8	1.1	1.7	0.9	0.8	1.1	0.8	0.2	0.2
OGN	"mimecan, OIF, SLRR3A"	ENSG00000106809	Osteoglycin	P20774	9	92383268-92404696	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 216.0"	"Group enriched"	"Detected in many"	8	"Endometrial stromal cells: 104.1;Fibroblasts: 326.2;Leydig cells: 166.2;Peritubular cells: 212.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.7"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 22.2;HSkMC: 9.7;JURKAT: 15.7;MOLT-4: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013132	Approved		Supported	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA		170000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA013132: AB_1854825"	"unprognostic (2.31e-1)"	"unprognostic (3.94e-3)"	"unprognostic (1.74e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.44e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (4.04e-4)"	"unprognostic (2.47e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (1.92e-4)"	"unprognostic (3.37e-3)"	"unprognostic (3.86e-2)"	"unprognostic (2.20e-3)"	"prognostic unfavorable (2.03e-4)"	100.1	22.5	1.4	6.0	3.0	0.2	53.8	4.7	6.8	216.0	11.0	43.0	10.6	130.5	44.9	30.8	67.1	164.7	79.8	1.7	2.3	6.4	4.1	18.6	2.1	1.8	1.8	91.8	11.1	117.3	19.1	22.7	2.0	57.9	32.2	0.0	3.2	19.3	2.6	3.8	23.6	118.0	2.3	2.4	22.0	13.3	2.2	4.5	14.7	22.0	5.6	54.0	23.3	2.1	0.0	0.0	0.0	0.0	4.4	22.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	9.7	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.1	32.2	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	1.4	3.0	4.7	6.8	1.7	2.3	1.8	1.8	2.0	2.3	2.2	2.1	10.3	6.4	1.5	1.0	0.4	4.2	0.1	0.0	1.2	0.6	0.7	0.4	2.6	10.0	7.4	3.7	0.0	2.0	0.6	0.1	0.0	0.0	1.2	2.9	104.1	5.2	0.0	0.0	1.9	0.0	1.7	326.2	7.7	1.7	1.3	0.0	20.0	0.1	4.6	0.0	1.8	0.0	0.0	0.3	11.1	4.2	166.2	2.3	1.8	16.9	0.2	0.1	0.0	2.0	1.6	0.0	0.0	212.1	0.7	0.4	0.0	0.0	2.9	0.2	6.6	4.7	22.7	0.6	0.6	0.7	4.5	5.7	2.1	1.6	0.0	0.2
OLFML3	"HNOEL-iso, OLF44"	ENSG00000116774	"Olfactomedin like 3"	Q9NRN5	1	113979391-114035572	"Predicted intracellular proteins, Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 136.6;Fibroblasts: 246.9;Leydig cells: 73.3;Theca cells: 126.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"myeloid DC: 2.1"	"Lineage enriched"	"Detected in single"	12	"dendritic cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 577.3;ASC TERT1: 312.6;BJ hTERT+: 374.8;HSkMC: 581.6;LHCN-M2: 602.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027991			Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		3000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles		"HPA027991: AB_2732440"	"unprognostic (1.04e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.80e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.41e-3)"	85.6	42.6	5.7	24.9	7.4	0.9	89.7	7.2	12.4	170.6	8.2	71.9	15.1	124.7	42.6	26.6	96.3	95.0	56.6	5.4	6.7	34.1	36.3	55.4	12.0	9.8	7.7	177.4	35.2	9.9	17.9	111.8	8.6	42.9	34.5	0.2	16.7	73.8	10.3	37.6	32.3	94.6	9.2	9.9	48.4	9.3	9.7	8.9	21.8	38.2	14.9	71.1	98.8	11.2	0.0	19.7	9.7	0.1	577.3	312.6	0.6	77.1	374.8	26.5	85.3	25.2	0.2	0.0	4.1	222.4	0.2	0.0	3.2	0.3	4.0	0.0	0.0	0.0	0.1	19.3	149.6	0.2	0.0	581.6	0.0	37.2	0.5	10.7	2.1	0.0	0.0	0.1	602.3	0.3	0.2	0.4	45.8	0.0	0.7	0.1	142.6	0.3	0.0	0.0	0.3	5.4	0.1	0.2	10.5	143.3	224.6	0.9	1.8	14.9	27.6	5.9	0.0	0.2	0.1	0.0	7.3	0.0	94.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.7	7.4	7.2	12.4	5.4	6.7	9.8	7.7	8.6	9.2	9.7	11.2	13.6	0.0	3.7	0.0	0.4	13.0	0.2	0.0	0.6	0.0	2.1	2.9	1.4	4.3	0.8	1.8	0.0	6.8	1.1	0.2	0.0	0.8	2.9	6.2	136.6	9.5	6.0	0.0	0.0	0.0	4.9	246.9	5.6	3.5	1.3	0.3	45.7	0.5	33.3	0.0	0.0	0.6	0.0	5.9	22.7	1.7	73.3	15.5	12.4	16.9	0.6	0.0	0.0	0.0	0.1	0.3	0.1	33.1	0.2	0.7	0.0	0.5	0.0	0.1	0.0	44.8	28.0	0.3	0.4	1.2	11.5	12.4	2.6	126.1	0.2	0.2
PCDH18	"KIAA1562, PCDH68L"	ENSG00000189184	"Protocadherin 18"	Q9HCL0	4	137518918-137532494	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.2"	"Group enriched"	"Detected in many"	4	"Endometrial stromal cells: 72.3;Fibroblasts: 56.3;Leydig cells: 37.9;Peritubular cells: 58.6;Sertoli cells: 19.7;Smooth muscle cells: 25.5;Theca cells: 18.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 148.2;ASC diff: 175.0;ASC TERT1: 190.8;BJ hTERT+: 86.8;fHDF/TERT166: 143.3;HHSteC: 129.4;HSkMC: 195.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017976	Approved		Approved	"Golgi apparatus,Cytosol"		No	NA		5900000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol	"Golgi apparatus"	"HPA017976: AB_1855045"	"unprognostic (2.77e-1)"	"unprognostic (1.86e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.20e-2)"	"unprognostic (8.76e-2)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (4.71e-4)"	22.2	5.2	2.6	7.9	3.0	0.1	13.5	2.8	3.2	25.3	2.6	12.2	9.3	30.4	11.2	6.4	11.7	22.5	6.5	2.5	4.8	7.1	2.1	7.2	1.7	4.1	5.8	21.0	1.5	2.0	2.4	44.2	3.8	17.5	13.8	2.1	6.5	13.5	2.6	4.1	8.7	18.4	3.2	6.4	6.7	4.5	3.9	3.6	5.1	23.2	1.4	10.8	8.4	3.0	0.0	0.3	148.2	0.0	175.0	190.8	0.1	27.4	86.8	5.0	7.7	0.3	0.0	0.0	0.1	143.3	0.4	0.4	34.2	0.7	2.6	0.2	1.0	0.0	0.0	0.0	129.4	0.0	0.1	195.9	0.3	9.4	3.8	4.7	1.0	0.7	0.0	0.6	2.8	0.0	3.9	0.1	0.3	0.0	2.7	11.7	4.1	0.0	0.0	0.1	0.0	9.6	0.0	0.0	0.2	38.3	0.9	0.0	0.0	69.3	4.2	13.9	0.5	0.2	0.0	0.0	3.9	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.0	2.8	3.2	2.5	4.8	4.1	5.8	3.8	3.2	3.9	3.0	3.4	0.0	0.5	1.3	0.0	4.1	0.4	0.1	2.2	2.5	1.1	1.7	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.6	1.9	72.3	3.0	0.0	0.0	0.2	0.0	0.3	56.3	0.0	1.7	0.0	6.4	2.5	0.0	3.1	0.0	9.0	0.0	0.0	0.0	7.8	1.3	37.9	0.9	1.8	10.3	0.0	6.8	0.0	0.0	0.6	0.0	0.0	58.6	0.1	0.0	0.0	0.1	0.0	0.2	19.7	6.6	25.5	0.6	0.1	1.2	2.6	0.8	0.7	18.5	0.0	0.1
PCOLCE	"PCPE, PCPE1"	ENSG00000106333	"Procollagen C-endopeptidase enhancer"	Q15113	7	100602363-100608175	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endometrial stromal cells: 491.6;Fibroblasts: 439.9;Leydig cells: 140.5;Smooth muscle cells: 442.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 879.0;BJ hTERT+: 663.0;fHDF/TERT166: 404.5;HSkMC: 973.2;SH-SY5Y: 689.9;U-2197: 1213.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 81.1"	"CAB017623, HPA042927"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to extracellular matrix"	NA	NA		1300000000	"Cluster 22: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"CAB017623: AB_2251882, HPA042927: AB_2678224"	"unprognostic (4.14e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (9.76e-4)"	"unprognostic (2.16e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.13e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.43e-2)"	101.5	45.5	2.4	51.5	3.8	0.6	72.6	3.5	10.2	162.8	4.6	30.5	7.8	81.7	11.0	26.9	80.6	112.5	110.8	2.3	2.5	21.9	59.7	72.4	41.3	3.0	2.4	47.7	20.6	10.3	31.2	59.5	2.9	45.5	16.7	0.2	24.9	33.5	16.9	45.0	21.6	59.9	3.1	13.8	22.9	13.7	3.6	10.5	49.1	32.7	17.4	86.4	86.7	2.5	0.2	0.5	2.2	3.0	321.5	879.0	2.4	355.5	663.0	161.1	142.7	14.5	0.8	1.1	1.2	404.5	0.5	0.2	0.0	1.2	15.9	2.5	2.5	0.3	6.1	19.8	82.1	0.1	3.5	973.2	0.3	86.3	0.6	0.4	0.1	1.7	8.3	2.0	0.7	2.1	0.6	3.3	72.2	0.0	4.2	1.0	1.5	0.8	0.4	0.6	1.1	689.9	0.2	2.4	1.6	8.2	2.0	0.0	3.5	391.8	107.6	1213.4	0.2	0.4	0.5	0.1	136.6	1.2	68.2	0.0	0.0	0.4	0.1	0.3	0.3	0.1	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.1	0.0	2.4	3.8	3.5	10.2	2.3	2.5	3.0	2.4	2.9	3.1	3.6	2.5	33.6	9.6	2.8	2.3	2.5	40.0	3.3	4.2	6.8	4.3	6.6	11.3	16.3	4.3	5.5	5.5	0.0	13.3	4.5	0.8	27.4	6.4	14.8	15.1	491.6	17.2	1.8	5.7	0.5	5.1	11.2	439.9	7.1	11.0	1.3	0.7	33.9	44.8	20.8	16.8	2.5	0.9	6.1	1.9	53.6	27.6	140.5	5.5	32.0	9.4	0.8	12.1	6.2	1.5	0.2	4.1	1.3	50.4	2.1	2.2	0.1	2.5	6.8	2.0	32.9	14.2	442.2	32.8	21.0	3.6	33.1	25.2	9.4	22.6	0.7	3.0
PCOLCE2	PCPE2	ENSG00000163710	"Procollagen C-endopeptidase enhancer 2"	Q9UKZ9	3	142815922-142889206	"Predicted secreted proteins"		Heparin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 87.6;heart muscle: 123.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 138.0;Extravillous trophoblasts: 63.1;Fibroblasts: 225.8;Syncytiotrophoblasts: 241.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 65.5;RPMI-8226: 36.8;U-2197: 77.9;U-266/70: 68.6;U-266/84: 34.3"	"Low region specificity"	"Detected in many"							HPA013203	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to extracellular matrix"	NA	NA		580000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"		"HPA013203: AB_1855084"	"unprognostic (1.31e-1)"	"unprognostic (3.75e-2)"	"unprognostic (5.71e-6)"	"unprognostic (8.36e-6)"	"unprognostic (3.03e-2)"	"unprognostic (1.06e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (1.96e-5)"	"unprognostic (1.85e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.74e-4)"	"prognostic unfavorable (1.08e-4)"	87.6	2.8	0.8	4.0	0.9	14.9	29.1	0.4	1.0	21.5	0.8	6.9	0.1	4.2	2.2	7.8	3.9	1.5	123.2	1.3	1.9	17.9	18.3	16.4	2.3	0.7	1.1	3.9	1.4	0.7	23.7	48.1	0.6	21.5	5.1	0.7	3.1	8.9	2.4	5.3	2.8	8.7	0.5	3.0	3.4	2.4	1.5	0.7	6.4	22.1	1.9	25.7	26.0	0.8	1.4	11.0	3.4	0.0	65.5	18.1	0.0	1.0	0.2	2.9	3.6	0.7	1.2	0.0	3.3	4.9	14.8	0.1	13.7	0.0	3.4	0.0	21.0	2.5	6.8	0.0	0.0	1.5	0.0	6.9	0.0	6.9	1.7	14.5	0.2	2.2	0.5	0.0	1.4	2.0	4.5	1.2	5.5	0.2	21.9	0.0	8.1	36.8	3.2	0.1	7.6	4.6	17.8	0.0	6.5	4.7	0.0	4.5	0.0	5.8	12.8	77.9	6.0	68.6	34.3	0.0	16.6	1.9	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.4	1.0	1.3	1.9	0.7	1.1	0.6	0.5	1.5	0.8	17.3	0.0	3.2	0.7	0.2	7.4	0.7	0.9	0.6	18.0	0.5	0.6	37.3	0.0	0.9	12.9	25.0	138.0	0.2	0.2	0.0	0.0	0.6	2.1	2.2	4.5	0.0	0.0	1.6	0.0	63.1	225.8	0.5	3.7	1.3	29.0	0.4	11.8	15.3	6.7	2.2	0.2	0.0	0.6	12.4	1.0	0.6	6.7	3.6	1.9	0.0	13.8	0.0	29.7	1.6	0.5	0.4	0.0	0.0	2.1	0.0	0.0	0.0	12.6	0.0	6.1	16.9	25.8	47.7	1.0	7.4	241.6	1.1	19.1	0.0	0.4
PDCD1LG2	"B7-DC, bA574F11.2, Btdc, CD273, PD-L2, PDL2"	ENSG00000197646	"Programmed cell death 1 ligand 2"	Q9BQ51	9	5510531-5571282	"Cancer-related genes, CD markers, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 15.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 17.9;Langerhans cells: 13.1;Microglial cells: 12.2;monocytes: 26.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 71.4;BJ hTERT+: 111.6;HDLM-2: 88.1;TIME: 49.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA013411	Approved		Uncertain	Cytosol	"Secreted - unknown location"	NA	NA		31000000	"Cluster 46: Basophils - DNA binding"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 3: Monocytes - Immune response regulation"	Cytosol		"HPA013411: AB_1855102"	"unprognostic (3.93e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.51e-3)"	"unprognostic (6.68e-3)"	"unprognostic (7.66e-2)"	"unprognostic (6.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.37e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.29e-2)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (5.00e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.01e-1)"	"unprognostic (7.51e-3)"	4.4	0.8	0.4	6.9	0.6	0.3	4.3	0.5	0.5	2.5	0.3	1.7	0.7	2.2	1.2	2.0	2.4	3.4	2.7	0.4	0.8	1.2	4.2	7.1	10.4	1.1	0.6	1.6	0.6	0.4	0.2	4.8	1.1	1.0	2.1	0.0	1.3	1.4	1.5	1.4	1.5	3.1	0.9	15.1	1.4	0.6	0.7	5.0	1.0	2.2	6.2	4.2	2.2	1.3	6.0	0.0	0.0	0.0	4.7	5.4	0.1	71.4	111.6	33.7	40.4	0.0	0.3	0.0	0.2	29.2	4.8	0.5	0.1	9.7	33.3	88.1	0.0	0.0	0.0	0.0	26.5	0.0	0.0	5.0	0.1	15.8	18.5	9.7	22.4	0.0	0.0	8.5	41.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.0	0.7	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.2	0.0	0.1	49.7	24.0	1.4	11.8	20.1	1.2	0.1	0.1	13.6	0.0	3.0	1.5	0.3	0.0	0.5	1.4	0.6	0.2	0.7	0.3	0.3	0.1	0.0	0.3	0.7	0.0	0.1	0.0	1.1	0.3	0.4	0.6	0.5	0.5	0.4	0.8	1.1	0.6	1.1	0.9	0.7	1.3	6.1	6.4	0.5	1.6	0.4	1.0	0.1	0.7	1.8	0.0	0.2	1.5	0.1	0.0	0.7	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.0	0.4	2.2	0.0	0.0	1.6	0.2	17.9	6.7	0.5	0.0	3.8	0.2	6.8	0.0	2.9	0.0	1.4	0.0	0.0	5.3	13.1	0.0	5.9	2.5	1.8	12.2	26.4	0.0	0.0	1.0	2.4	3.7	0.0	2.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	2.2	3.1	0.0	0.0	0.3	1.0	0.8	1.1	0.1	0.0	0.1
PDGFRA	"CD140a, GAS9, PDGFR2"	ENSG00000134853	"Platelet derived growth factor receptor alpha"	P16234	4	54229280-54298245	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins"	"Chemotaxis, Host-virus interaction"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 190.2"	"Group enriched"	"Detected in many"	8	"Endometrial stromal cells: 423.9;Fibroblasts: 256.4;Leydig cells: 449.8;Oligodendrocyte precursor cells: 499.6;Peritubular cells: 408.9"	"Cancer enhanced"	"Detected in all"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 468.1;ASC TERT1: 216.1;BJ hTERT+: 279.4;fHDF/TERT166: 195.9;HHSteC: 156.3;HSkMC: 392.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004947, CAB018143"	Supported		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA		300000	"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Plasma membrane, Cell Junctions"		"CAB018143: AB_2162351, HPA004947: AB_2732399"	"unprognostic (1.67e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.92e-2)"	"prognostic favorable (9.33e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (9.79e-6)"	"unprognostic (9.58e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.72e-3)"	46.0	28.9	13.9	40.4	13.7	1.6	40.1	8.1	12.8	50.8	18.1	37.7	22.4	44.3	21.8	22.5	50.9	38.5	32.1	11.9	11.0	26.5	16.0	37.9	8.5	16.7	11.9	190.2	13.4	3.0	3.7	62.7	15.1	15.0	35.2	5.3	16.6	18.9	9.6	14.8	31.3	48.1	12.1	46.2	29.4	13.6	8.9	7.6	16.5	41.9	7.2	63.9	38.0	20.0	0.1	0.0	1.0	0.8	468.1	216.1	0.5	25.4	279.4	0.1	0.7	67.6	0.5	0.5	0.5	195.9	0.8	0.6	19.6	0.2	0.1	2.6	1.0	0.7	0.7	1.2	156.3	0.3	0.4	392.0	0.0	31.4	0.0	5.4	0.0	0.7	0.6	0.9	1.1	0.1	0.4	1.2	3.5	0.3	1.1	0.5	0.1	0.1	0.0	0.4	0.6	37.9	0.0	0.5	0.2	2.0	0.7	0.1	0.8	84.9	3.2	93.9	0.2	0.4	0.1	0.8	2.6	0.1	2.2	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.9	13.7	8.1	12.8	11.9	11.0	16.7	11.9	15.1	12.1	8.9	20.0	11.1	0.0	0.5	0.3	0.6	17.1	0.6	2.4	1.2	5.5	4.3	3.2	4.8	0.0	0.8	0.0	0.0	1.4	0.9	0.1	1.9	4.2	2.2	11.7	423.9	5.7	0.0	0.0	1.1	6.7	2.0	256.4	5.1	9.0	0.0	2.6	26.0	1.0	3.1	0.0	19.5	0.2	10.2	0.6	27.3	17.2	449.8	5.4	23.2	39.4	4.7	17.5	0.0	499.6	0.4	20.0	0.0	408.9	0.2	0.9	0.0	0.1	0.5	0.6	0.0	25.7	13.9	1.0	3.4	8.1	15.8	1.4	2.5	49.6	0.0	1.0
PEAK1	"KIAA2002, sgk269"	ENSG00000173517	"Pseudopodium enriched atypical kinase 1"	Q9H792	15	77100656-77420144	"Enzymes, Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 147.4;Excitatory neurons: 162.1;Oligodendrocyte precursor cells: 513.2;Oligodendrocytes: 338.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.8"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.8"	"Cell line enhanced"	"Detected in all"		"TIME: 52.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026313, HPA026517"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA026313: AB_1856801, HPA026517: AB_1856802"	"unprognostic (1.15e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.26e-2)"	"unprognostic (8.82e-2)"	"unprognostic (6.63e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.00e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (2.25e-3)"	"unprognostic (5.73e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.33e-1)"	"unprognostic (5.65e-3)"	13.8	4.4	8.9	5.8	13.3	9.1	9.5	5.5	8.8	11.3	1.0	7.8	5.9	7.4	6.4	5.2	5.7	10.0	16.2	8.2	8.4	5.0	3.8	18.0	6.8	6.4	7.8	7.5	4.8	5.4	2.9	16.7	5.8	6.0	8.1	13.7	5.5	7.3	6.7	6.7	7.3	9.9	4.9	29.4	4.9	9.9	11.8	4.7	6.3	8.5	4.7	9.0	7.5	11.7	5.4	7.8	18.1	4.3	33.4	35.7	6.3	28.6	19.7	14.9	14.9	6.3	4.7	4.1	5.0	41.4	5.7	2.6	14.6	4.5	16.9	4.2	7.6	7.7	12.2	3.8	12.2	4.6	3.9	27.6	4.3	28.8	4.8	16.3	42.3	6.6	10.0	4.0	16.1	2.2	2.6	4.9	8.4	3.7	2.1	5.3	10.8	3.0	4.4	9.6	4.0	4.9	11.2	2.3	18.6	19.7	1.7	3.2	52.1	31.5	15.2	13.2	12.2	6.3	9.5	5.9	5.5	10.5	17.3	0.1	0.2	0.4	0.2	0.0	0.4	0.3	0.0	0.0	0.1	0.2	0.1	0.1	0.1	1.8	0.1	0.2	0.0	0.2	8.9	13.3	5.5	8.8	8.2	8.4	6.4	7.8	5.8	4.9	11.8	11.7	48.3	147.4	46.8	101.9	12.6	21.9	7.5	5.6	2.2	18.4	6.1	5.8	46.9	10.0	29.2	1.8	12.5	3.1	12.3	23.9	0.0	6.9	15.1	22.9	19.5	41.2	3.0	10.8	162.1	5.4	2.0	35.6	15.8	10.1	17.7	6.3	31.8	6.0	18.9	20.2	84.4	11.9	2.0	21.3	34.7	13.6	19.9	20.2	12.4	124.6	8.5	28.1	10.3	513.2	338.1	9.8	10.7	16.1	7.0	8.3	15.7	3.7	41.6	20.1	13.1	23.0	37.7	13.6	13.7	5.8	18.0	6.3	8.2	22.6	12.3	7.2
PI16	"CD364, dJ90K10.5, MGC45378, MSMBBP"	ENSG00000164530	"Peptidase inhibitor 16"	Q6UXB8	6	36948263-36964837	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 140.6;heart muscle: 127.7;vagina: 127.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 204.8;Leydig cells: 205.9;Oligodendrocytes: 67.3;Peritubular cells: 149.7"	"Cancer enhanced"	"Detected in many"		"glioma: 15.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 66.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 66.1"	"Cell line enriched"	"Detected in some"	6	"JURKAT: 29.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	7	"spinal cord: 33.2"	HPA076574	Approved				"Secreted to blood"	NA	NA		2900000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA076574: AB_2732314"	"unprognostic (6.24e-3)"	"unprognostic (6.00e-3)"	"unprognostic (7.34e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.76e-2)"	57.8	3.5	12.2	3.1	17.7	0.2	66.1	14.3	15.1	140.6	7.9	11.6	1.5	5.7	29.0	10.6	15.0	46.4	127.7	10.1	16.1	1.5	0.7	11.4	2.2	15.3	14.2	3.4	5.6	0.9	8.4	2.4	15.8	31.3	7.9	0.0	14.0	34.2	15.1	51.7	4.5	8.4	13.4	1.3	22.1	14.7	16.4	2.4	23.2	33.6	6.0	116.1	127.6	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.9	0.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	29.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	1.8	0.6	19.7	5.7	0.0	1.3	6.4	2.2	0.5	13.5	0.0	0.5	66.1	3.3	12.2	17.7	14.3	15.1	10.1	16.1	15.3	14.2	15.8	13.4	16.4	19.3	10.9	0.0	1.5	3.3	0.7	21.5	0.1	0.0	0.6	0.0	0.4	0.4	4.5	0.0	0.6	1.8	0.0	0.0	0.4	0.0	1.9	0.1	10.8	0.1	0.2	11.0	0.0	0.0	0.1	0.0	0.0	204.8	4.1	0.1	0.0	0.0	10.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	39.6	19.0	205.9	1.9	10.6	3.7	0.0	0.0	0.0	0.0	67.3	0.1	0.0	149.7	0.6	0.1	0.0	0.2	0.0	0.0	0.0	7.7	4.2	2.4	1.3	0.4	18.5	0.1	3.5	0.3	0.0	0.2
PLTP	BPIFE	ENSG00000100979	"Phospholipid transfer protein"	P55058	20	45898621-45912155	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Hofbauer cells: 1640.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 33.1;eosinophil: 29.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 220.8;BEWO: 186.8;HHSteC: 233.2;HSkMC: 302.2;U-87 MG: 326.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032873	Approved				"Secreted to blood"	NA	NA	9720000000	210000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"CAB032873: AB_2283977"	"unprognostic (1.27e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (9.52e-8)"	"unprognostic (3.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.68e-2)"	437.9	188.9	107.9	80.5	109.8	20.7	122.6	100.8	142.0	155.4	197.6	76.9	41.6	114.9	72.6	62.0	173.5	182.3	123.4	100.4	119.0	198.9	29.5	97.1	61.3	119.5	152.2	159.5	296.9	22.1	38.5	428.8	126.0	50.7	42.4	4.8	132.1	71.5	24.0	68.0	71.6	181.9	124.7	57.6	89.7	32.3	114.5	229.9	44.4	20.8	21.1	339.7	113.1	118.1	13.8	1.9	94.9	0.1	220.8	66.8	186.8	5.3	16.3	18.5	11.0	78.7	15.9	3.5	151.6	23.6	0.4	154.7	29.2	0.6	8.4	1.8	0.2	28.8	3.3	37.7	233.2	0.0	35.5	302.2	7.7	49.1	0.9	74.1	41.3	3.2	9.5	44.9	6.2	3.9	3.2	123.1	16.9	12.5	74.5	1.3	0.1	1.7	0.5	0.0	10.1	35.4	3.7	110.3	160.9	15.7	1.5	117.2	9.0	46.2	1.1	24.2	0.8	19.7	5.3	5.4	326.4	34.3	7.8	33.1	2.7	29.7	1.6	7.1	1.2	8.7	0.4	1.6	2.5	3.2	0.0	1.0	1.4	4.9	12.6	17.5	0.8	2.7	107.9	109.8	100.8	142.0	100.4	119.0	119.5	152.2	126.0	124.7	114.5	118.1	21.9	0.0	2.3	30.3	3.8	40.7	34.9	53.0	33.0	0.4	9.5	22.6	1.5	5.7	9.6	27.6	0.0	14.8	3.5	0.5	1.9	3.4	16.3	54.6	36.9	27.9	0.0	9.0	0.8	103.2	97.7	256.8	3.6	5.7	0.0	23.4	121.1	2.8	1640.3	3.3	1.4	1.2	12.2	254.0	40.9	24.9	307.9	71.8	35.6	4.7	3.8	13.8	7.2	0.5	0.2	9.9	0.0	199.0	11.8	15.7	0.0	18.2	70.8	1.1	32.9	16.1	35.6	5.7	7.3	24.0	35.8	31.7	3.3	99.5	0.7	18.4
PLXDC2	"FLJ14623, TEM7R"	ENSG00000120594	"Plexin domain containing 2"	Q6UX71	10	19816239-20289856	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Microglial cells: 1508.4;Oligodendrocytes: 470.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 57.5;intermediate monocyte: 33.4;myeloid DC: 36.0;neutrophil: 81.6;non-classical monocyte: 37.3"	"Group enriched"	"Detected in many"	13	"dendritic cells: 36.0;granulocytes: 81.6;monocytes: 57.5"	"Cell line enhanced"	"Detected in some"		"HHSteC: 19.4;U-2197: 45.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017268, HPA070793"	Approved		Supported	"Nuclear bodies"		No	No		720000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear bodies"		"HPA017268: AB_10965928, HPA070793: AB_2686313"	"unprognostic (1.75e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.05e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.32e-2)"	"unprognostic (7.52e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.44e-2)"	"unprognostic (3.91e-3)"	"unprognostic (8.71e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.66e-2)"	12.4	9.4	13.3	7.3	14.1	5.2	11.5	9.6	13.3	12.7	16.8	5.3	4.2	10.7	3.5	7.5	10.1	17.4	10.2	11.3	25.6	10.7	3.1	17.1	2.4	18.0	17.3	9.4	3.6	16.2	3.3	4.7	19.2	7.6	4.6	18.2	6.2	7.7	5.0	15.5	7.1	16.2	16.2	9.4	3.8	5.9	22.3	2.5	6.8	10.0	2.8	8.5	8.9	29.1	0.0	0.0	5.8	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	7.7	2.2	1.8	0.0	0.0	0.7	2.8	8.6	0.4	19.4	0.0	0.0	7.7	0.6	0.0	2.3	8.9	0.0	0.0	0.1	1.7	0.9	1.1	0.6	0.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.4	0.2	2.4	0.4	0.0	1.8	0.8	0.9	0.0	7.6	3.9	45.9	0.0	0.1	0.0	0.0	3.5	0.1	0.0	10.7	57.5	11.8	1.3	33.4	2.7	0.0	0.0	0.3	36.0	0.0	0.0	0.0	81.6	4.4	37.3	1.6	0.0	17.7	13.3	14.1	9.6	13.3	11.3	25.6	18.0	17.3	19.2	16.2	22.3	29.1	101.4	16.0	8.9	131.9	2.6	36.8	23.8	12.3	41.5	44.2	14.4	45.3	10.9	15.7	10.9	5.5	8.4	0.9	2.9	7.1	0.0	6.9	2.9	16.5	7.6	45.3	3.0	10.5	190.9	0.0	8.1	97.2	1.1	19.4	31.6	80.9	82.1	4.2	94.3	1.7	59.9	27.3	8.2	91.3	46.3	2.1	19.3	147.7	7.2	1508.4	94.5	25.5	5.2	158.3	470.2	1.0	16.6	57.2	3.8	5.5	16.0	22.2	3.0	73.6	19.7	110.1	12.7	1.6	1.2	35.5	38.1	1.2	4.2	71.4	8.8	11.7
PRDM5	PFM2	ENSG00000138738	"PR/SET domain 5"	Q9NQX1	4	120684919-120922870	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 51.2;Early spermatids: 75.6;Inhibitory neurons: 31.9;Late spermatids: 31.0;Oligodendrocyte precursor cells: 52.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	27	"eosinophil: 7.5;neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	32	"granulocytes: 7.5"	"Cell line enhanced"	"Detected in many"		"U-266/84: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051406	Enhanced		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoplasm, Nuclear bodies"	Nucleoli	"HPA051406: AB_2681472"	"unprognostic (7.74e-2)"	"unprognostic (8.45e-3)"	"unprognostic (3.15e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.20e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.28e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.13e-1)"	"unprognostic (3.00e-2)"	"unprognostic (4.91e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.56e-3)"	3.0	4.0	1.8	1.6	2.0	3.5	3.0	3.2	2.0	5.2	4.2	3.2	1.3	6.0	2.8	2.2	4.6	2.4	3.0	1.6	3.2	1.9	0.4	4.2	0.9	4.1	4.0	10.3	4.8	8.6	3.9	3.5	4.0	4.1	2.9	4.7	1.8	4.3	1.6	1.5	1.8	4.4	4.7	2.4	2.1	3.6	2.9	1.4	5.8	3.0	0.8	2.9	3.3	4.4	2.2	3.4	7.8	0.1	4.5	9.3	9.2	4.7	9.9	4.7	4.2	4.4	1.2	0.4	1.2	6.2	4.5	0.1	0.0	1.0	6.0	0.0	1.4	2.9	3.1	0.3	4.9	10.0	0.1	6.6	2.9	3.3	4.1	4.3	3.4	1.2	0.0	14.2	5.7	0.4	1.5	0.1	5.7	0.8	2.7	0.0	9.3	6.1	1.6	0.0	1.4	6.2	0.0	0.1	0.9	4.0	6.4	4.1	1.4	0.2	2.7	4.8	4.6	13.0	19.7	0.1	3.6	0.1	3.6	0.1	0.0	7.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.0	1.8	2.0	3.2	2.0	1.6	3.2	4.1	4.0	4.0	4.7	2.9	4.4	7.1	12.8	5.6	51.2	0.5	1.7	2.7	2.4	9.1	9.1	1.1	2.4	8.2	2.8	3.8	1.8	8.4	1.0	0.2	1.5	1.9	2.3	75.6	1.4	9.4	6.3	3.6	0.0	25.0	2.5	2.6	9.6	2.6	1.4	2.5	15.5	3.6	0.0	0.8	0.0	31.9	3.6	4.1	0.3	0.7	31.0	8.7	0.6	1.8	23.4	0.2	7.6	0.0	52.8	8.0	1.5	0.8	9.4	0.7	2.6	0.1	0.2	1.8	7.5	6.6	10.1	6.6	8.2	3.5	4.6	1.7	0.5	1.2	14.9	3.0	0.7
PRICKLE1	"EPM1B, FLJ31937, RILP"	ENSG00000139174	"Prickle planar cell polarity protein 1"	Q96MT3	12	42456757-42590355	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 72.8;Excitatory neurons: 307.7;Inhibitory neurons: 122.2;Microglial cells: 64.6;Oligodendrocyte precursor cells: 114.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 7.6;naive B-cell: 11.5"	"Lineage enriched"	"Detected in many"	4	"B-cells: 11.5"	"Cell line enriched"	"Detected in many"	18	"HBEC3-KT: 1015.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001379, HPA050037"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA001379: AB_1855703, HPA050037: "	"unprognostic (2.44e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.22e-1)"	"unprognostic (2.34e-4)"	"unprognostic (3.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.89e-2)"	"unprognostic (5.29e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.29e-4)"	"unprognostic (1.12e-1)"	"unprognostic (8.95e-3)"	"unprognostic (5.33e-4)"	6.3	3.0	3.7	5.2	5.0	1.7	5.0	0.0	7.2	12.5	0.0	4.2	2.6	12.1	1.6	2.4	6.4	10.0	13.8	4.2	0.0	5.0	1.7	9.5	4.6	0.1	1.3	12.5	2.0	1.4	2.0	5.3	0.0	5.1	2.2	4.2	7.8	5.6	3.9	4.7	2.4	12.7	0.0	14.8	2.9	6.0	3.9	1.6	7.9	4.6	3.4	5.5	6.3	1.0	7.7	4.4	17.0	0.5	12.4	13.1	0.5	11.0	5.2	3.0	5.1	0.5	16.0	0.5	31.4	1.6	0.0	2.9	12.5	1015.4	3.5	0.6	6.4	17.5	0.9	0.4	1.7	0.3	0.2	19.3	7.5	12.7	1.7	1.8	39.7	0.3	1.8	3.1	2.9	0.3	0.1	0.5	56.1	0.1	18.0	0.2	0.7	0.1	21.1	0.7	4.4	3.0	0.3	0.7	0.7	13.7	0.3	35.1	2.9	0.9	13.4	14.0	14.2	0.9	0.6	6.1	0.2	10.7	0.6	2.6	1.8	0.4	0.2	1.0	0.7	7.6	0.2	0.2	1.0	11.5	0.4	0.2	2.4	0.5	0.6	1.6	0.2	0.9	3.7	5.0	0.0	7.2	4.2	0.0	0.1	1.3	0.0	0.0	3.9	1.0	6.9	16.0	8.2	8.8	13.2	2.7	5.3	7.3	4.0	13.5	4.0	2.2	5.7	14.3	2.6	1.8	2.1	0.6	0.2	0.0	0.0	3.8	72.8	5.2	43.0	8.1	0.0	0.4	307.7	2.6	0.2	19.2	3.6	8.6	1.3	59.1	14.6	0.1	0.6	8.4	122.2	0.0	2.0	0.9	2.3	25.4	9.9	1.2	7.2	64.6	1.1	2.7	0.0	114.6	5.3	3.9	0.1	24.8	3.1	1.0	0.0	3.3	0.3	4.5	0.0	3.8	7.9	5.1	4.8	1.9	1.4	0.7	1.1	18.6	0.0	0.8
PRKAR2B	PRKAR2	ENSG00000005249	"Protein kinase cAMP-dependent type II regulatory subunit beta"	P31323	7	107044705-107161811	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 135.8"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 110.2;Excitatory neurons: 146.3;Granulosa cells: 712.1;Theca cells: 271.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 70.7;Daudi: 99.8;K-562: 61.4;U-698: 254.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008421, HPA063879"	Enhanced		Uncertain	Mitochondria		NA	NA		570000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria		"HPA008421: AB_1855421, HPA063879: "	"unprognostic (3.18e-1)"	"unprognostic (2.48e-2)"	"prognostic favorable (6.38e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.43e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.50e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (7.15e-2)"	135.8	44.9	10.7	4.8	12.1	14.2	51.3	5.7	17.5	8.0	5.3	11.1	3.6	6.9	4.4	11.2	7.0	4.9	15.5	13.2	9.5	8.8	2.5	7.6	3.8	6.2	10.2	26.4	8.7	6.5	11.4	15.1	8.3	9.2	6.9	7.5	9.9	4.4	1.5	3.7	11.5	5.1	6.9	16.7	9.1	13.6	7.8	2.6	3.5	6.1	4.0	20.3	6.2	10.1	0.1	1.5	9.1	70.7	36.8	0.0	0.1	3.6	11.5	3.0	2.7	0.0	0.2	99.8	0.8	2.3	8.6	0.1	7.1	0.0	5.5	2.8	7.9	33.3	0.1	0.0	10.3	0.6	4.5	0.5	0.0	0.3	0.0	3.1	42.9	5.4	61.4	2.9	0.1	7.5	14.0	0.4	17.3	0.0	2.8	4.0	0.2	0.0	0.1	0.1	11.6	16.7	5.4	1.2	3.9	22.9	2.1	7.0	24.4	3.5	9.2	0.0	7.1	2.1	0.1	254.8	2.5	17.5	33.9	0.6	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.0	0.6	10.7	12.1	5.7	17.5	13.2	9.5	6.2	10.2	8.3	6.9	7.8	10.1	39.6	3.2	1.5	9.8	1.9	2.4	1.6	2.1	0.6	33.5	27.9	10.5	35.9	12.8	5.1	7.3	10.4	0.1	3.7	1.7	0.0	2.5	7.9	1.8	16.2	17.4	0.0	110.2	146.3	0.0	0.6	17.5	3.6	0.9	4.5	712.1	19.2	0.0	1.6	5.0	71.9	1.9	4.1	19.6	26.4	8.5	29.8	64.1	17.8	15.9	17.0	6.4	3.1	60.8	10.9	0.1	2.1	53.0	2.0	3.5	0.0	0.8	5.4	11.9	19.7	5.4	57.7	2.5	6.5	0.7	2.4	0.0	3.7	271.7	2.7	4.6
PRPH2	"CACD2, rd2, RDS, RP7, TSPAN22"	ENSG00000112619	"Peripherin 2"	P23942	6	42696598-42722597	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Sensory transduction, Vision"		"Cone-rod dystrophy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"retina: 641.4"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 260.6;Rod photoreceptor cells: 482.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.0;ASC TERT1: 3.4;fHDF/TERT166: 5.3;HHSteC: 7.8;HSkMC: 6.0;LHCN-M2: 3.5"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 2.4"	"Not detected"	"Not detected"			HPA029458	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA029458: AB_10602193"	"unprognostic (2.37e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.96e-3)"	1.1	0.8	2.1	0.5	1.5	0.0	0.5	0.4	1.8	2.0	0.1	2.2	0.4	2.1	1.8	0.7	1.3	1.1	1.5	3.1	2.1	1.4	0.2	1.5	0.1	0.9	1.0	3.1	2.3	4.3	2.5	0.9	1.2	1.5	0.8	641.4	0.7	1.1	13.2	0.3	1.4	1.9	0.4	0.8	1.2	3.7	2.7	0.2	4.1	2.9	0.1	1.2	1.1	1.2	0.0	0.0	0.0	0.0	3.0	3.4	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	7.8	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.2	0.0	0.1	0.0	2.1	1.5	0.4	1.8	3.1	2.1	0.9	1.0	1.2	0.4	2.7	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	39.3	0.1	0.0	0.9	0.0	0.1	0.0	260.6	0.1	0.0	0.0	3.9	0.3	0.2	0.1	0.9	2.3	0.0	0.0	2.3	0.2	0.0	1.3	0.0	0.1	0.0	0.2	0.4	0.2	0.0	11.8	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.9	0.0	42.6	1.0	0.5	0.6	0.5	0.0	1.9	0.0	0.2	0.0	0.2	0.0	482.7	0.0	0.9	0.8	2.3	0.5	0.1	0.3	0.1	0.0	1.3	0.0	0.1
PRSS35	"C6orf158, dJ223E3.1, MGC46520"	ENSG00000146250	"Serine protease 35"	Q8N3Z0	6	83512534-83525704	"Enzymes, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 50.5"	"Cell type enriched"	"Detected in some"	36	"Muller glia cells: 410.9"	"Group enriched"	"Detected in some"	4	"glioma: 2.8;testis cancer: 4.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"MAIT T-cell: 19.5"	"Lineage enriched"	"Detected in single"	195	"T-cells: 19.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.4;CACO-2: 86.3;HAP1: 12.8;RPTEC TERT1: 24.6;SuSa: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 2.9;cerebellum: 3.6;cerebral cortex: 5.8;hippocampal formation: 5.3;olfactory bulb: 2.7"	"HPA038787, HPA038788"	Uncertain				"Secreted in female reproductive system"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"			"HPA038787: AB_10675951, HPA038788: AB_2676208"	"unprognostic (6.17e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.70e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.33e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.88e-6)"	"unprognostic (7.15e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-4)"	1.3	2.4	2.9	0.1	3.8	0.0	0.3	1.7	6.8	2.9	1.5	0.1	0.3	1.3	1.1	0.3	1.4	4.2	4.4	3.2	2.1	3.1	0.4	1.3	0.7	1.8	1.9	10.2	0.3	0.3	1.1	3.6	1.8	1.1	0.3	50.5	0.3	0.4	0.1	0.2	0.1	1.5	1.8	0.7	0.3	3.1	2.6	0.1	0.4	0.1	0.1	1.3	0.5	2.2	0.0	0.5	1.9	0.0	0.1	0.0	0.0	0.3	10.4	1.0	2.0	86.3	0.0	0.0	0.1	0.4	0.0	0.0	12.8	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	3.1	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.6	0.4	8.2	0.0	0.0	0.0	24.6	0.0	0.0	1.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	19.5	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	3.8	1.7	6.8	3.2	2.1	1.8	1.9	1.8	1.8	2.6	2.2	0.3	3.2	0.5	8.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	1.5	0.0	0.0	1.8	0.0	0.3	0.0	0.1	9.8	0.1	0.1	0.0	0.3	0.8	1.8	0.0	0.2	0.0	0.0	4.4	0.0	0.0	0.0	0.9	0.0	0.3	0.4	6.7	0.2	0.0	0.0	0.0	0.0	0.2	1.2	0.1	0.0	1.0	0.0	410.9	0.0	1.0	0.1	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	11.4	6.6	0.1	3.7	0.1	0.5	0.0	0.0	0.1	0.7	5.1	0.0	0.0
PRTFDC1	HHGP	ENSG00000099256	"Phosphoribosyl transferase domain containing 1"	Q9NRG1	10	24848614-24952606	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 136.1;Oligodendrocyte precursor cells: 111.6;Oligodendrocytes: 148.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 4.4"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 4.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 75.9;CAPAN-2: 94.3;HEL: 56.2"					"Low region specificity"	"Detected in all"			HPA021458	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA021458: AB_1855793"	"unprognostic (2.61e-1)"	"unprognostic (3.47e-1)"	"unprognostic (3.69e-1)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (9.49e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (2.25e-2)"	"unprognostic (2.50e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.94e-2)"	5.4	22.2	21.7	4.5	28.7	0.9	7.6	24.9	27.2	12.9	16.1	9.9	17.7	15.8	7.4	5.5	9.8	14.8	10.9	22.4	24.6	4.8	2.8	4.3	4.2	26.7	24.0	20.2	4.6	13.4	11.4	2.9	28.0	7.8	11.3	16.5	9.7	8.2	1.3	1.8	17.1	9.8	25.8	3.2	17.5	2.2	23.7	6.8	5.3	2.8	3.2	7.4	6.3	37.1	19.5	41.3	30.2	12.4	4.9	24.4	0.0	20.2	15.1	14.2	19.3	75.9	94.3	0.0	3.1	23.7	1.2	10.7	34.7	0.0	22.0	0.0	1.4	56.2	7.6	0.1	14.6	0.0	0.0	7.1	0.2	7.7	0.0	13.3	22.6	2.2	18.6	10.5	6.8	0.5	8.8	0.1	20.9	3.3	0.7	9.7	0.1	0.2	12.7	0.5	21.5	0.9	19.3	0.1	0.0	0.6	1.1	4.3	12.2	6.3	15.5	23.1	12.2	0.9	0.0	0.0	16.8	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	4.4	0.0	0.1	0.0	0.9	21.7	28.7	24.9	27.2	22.4	24.6	26.7	24.0	28.0	25.8	23.7	37.1	3.5	0.0	0.5	136.1	0.7	2.7	4.6	5.4	2.8	10.2	1.1	5.8	8.6	7.2	3.9	3.7	2.1	1.0	0.8	3.8	5.9	5.8	1.4	1.5	27.3	2.8	5.4	3.0	38.2	0.5	4.9	20.6	12.2	2.2	0.0	25.1	7.5	0.1	7.2	6.7	43.0	7.3	0.0	0.9	3.1	1.0	12.2	7.8	3.6	24.4	1.5	45.8	0.0	111.6	148.2	2.3	2.1	9.8	1.3	1.1	12.2	0.1	1.1	15.9	0.0	16.4	10.4	3.4	6.3	0.4	2.8	0.8	1.0	22.7	11.6	1.5
RARRES2	"HP10433, TIG2"	ENSG00000106538	"Retinoic acid receptor responder 2"	Q99969	7	150338317-150341662	"Plasma proteins, Predicted secreted proteins"	"Chemotaxis, Differentiation, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 2400.4;liver: 1994.6;pancreas: 1482.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 659.2;Hepatocytes: 2819.0;Muller glia cells: 785.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 420.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 5.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 5.4"	"Group enriched"	"Detected in many"	6	"AF22: 132.9;Hep G2: 213.8;HHSteC: 172.9;NTERA-2: 411.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	75000000	460000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.81e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (6.83e-4)"	"unprognostic (2.94e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.17e-2)"	525.6	2400.4	61.0	87.4	62.1	0.4	295.6	56.2	70.2	522.4	321.7	386.8	53.2	359.2	55.9	78.7	408.5	116.5	212.7	62.0	63.3	271.9	1994.6	466.8	109.8	65.9	73.6	626.3	1482.0	627.1	104.1	59.0	63.3	262.5	78.3	33.9	56.2	114.7	18.3	60.4	185.9	103.0	64.8	149.5	180.0	26.9	64.5	9.8	85.0	34.6	63.1	265.3	380.7	66.7	0.0	0.1	132.9	0.3	0.0	0.0	2.1	11.9	25.2	4.2	17.2	1.2	8.2	1.1	15.0	2.9	1.3	0.5	0.0	0.0	0.0	2.4	0.5	0.6	23.6	213.8	172.9	2.2	0.4	36.4	0.0	0.0	0.0	2.8	0.0	0.4	0.4	0.4	4.2	0.9	2.1	2.4	411.9	1.2	0.0	0.1	17.1	0.4	2.8	1.1	0.6	1.2	2.3	0.1	0.4	1.9	0.6	0.0	0.0	0.4	1.8	0.8	0.6	1.4	0.9	1.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	5.4	0.0	0.0	61.0	62.1	56.2	70.2	62.0	63.3	65.9	73.6	63.3	64.8	64.5	66.7	47.1	67.3	32.0	9.4	7.0	35.1	80.7	16.8	15.9	7.0	26.2	39.0	75.0	381.8	45.0	82.8	2.1	10.1	1.9	172.6	103.7	19.8	3.7	39.9	128.7	27.1	97.4	32.0	0.4	659.2	4.3	469.6	8.2	16.4	12.0	207.5	84.6	2819.0	11.6	10.1	0.4	233.9	541.2	53.8	42.4	19.3	454.2	8.9	44.4	7.5	1.0	785.1	0.0	9.0	0.3	209.1	107.4	194.9	1.2	82.0	1.2	269.1	29.8	25.4	13.1	302.5	181.1	4.9	5.2	4.4	28.8	14.6	12.3	307.5	418.7	31.9
RECK	"hRECK, ST15"	ENSG00000122707	"Reversion inducing cysteine rich protein with kazal motifs"	O95980	9	36036913-36124455	"Plasma proteins, Predicted membrane proteins"	"Wnt signaling pathway"	"Protease inhibitor, Serine protease inhibitor"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 63.1;Inhibitory neurons: 71.1;Oligodendrocyte precursor cells: 80.4;Oligodendrocytes: 119.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 199.5;ASC TERT1: 158.5;BJ: 65.1;BJ hTERT+: 93.0;fHDF/TERT166: 57.8;HSkMC: 71.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025109, HPA071729"	Supported		Supported	"Plasma membrane"		NA	NA		64000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"CAB025109: , HPA071729: AB_2686438"	"unprognostic (3.42e-1)"	"unprognostic (4.01e-3)"	"unprognostic (5.50e-2)"	"unprognostic (5.05e-4)"	"unprognostic (8.87e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.51e-2)"	"unprognostic (9.06e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (7.31e-4)"	"unprognostic (2.68e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.60e-2)"	14.7	7.4	3.0	4.6	3.3	1.2	13.7	3.4	4.3	15.2	2.7	6.8	3.7	14.4	6.1	11.7	8.0	13.7	8.5	4.6	3.3	5.7	5.8	12.7	5.8	3.4	3.1	14.3	3.2	3.7	3.1	11.3	3.5	8.3	6.3	4.7	4.7	7.3	3.7	7.6	5.1	14.7	3.1	7.3	5.7	3.2	3.4	6.6	6.2	16.0	4.4	12.1	7.5	4.0	1.4	2.4	8.0	4.4	199.5	158.5	0.1	65.1	93.0	4.7	11.0	0.0	0.0	2.5	6.0	57.8	3.7	0.4	1.8	1.2	6.4	4.1	3.7	2.6	2.8	0.2	16.2	0.3	11.1	71.3	1.6	7.1	2.7	18.4	14.6	4.8	0.0	2.1	12.2	0.3	6.6	1.0	2.7	0.0	2.0	6.9	6.2	0.0	3.2	0.2	0.7	4.5	1.5	0.8	2.7	8.3	0.0	8.9	44.4	9.0	3.3	5.9	3.6	2.9	3.4	2.7	5.5	8.7	5.8	1.0	2.6	0.7	3.9	2.8	4.4	1.2	5.2	4.2	2.9	2.7	6.3	4.6	0.3	3.0	4.8	1.6	2.6	2.3	3.0	3.3	3.4	4.3	4.6	3.3	3.4	3.1	3.5	3.1	3.4	4.0	12.8	3.2	5.4	40.1	11.7	7.1	4.0	5.0	4.6	12.5	4.2	5.6	3.6	1.5	2.5	3.7	14.6	0.9	9.3	0.2	0.0	6.6	38.3	0.9	11.6	19.6	6.1	5.7	63.1	1.5	7.7	53.4	3.6	0.6	9.5	9.2	25.4	1.1	15.6	8.4	71.1	1.3	4.1	15.7	15.9	35.5	18.6	8.3	3.6	41.2	8.8	14.3	2.1	80.4	119.8	1.3	0.4	17.7	5.9	4.3	0.3	1.6	4.1	7.8	0.0	14.2	15.3	41.2	27.4	1.3	7.5	0.8	10.2	7.8	0.8	1.2
S100A4	"18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98"	ENSG00000196154	"S100 calcium binding protein A4"	P26447	1	153543613-153550136	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 2708.8;Langerhans cells: 5952.7;Macrophages: 2786.0;monocytes: 3172.6;NK-cells: 2130.8;Skeletal myocytes: 2034.0;T-cells: 2111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 2614.3;ASC diff: 3300.1;BJ hTERT+: 6738.6;fHDF/TERT166: 4819.1;RPMI-8226: 2700.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"spinal cord: 39.6"	"CAB002618, HPA007486, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228"	Enhanced		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	NA	NA		9600000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"CAB002618: , CAB027387: , CAB058698: AB_2665603, CAB068227: AB_2665602, CAB068228: AB_2665601, HPA007486: , HPA007973: AB_1079858"	"unprognostic (1.56e-1)"	"unprognostic (6.10e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.21e-2)"	"prognostic favorable (4.03e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.39e-2)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.16e-2)"	982.3	77.1	25.5	353.9	26.2	1090.8	561.9	27.5	53.1	566.3	32.0	301.7	91.7	177.8	124.5	224.0	217.6	167.6	268.5	24.7	27.4	247.0	64.3	874.2	221.0	31.7	26.4	51.0	53.8	18.1	24.8	182.9	29.8	223.7	331.5	10.0	245.4	155.8	163.0	371.5	234.3	297.7	27.8	443.0	133.3	32.2	33.7	112.6	191.9	424.6	315.4	391.6	455.2	34.1	11.8	2614.3	13.2	77.0	3300.1	2410.9	3.7	1664.4	6738.6	32.1	148.4	20.0	180.3	0.8	299.7	4819.1	3.5	65.3	8.8	20.9	23.6	405.2	2.3	1186.8	529.0	59.4	4.3	106.9	1924.6	364.2	21.5	62.2	13.0	4.9	2.6	0.7	9.9	4.2	2468.1	10.6	3.8	1273.9	7.2	189.7	1050.4	64.1	3.7	2700.2	103.5	71.3	108.5	11.6	24.9	1286.6	9.4	412.5	77.1	1493.7	3.1	8.5	13.7	2159.5	9.3	82.8	647.5	14.3	6.1	1367.9	127.2	2789.7	13536.2	1408.0	5800.5	9099.6	6077.0	761.6	5167.7	4700.0	9268.4	282.5	882.4	2641.3	12129.7	837.1	11862.4	1626.0	7406.7	24075.8	25.5	26.2	27.5	53.1	24.7	27.4	31.7	26.4	29.8	27.8	33.7	34.1	226.0	490.4	398.4	0.0	266.1	772.9	19.5	159.0	93.9	0.7	44.9	65.9	14.9	35.8	273.8	893.8	0.0	52.4	1345.4	8.9	111.6	21.9	7.3	53.0	473.0	209.1	4.8	730.9	0.0	23.5	255.5	1378.8	54.0	41.9	1395.8	0.6	96.4	18.6	1966.1	45.4	0.0	10.0	345.8	2708.8	5952.7	24.0	235.8	2786.0	1193.5	12.2	3172.6	3.6	2130.8	0.0	0.1	35.7	17.0	45.9	266.5	12.9	3.2	19.7	154.9	2.3	151.2	2034.0	1309.6	1.9	5.5	77.6	694.0	53.4	2111.1	32.5	11.3	73.1
S1PR2	"AGR16, DFNB68, EDG5, Gpcr13, H218"	ENSG00000267534	"Sphingosine-1-phosphate receptor 2"	O95136	19	10221433-10231331	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 92.9;Early spermatids: 92.3;Late spermatids: 184.9;Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 45.0"	"Group enriched"	"Detected in many"	8	"granulocytes: 45.0;T-cells: 12.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 29.4;Daudi: 54.1;U-266/70: 38.9;U-698: 57.3;WM-115: 38.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA014255, HPA014307"	Approved		Uncertain	"Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	"Nuclear speckles"	"HPA014255: , HPA014307: AB_1847989"	"unprognostic (5.38e-3)"	"unprognostic (1.83e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.05e-3)"	"unprognostic (8.50e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (4.36e-10)"	"unprognostic (4.91e-2)"	"unprognostic (4.56e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.09e-2)"	7.7	2.5	1.9	6.4	1.8	1.2	5.5	1.7	1.8	10.4	1.9	4.8	1.8	8.3	2.7	3.3	8.4	6.2	6.6	1.6	2.0	3.1	5.6	13.7	10.9	2.8	1.9	5.6	2.9	2.5	3.0	18.5	2.2	6.9	2.4	1.2	4.1	2.3	0.8	5.4	4.8	4.2	2.0	1.9	4.3	13.2	2.1	1.4	3.4	1.3	10.9	8.3	7.0	2.9	3.0	0.4	3.4	6.9	18.2	22.2	29.4	4.4	8.9	1.9	4.1	1.9	1.7	54.1	5.1	8.2	2.3	1.7	1.2	2.1	1.3	5.5	2.7	1.2	1.2	1.3	6.1	1.4	1.1	12.2	1.1	3.8	1.3	5.3	0.2	2.6	1.3	11.1	1.3	2.5	0.6	2.5	3.4	0.9	1.7	3.8	1.4	2.0	1.6	2.5	2.4	4.7	2.5	1.5	3.8	2.6	1.2	1.3	0.4	6.9	2.2	15.9	1.3	38.9	19.6	57.3	2.6	2.7	38.6	45.0	2.8	0.6	7.2	2.4	8.9	0.3	9.2	7.0	2.6	0.5	3.7	3.8	0.7	3.6	1.0	0.4	12.4	2.0	1.9	1.8	1.7	1.8	1.6	2.0	2.8	1.9	2.2	2.0	2.1	2.9	2.0	0.0	1.1	0.3	2.0	0.0	4.6	0.0	1.2	0.6	8.3	4.6	0.6	2.8	0.6	1.8	2.1	92.9	5.4	0.0	0.0	3.6	92.3	8.6	21.5	2.0	2.4	0.0	0.3	3.3	18.1	17.7	0.0	18.1	0.0	2.0	3.9	7.6	13.2	0.0	0.9	0.5	0.0	3.1	0.0	184.9	22.1	7.2	0.0	0.0	4.0	7.1	3.1	6.6	0.5	2.7	0.3	13.2	2.6	4.9	0.0	0.9	0.0	0.5	13.1	2.0	4.6	1.5	1.2	2.0	0.0	68.4	4.2	1.1	0.2	4.1
SCD5	"ACOD4, FADS4, FLJ21032, HSCD5, SCD4"	ENSG00000145284	"Stearoyl-CoA desaturase 5"	Q86SK9	4	82629539-82798796	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 156.7;brain: 353.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 248.4;Oligodendrocyte precursor cells: 892.7;Oligodendrocytes: 513.6"	"Group enriched"	"Detected in all"	6	"glioma: 152.4;thyroid cancer: 38.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 69.2;RPTEC TERT1: 90.1"					"Low region specificity"	"Detected in all"			HPA042380	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA042380: AB_10794797"	"unprognostic (3.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.86e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.82e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (2.32e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.92e-2)"	6.8	156.7	226.1	3.7	283.7	2.9	5.7	302.5	260.4	10.6	85.2	12.9	4.5	12.5	97.6	5.8	18.7	9.3	8.1	212.6	277.4	33.1	2.5	15.0	3.0	353.6	272.7	93.7	40.9	18.7	31.4	7.5	291.0	12.7	4.0	70.2	18.0	24.3	1.3	8.2	6.0	12.0	314.1	4.5	10.6	33.3	255.6	10.6	35.5	4.2	4.4	7.7	8.7	316.2	11.2	7.1	36.0	18.6	19.7	12.5	0.6	69.2	33.9	29.7	22.8	0.5	1.7	22.5	23.5	14.5	8.0	19.9	10.6	7.6	37.0	4.4	4.7	1.0	8.1	0.7	2.9	10.0	6.9	10.0	30.6	5.9	5.2	30.5	48.4	25.8	1.3	2.2	15.6	4.4	42.6	2.1	2.6	0.2	5.0	35.6	21.5	17.9	90.1	11.2	20.1	11.5	11.4	0.5	6.8	3.5	1.3	5.0	59.5	31.5	18.1	11.9	18.9	6.0	2.5	2.2	15.3	10.5	9.0	1.9	0.6	0.1	3.9	0.2	2.5	0.2	0.8	2.3	0.3	0.4	0.7	2.6	0.7	1.1	0.4	0.7	0.2	1.2	226.1	283.7	302.5	260.4	212.6	277.4	353.6	272.7	291.0	314.1	255.6	316.2	1.4	44.8	3.9	248.4	0.8	10.7	16.5	16.3	5.7	101.4	6.8	4.8	2.9	27.1	25.7	27.6	25.0	1.9	3.9	0.4	13.7	79.7	115.0	13.5	9.3	7.7	7.7	0.0	84.3	46.9	0.2	16.8	2.6	14.8	0.0	10.5	10.4	0.2	1.1	101.0	107.0	0.3	10.2	1.3	3.3	100.3	55.0	1.8	3.6	23.4	1.9	145.3	4.1	892.7	513.6	8.9	0.0	58.3	0.7	11.3	0.2	20.4	13.0	14.6	6.6	3.6	11.5	2.9	3.7	2.7	7.2	0.1	3.2	137.4	2.0	9.3
SCN7A	"NaG, Nav2.1, Nav2.2, SCN6A"	ENSG00000136546	"Sodium voltage-gated channel alpha subunit 7"	Q01118	2	166403573-166611482	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 45.4"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 102.0;Leydig cells: 100.9;Peritubular cells: 159.9;Sertoli cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 7.9;HMC-1: 4.5;Karpas-707: 5.8;SK-BR-3: 15.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 7.6"	HPA072715	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA072715: "	"unprognostic (1.22e-1)"	"unprognostic (6.42e-3)"	"unprognostic (9.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.84e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-4)"	4.6	8.6	3.4	3.4	3.0	0.3	10.2	0.1	1.8	7.8	0.0	35.8	3.4	9.0	6.3	10.1	10.9	3.8	20.6	1.1	7.1	1.8	1.2	27.6	0.5	4.0	7.1	45.4	4.9	0.7	1.0	12.3	5.4	11.0	8.5	10.6	6.1	10.1	7.2	2.4	6.8	7.6	2.9	3.2	7.8	5.6	9.8	3.2	1.2	15.0	0.4	4.7	7.1	1.2	0.1	0.1	0.7	0.9	0.2	0.0	0.8	0.7	0.0	1.3	0.0	0.6	0.2	0.4	0.1	0.0	0.3	0.3	0.1	0.1	0.0	7.9	0.5	0.2	1.5	0.6	0.0	0.2	4.5	0.0	0.0	0.4	0.1	0.4	0.0	0.4	1.2	5.8	0.0	1.0	0.8	0.5	1.1	0.3	0.3	0.0	0.5	0.0	0.1	0.8	0.2	0.4	0.3	15.4	0.0	0.3	0.4	0.1	0.4	0.2	1.0	0.7	0.4	1.0	0.3	1.1	0.2	0.2	0.4	1.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.8	3.4	3.0	0.1	1.8	1.1	7.1	4.0	7.1	5.4	2.9	9.8	1.2	1.4	0.0	1.1	1.0	0.0	0.3	0.2	0.0	5.7	21.5	0.2	0.3	16.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.9	0.0	2.4	0.0	0.3	4.1	0.0	0.0	7.7	0.0	0.0	102.0	0.0	0.0	15.9	0.1	9.3	0.0	0.2	0.0	20.9	0.0	0.0	0.0	1.2	4.1	100.9	1.8	5.4	14.0	0.0	4.9	0.0	14.1	0.3	0.1	0.0	159.9	1.2	0.5	0.0	0.5	0.0	1.8	151.2	16.7	26.1	0.5	1.2	1.7	1.1	0.0	0.2	0.3	0.0	0.3
SERPING1	"C1-INH, C1IN, C1INH, C1NH, HAE1, HAE2"	ENSG00000149131	"Serpin family G member 1"	P05155	11	57597387-57619171	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Complement pathway, Fibrinolysis, Hemostasis, Immunity, Innate immunity"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 2622.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 726.4;Ductal cells: 604.0;Fibroblasts: 793.6;Hepatocytes: 2530.0;Leydig cells: 735.3"	"Cancer enhanced"	"Detected in all"		"liver cancer: 609.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 65.2;plasmacytoid DC: 60.6"	"Group enriched"	"Detected in many"	243	"dendritic cells: 60.6;granulocytes: 65.2;monocytes: 25.7"	"Group enriched"	"Detected in many"	6	"ASC diff: 1372.2;ASC TERT1: 694.9;HSkMC: 1159.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 194.1"	"CAB026161, HPA048738"	Supported				"Secreted to blood"	NA	NA		28000000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"			"CAB026161: , HPA048738: AB_2680505"	"unprognostic (1.35e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (9.96e-4)"	"unprognostic (4.26e-2)"	"unprognostic (4.38e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.12e-3)"	"unprognostic (2.13e-1)"	"unprognostic (8.95e-2)"	"prognostic favorable (8.03e-4)"	"unprognostic (5.92e-3)"	"unprognostic (3.76e-2)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (2.60e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.17e-1)"	971.5	144.2	27.4	90.0	27.5	10.9	733.0	27.1	36.0	629.4	53.4	358.7	52.0	616.7	163.3	162.0	793.2	533.0	547.1	26.2	34.8	337.3	2622.4	785.0	147.6	67.4	34.7	918.3	267.5	55.2	138.2	198.9	34.2	329.3	97.0	34.5	250.5	258.1	151.8	293.5	283.5	226.8	42.3	240.7	344.8	50.6	37.2	36.1	338.2	173.4	64.4	555.9	519.8	35.1	0.0	0.0	48.2	0.0	1372.2	694.9	7.3	74.2	57.0	16.8	30.7	2.5	0.0	0.0	96.7	42.1	0.0	0.0	0.4	4.7	9.4	0.0	0.1	33.7	0.0	1.7	170.3	0.9	5.4	1159.0	15.5	5.7	0.2	6.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	1.3	46.6	0.0	0.0	4.3	4.0	0.7	7.4	0.0	0.2	14.4	0.3	0.0	0.9	41.8	0.2	3.3	0.0	0.8	21.2	0.7	0.0	0.2	0.4	0.6	0.2	0.5	0.0	0.0	18.3	0.3	0.0	25.7	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	65.2	0.2	11.5	60.6	0.0	5.7	27.4	27.5	27.1	36.0	26.2	34.8	67.4	34.7	34.2	42.3	37.2	35.1	162.1	118.6	110.8	5.5	8.0	75.8	61.2	7.1	24.5	0.8	24.2	57.7	28.7	726.4	57.5	158.2	0.0	37.1	15.3	0.0	43.0	604.0	4.8	76.0	297.4	150.5	0.0	69.2	3.6	44.0	93.4	793.6	8.6	69.6	7.6	8.3	260.5	2530.0	43.6	0.0	6.2	0.1	2.0	118.9	94.2	25.6	735.3	46.9	90.7	15.9	10.4	57.2	0.0	3.5	0.5	41.4	0.0	228.7	4.5	32.4	0.0	53.5	23.1	4.5	269.5	143.6	259.6	2.5	10.4	9.0	59.5	25.2	16.8	3.4	0.0	37.4
SETBP1	"KIAA0437, SEB"	ENSG00000152217	"SET binding protein 1"	Q9Y6X0	18	44680173-45068510	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Excitatory neurons: 349.0;Inhibitory neurons: 548.3;Oligodendrocyte precursor cells: 170.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 11.6"	"Immune cell enhanced"	"Detected in some"		"naive B-cell: 3.0;plasmacytoid DC: 2.8"	"Group enriched"	"Detected in many"	5	"B-cells: 3.0;dendritic cells: 2.8;monocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"AF22: 16.1;Karpas-707: 44.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049022, HPA057259"	Uncertain		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		66000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA049022: AB_2680602, HPA057259: AB_2683384"	"unprognostic (1.25e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.97e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.71e-3)"	"unprognostic (6.52e-2)"	"prognostic favorable (6.34e-8)"	"unprognostic (2.18e-2)"	"unprognostic (2.29e-1)"	"unprognostic (6.06e-2)"	"unprognostic (7.81e-5)"	7.3	1.9	2.0	3.7	3.7	1.8	6.3	11.6	5.7	11.6	0.0	10.9	1.7	8.3	7.2	4.5	7.2	5.0	4.3	2.6	0.2	7.4	4.7	6.6	5.3	0.0	0.1	7.7	5.8	3.7	2.7	7.2	0.1	7.8	3.5	3.0	4.3	9.2	10.7	4.4	4.6	7.4	0.0	3.7	5.6	1.8	0.0	4.4	5.1	9.7	4.7	8.1	8.5	3.8	0.0	2.4	16.1	0.0	4.1	1.2	1.0	1.3	3.0	1.5	1.3	0.2	0.0	1.0	0.5	1.8	1.0	4.8	1.8	4.9	1.0	1.4	0.8	0.0	1.8	1.2	0.0	0.0	0.0	3.8	2.0	0.0	3.0	2.7	0.5	0.0	0.1	44.7	0.4	0.8	0.0	0.1	2.0	0.0	1.1	5.6	0.0	5.5	4.9	3.9	8.2	4.2	0.0	0.0	0.9	7.1	2.2	0.0	0.0	9.5	3.3	0.0	7.7	8.6	0.5	0.0	5.8	0.2	5.5	0.1	0.0	0.0	0.4	0.6	0.0	2.0	0.0	0.2	0.0	3.0	0.0	0.1	0.0	0.0	1.0	2.8	0.0	0.1	2.0	3.7	11.6	5.7	2.6	0.2	0.0	0.1	0.1	0.0	0.0	3.8	7.6	0.0	1.8	85.5	42.4	15.4	8.6	8.3	7.4	12.5	11.0	12.6	3.9	14.3	4.2	16.5	18.8	1.5	25.5	1.6	3.9	4.5	1.3	12.9	15.6	8.3	12.0	0.8	349.0	3.5	1.4	29.3	4.1	14.8	0.0	0.7	17.9	16.5	2.0	3.3	548.3	4.4	10.2	2.4	8.7	3.7	62.7	4.6	3.6	88.1	1.5	10.7	6.2	170.4	62.9	3.7	9.1	39.9	29.6	8.1	0.4	10.5	5.8	18.2	6.6	18.4	28.6	0.3	0.8	4.0	15.2	0.8	5.9	0.1	4.7	1.5
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362851-110391082	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 124.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 71.7;Proximal tubular cells: 192.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 20.4;BJ hTERT+: 20.7;CAPAN-2: 30.8;HHSteC: 19.2;hTERT-RPE1: 42.6;SK-MEL-30: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: AB_2679892, HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	4.9	2.9	2.7	4.6	3.1	1.0	6.9	5.8	4.4	4.2	15.4	3.6	9.5	3.0	22.4	2.7	4.0	13.7	4.6	3.5	4.1	124.1	16.3	9.2	3.4	4.1	3.1	21.4	0.9	0.4	3.8	28.6	3.9	3.8	1.6	2.3	3.6	5.8	1.3	1.3	11.4	3.4	4.1	2.7	2.7	5.2	3.0	0.6	8.5	3.9	1.1	7.9	3.5	4.2	0.4	9.8	2.3	2.7	6.3	12.9	20.4	5.3	20.7	1.8	5.3	3.1	30.8	0.6	5.7	17.1	0.1	0.5	0.1	1.9	1.9	0.5	2.5	0.5	2.7	3.3	19.2	0.9	0.5	10.0	0.3	3.0	0.2	42.6	4.1	0.8	0.5	1.2	3.3	1.0	0.4	0.6	0.9	0.0	0.3	0.2	1.3	0.1	3.7	0.4	1.2	0.9	0.6	9.8	30.6	9.0	0.7	0.1	0.4	1.4	0.7	0.3	1.5	0.5	0.1	1.6	1.1	0.4	6.1	0.0	0.2	0.1	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1	2.7	3.1	5.8	4.4	3.5	4.1	4.1	3.1	3.9	4.1	3.0	4.2	1.9	12.8	20.8	2.3	5.8	3.1	6.1	11.2	1.2	11.5	14.7	6.5	1.1	11.5	6.8	71.7	6.2	39.5	5.8	0.9	3.9	2.7	0.5	3.3	6.8	4.6	3.5	2.7	8.2	0.9	34.6	18.2	1.5	3.3	5.1	5.2	4.2	5.0	4.2	3.3	7.1	0.9	4.1	1.6	3.0	2.2	18.0	1.8	10.6	15.0	1.8	2.4	9.2	2.5	4.7	1.9	1.2	11.7	1.2	3.1	38.4	192.3	3.5	20.1	0.0	4.5	5.4	3.4	1.9	0.5	3.7	35.2	3.9	7.0	1.4	7.2
SLC66A3	"C2orf22, MGC33602, PQLC3"	ENSG00000162976	"Solute carrier family 66 member 3"	Q8N755	2	11155198-11178870	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 15.5;Cytotrophoblasts: 17.5;Extravillous trophoblasts: 82.4;Fibroblasts: 16.1;Hofbauer cells: 56.3"	"Cancer enhanced"	"Detected in all"		"testis cancer: 72.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 64.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061607			Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA061607: AB_2797264"	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.55e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.11e-2)"	"unprognostic (3.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.93e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.00e-2)"	30.6	26.3	9.7	17.3	9.8	9.9	29.2	10.2	14.0	38.4	17.0	17.6	10.8	23.8	47.3	14.3	19.8	27.8	15.1	9.6	10.2	25.8	17.5	27.0	22.5	12.0	10.1	29.9	29.0	13.2	5.8	14.4	12.0	22.6	19.3	2.5	17.1	19.8	8.5	14.7	15.5	21.4	11.3	39.8	20.0	11.6	10.2	14.3	17.3	17.1	16.8	22.5	17.2	14.2	7.1	23.3	4.3	13.4	64.6	43.9	15.5	14.8	19.3	6.8	8.0	4.3	27.3	2.5	10.5	28.5	29.3	9.1	6.9	7.3	6.8	43.8	3.2	6.5	2.7	3.0	26.1	3.3	19.5	31.7	24.5	4.3	9.7	14.5	15.5	15.3	6.2	14.8	18.8	31.6	4.8	6.6	9.1	25.2	7.6	6.2	7.2	7.7	25.8	11.6	1.6	7.2	12.4	37.9	27.9	19.1	33.9	12.2	22.0	9.6	3.8	10.2	4.1	25.2	19.6	1.2	24.9	15.5	19.4	79.4	153.7	150.3	68.8	194.9	60.7	42.4	65.6	66.7	153.6	31.9	35.9	49.5	9.5	59.9	207.4	28.7	73.2	166.2	9.7	9.8	10.2	14.0	9.6	10.2	12.0	10.1	12.0	11.3	10.2	14.2	15.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	17.5	11.9	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	82.4	16.1	0.0	0.0	0.0	0.0	0.0	0.0	56.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	11.2	2.2	0.0	0.0	0.0
SOD3	EC-SOD	ENSG00000109610	"Superoxide dismutase 3"	P08294	4	24789912-24800842	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		"Antioxidant, Heparin-binding, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 436.1"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 498.5;Leydig cells: 424.1;Peritubular cells: 365.6;Smooth muscle cells: 428.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 66.2;BJ: 38.1;PC-3: 55.1;RPTEC TERT1: 231.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042110	Supported				"Secreted to blood"	NA	NA	50400000	510000000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA042110: AB_2677850"	"unprognostic (7.67e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.80e-2)"	"unprognostic (3.32e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.73e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.80e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.45e-2)"	221.4	20.4	14.3	26.1	20.9	0.0	134.2	15.8	23.8	226.5	436.1	122.7	18.2	151.6	10.4	62.1	177.6	22.4	150.1	47.1	14.1	124.1	16.5	155.0	10.6	22.9	23.4	59.7	86.7	2.6	19.8	39.8	17.5	131.3	13.4	1.9	70.9	23.4	22.0	91.9	65.2	37.1	16.4	24.8	102.1	74.1	19.0	5.8	176.6	22.9	7.0	178.3	170.4	13.6	0.0	0.0	0.0	0.0	66.2	17.3	2.0	38.1	16.7	2.3	1.4	0.5	0.0	0.0	11.8	8.0	0.1	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	16.8	0.0	15.8	0.0	17.9	0.1	0.0	1.1	0.0	0.0	0.1	0.3	1.1	8.0	0.0	55.1	0.0	0.0	0.6	231.3	0.8	0.2	0.2	0.0	1.2	0.0	2.1	32.8	0.0	0.0	8.7	1.0	1.6	0.4	0.1	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	20.9	15.8	23.8	47.1	14.1	22.9	23.4	17.5	16.4	19.0	13.6	46.1	12.8	18.1	7.2	1.0	90.8	65.5	0.6	10.2	0.4	21.7	22.1	23.0	144.4	7.6	90.1	0.0	211.4	1.8	25.6	15.6	63.6	18.7	81.9	45.8	21.0	34.6	0.0	0.1	1.8	17.0	498.5	5.1	80.3	0.0	0.1	15.4	0.2	17.3	0.0	0.1	51.9	0.0	0.3	115.5	33.9	424.1	3.2	80.0	3.7	0.0	20.7	0.0	0.5	0.7	3.5	89.3	365.6	1.1	80.4	0.0	142.7	0.1	1.4	197.2	6.5	428.9	73.2	4.4	6.1	70.3	190.0	7.6	6.1	51.8	9.6
SPSB4	SSB-4	ENSG00000175093	"SplA/ryanodine receptor domain and SOCS box containing 4"	Q96A44	3	141051347-141148611	"Predicted intracellular proteins"	"Biological rhythms, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"choroid plexus: 2.9;pancreas: 7.0;pituitary gland: 3.0;testis: 2.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 23.6;Late spermatids: 11.7;Oligodendrocyte precursor cells: 41.7;Spermatocytes: 22.1"	"Group enriched"	"Detected in some"	5	"glioma: 4.6;testis cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.5;NTERA-2: 3.5;RH-30: 4.2;SH-SY5Y: 3.6;U-2 OS: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062793			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"		"HPA062793: AB_2732689"	"unprognostic (5.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-3)"	"prognostic favorable (3.72e-4)"	"unprognostic (7.49e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.48e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.46e-4)"	"unprognostic (9.80e-3)"	0.3	0.3	0.5	0.0	0.9	0.0	0.1	0.8	1.2	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.3	2.0	0.3	0.0	0.4	0.0	2.8	2.1	0.0	7.0	0.2	3.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.0	1.5	1.1	0.0	2.9	1.1	0.2	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	12.5	0.2	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.9	0.0	3.5	0.0	0.0	0.0	4.2	0.6	0.0	0.0	1.1	3.6	0.0	0.0	0.0	2.0	0.2	0.3	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.8	1.2	0.3	2.0	2.8	2.1	1.6	1.5	1.1	0.9	0.4	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.9	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.6	0.0	0.1	0.1	0.0	0.0	2.8	0.5	0.0	3.2	0.0	0.0	0.0	0.4	0.4	0.1	0.2	0.0	5.6	0.0	0.0	5.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.3	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.4	22.1	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
TMEM45A	"DERP7, FLJ10134"	ENSG00000181458	"Transmembrane protein 45A"	Q9NWC5	3	100492619-100577444	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"skin 1: 475.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 425.3;Club cells: 841.5;Early spermatids: 207.3;Suprabasal keratinocytes: 254.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 406.9;ASC TERT1: 118.3;HSkMC: 125.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA062101	Uncertain		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 61: Skin - Cornification"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"	Vesicles	"HPA062101: AB_2684682"	"unprognostic (5.92e-3)"	"unprognostic (5.44e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.43e-3)"	"unprognostic (7.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (6.18e-11)"	"unprognostic (1.24e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.02e-5)"	"unprognostic (2.68e-2)"	19.4	18.1	1.4	11.7	3.3	2.0	42.8	1.7	2.5	38.4	2.3	10.3	3.6	18.3	3.2	16.5	20.9	18.9	21.9	1.5	1.8	3.7	99.0	13.1	2.6	1.9	1.9	11.9	23.3	2.7	22.9	40.9	1.8	9.1	6.6	1.7	26.9	6.3	3.2	475.1	6.4	25.4	1.7	5.0	7.0	13.3	1.9	1.6	9.1	2.5	50.7	19.5	79.5	2.1	28.6	2.0	2.7	9.6	406.9	118.3	0.3	66.9	62.0	9.4	84.8	2.5	0.6	0.0	32.6	44.1	24.6	31.9	2.4	13.0	23.4	7.2	8.4	23.9	9.3	8.0	25.7	0.4	1.5	125.4	7.4	17.1	25.4	39.0	3.5	0.0	0.6	3.2	22.6	0.3	0.1	0.7	3.2	0.0	16.8	0.0	23.3	0.4	0.6	1.0	2.9	19.4	16.4	8.5	7.3	18.2	0.8	13.6	9.3	62.9	44.3	0.5	15.2	53.8	32.9	0.1	49.7	1.9	42.6	0.0	0.9	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.6	1.4	3.3	1.7	2.5	1.5	1.8	1.9	1.9	1.8	1.7	1.9	2.1	1.6	60.9	61.4	0.7	3.0	94.6	5.4	425.3	9.6	3.2	19.1	8.9	2.5	1.5	841.5	0.0	0.0	2.6	0.4	0.2	0.0	7.5	207.3	3.0	79.1	8.9	1.2	1.3	0.8	14.9	46.3	56.3	2.0	2.0	65.0	10.7	15.0	137.1	5.8	8.4	2.4	2.0	63.1	6.5	25.4	25.4	16.1	6.6	23.2	13.1	1.1	3.5	0.0	16.1	11.8	6.5	2.6	27.8	26.8	3.1	0.3	0.2	121.0	0.9	6.6	22.8	56.6	1.5	3.3	5.4	254.9	7.5	6.4	26.7	0.1	4.4
VAMP5		ENSG00000168899	"Vesicle associated membrane protein 5"	O95183	2	85584431-85593406	"Predicted membrane proteins"	"Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 487.9;Endothelial cells: 337.8;Hepatic stellate cells: 486.2;Kupffer cells: 340.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 364.7;LHCN-M2: 428.9;TIME: 250.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035082	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		130000	"Cluster 7: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"HPA035082: AB_10610564"	"unprognostic (1.92e-1)"	"unprognostic (3.09e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.13e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.28e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (9.61e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.60e-1)"	134.0	117.4	71.0	59.9	74.1	41.2	118.4	72.9	89.1	78.6	66.8	76.4	23.3	79.4	33.2	45.3	84.3	58.0	114.7	69.4	76.1	90.0	79.3	134.6	92.7	79.1	71.4	52.8	29.0	14.7	31.9	74.1	74.2	72.8	20.5	2.9	36.9	36.7	217.3	44.5	54.1	77.2	73.8	97.5	54.0	11.4	78.0	50.9	63.8	199.6	41.2	87.1	69.7	71.7	0.8	0.2	2.4	0.0	89.3	155.8	2.4	98.5	155.9	95.5	104.5	39.5	15.1	0.3	2.3	172.2	50.7	1.1	0.0	2.4	42.2	142.9	2.8	1.9	2.5	56.1	187.2	4.5	0.9	108.4	9.6	40.1	1.1	138.9	364.7	61.7	0.4	0.3	428.9	14.5	63.1	13.8	0.1	27.2	0.6	92.4	0.4	2.7	2.7	3.6	0.2	3.4	0.6	27.4	0.5	2.2	3.2	5.1	250.0	2.3	6.7	7.5	0.2	0.1	3.1	2.4	110.5	5.4	65.9	59.1	222.6	176.5	180.5	503.8	171.7	60.7	136.1	135.2	79.0	54.5	102.4	125.1	70.2	94.4	424.9	86.4	248.7	283.0	71.0	74.1	72.9	89.1	69.4	76.1	79.1	71.4	74.2	73.8	78.0	71.7	487.9	19.2	21.2	3.6	43.9	60.8	39.8	104.1	39.3	0.8	14.9	27.3	84.4	71.4	70.1	44.1	0.0	22.9	64.5	38.8	29.4	29.9	1.8	7.7	64.7	337.8	12.6	35.6	0.1	49.1	7.2	148.0	9.7	7.9	44.4	22.2	486.2	198.6	80.3	3.3	0.2	20.5	36.7	340.8	91.5	10.2	192.6	147.8	275.7	4.7	136.0	17.5	112.3	0.5	1.6	44.2	51.9	165.1	68.4	64.7	126.5	91.2	50.6	1.0	59.2	152.2	83.9	5.5	6.6	19.8	45.3	21.6	88.5	19.2	7.8	49.4
VIT		ENSG00000205221	Vitrin	Q6UXI7	2	36696690-36814792	"Predicted intracellular proteins, Predicted secreted proteins"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 35.4;tongue: 41.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 68.3;Fibroblasts: 58.8;Granulosa cells: 45.1;Leydig cells: 115.2;Skeletal myocytes: 45.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.3;naive CD8 T-cell: 1.3"	"Lineage enriched"	"Detected in single"	10	"T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 33.6;ASC TERT1: 65.2;BJ: 32.9;fHDF/TERT166: 112.3;SuSa: 62.2;THP-1: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		140000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (5.34e-4)"	"unprognostic (4.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.78e-3)"	"unprognostic (8.32e-2)"		"unprognostic (1.81e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.66e-6)"	"unprognostic (2.09e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.41e-2)"	35.4	0.9	0.2	0.5	0.5	0.9	15.4	0.8	0.9	6.0	0.4	3.9	0.4	1.0	0.6	8.7	7.9	2.3	18.6	0.3	0.1	0.2	0.0	1.2	2.3	0.1	0.1	28.7	1.0	0.6	3.1	2.2	0.1	7.0	1.5	0.0	11.6	2.3	12.5	12.7	2.7	0.2	0.0	0.1	4.7	3.0	0.3	1.0	8.9	41.1	2.2	15.0	14.6	0.2	0.0	0.0	0.0	0.0	33.6	65.2	0.0	32.9	7.7	10.4	4.3	0.0	0.0	0.0	0.0	112.3	0.1	0.2	6.2	0.0	6.9	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	3.3	1.6	0.0	0.0	0.0	2.5	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.7	0.0	62.2	0.0	35.6	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	2.5	2.5	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.5	0.8	0.9	0.3	0.1	0.1	0.1	0.1	0.0	0.3	0.2	4.1	0.0	0.0	0.7	0.0	4.2	0.9	0.0	68.3	0.0	0.2	10.0	3.2	0.0	0.0	0.0	0.0	10.6	0.9	0.3	0.0	0.0	1.2	0.4	0.4	1.1	0.0	0.0	1.8	0.0	11.0	58.8	0.0	0.0	0.0	45.1	0.4	0.0	1.1	0.0	0.7	0.4	0.0	0.0	3.5	2.7	115.2	0.5	7.2	20.6	0.0	0.0	4.1	0.5	0.3	0.0	0.1	23.3	0.8	0.1	0.0	0.0	0.0	0.0	6.6	45.2	6.1	1.1	0.6	1.6	3.4	4.2	1.1	0.1	0.3	0.2
ZNF423	"Ebfaz, hOAZ, JBTS19, KIAA0760, NPHP14, OAZ, Zfp104"	ENSG00000102935	"Zinc finger protein 423"	Q2M1K9	16	49487524-49857919	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Ciliopathy, Disease variant, Joubert syndrome, Nephronophthisis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.4;skeletal muscle: 27.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 75.4;Late spermatids: 115.7;Microglial cells: 53.4;Oligodendrocyte precursor cells: 38.7;Peritubular cells: 54.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 62.6;NTERA-2: 33.2;REH: 27.5;SCLC-21H: 35.1;SH-SY5Y: 87.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015258, HPA065820"			Enhanced	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA015258: , HPA065820: AB_2685563"	"unprognostic (2.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.86e-1)"	"unprognostic (8.65e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.13e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.64e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (5.84e-2)"	9.1	2.9	13.5	2.3	9.6	0.3	6.7	14.0	10.2	6.3	1.0	4.3	1.3	5.4	3.4	4.7	9.3	5.8	7.8	9.7	11.0	2.0	0.7	2.9	1.9	14.9	30.4	7.6	3.4	3.0	4.0	4.2	11.8	6.0	2.7	3.6	2.8	9.5	27.5	2.0	2.6	6.5	8.6	1.4	2.0	4.5	26.3	1.8	4.3	14.7	1.2	3.9	5.4	7.8	0.0	0.0	62.6	3.3	5.1	0.6	7.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	1.4	0.0	0.0	1.9	0.5	0.0	3.6	0.1	0.2	0.0	0.0	4.4	0.3	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	8.8	0.4	33.2	0.0	0.0	27.5	0.1	0.0	0.0	1.7	35.1	87.7	0.0	0.1	0.0	17.6	0.0	0.0	0.0	0.0	1.0	16.4	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	13.5	9.6	14.0	10.2	9.7	11.0	14.9	30.4	11.8	8.6	26.3	7.8	12.7	0.0	0.0	75.4	0.0	2.7	0.3	0.1	1.2	9.8	0.6	0.6	2.6	0.0	0.0	0.0	0.0	0.5	0.1	2.3	1.9	0.2	23.5	2.7	7.6	11.4	0.0	0.0	10.9	0.2	0.7	15.8	0.0	0.6	0.0	1.6	15.4	0.9	0.7	0.0	7.4	1.0	0.0	0.3	5.1	115.7	27.7	0.4	1.8	53.4	0.0	11.7	0.0	38.7	5.1	0.2	0.4	54.5	0.2	0.1	0.2	0.6	0.0	1.1	0.0	4.5	6.4	0.8	1.9	0.1	1.7	0.3	0.3	5.5	0.7	0.1